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Abstract 
Mouse models lack affordable genomic technologies slowing the identification of 
candidate variants contributing to complex phenotypes. The Mouse Diversity Genotyping 
Array (MDGA) is a low cost, high-resolution platform permitting genomic diversity 
assessment. Using a validated list of >500,000 single nucleotide polymorphisms (SNPs), we 
applied the first comprehensive analysis of SNP differences to detect genetic distance across 
362 Mus musculus samples. Genetic distance measured between distantly and closely related 
mice correlates with known phylogeny and genealogy. Variation detected between C57BL/6J 
mice is consistent with previous reports of variants within this strain. Putative genetic 
variation detected between and within tissues indicates somatic mosaicism. Genotype 
differences detected within a mouse are a complex mixture of technical errors and biological 
differences. Detailed reconstruction experiments are therefore required to determine array 
sensitivity at detecting true biological variants. The MDGA shows promise for analyzing 
mutation accumulation with development, aging, environmental mutagenesis and diseases 
such as cancers.  
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Chapter 1 : Introduction 
1.1 General Introduction 
The phenotypic variation observed between individuals results from the interaction 
between genetics and environment. Variation at the genetic level causes different phenotypic 
outcomes and is one of the primary causes for variation between individuals within a 
population. The sum total of the genetic variation between individuals arises from inherited 
and acquired mutations, and the study of the origins and mechanisms of this variation is 
relevant to understanding development and aging. We know that mutation accumulation 
begins early in development; however, the extent to which tissues and organisms vary in 
mutation accumulation remains unknown from a genomic perspective. By expanding 
mutation research to understand how and where mutations accumulate across the genome in 
a tissue-specific manner, researchers may be able to identify mutation signatures or patterns 
with specific phenotypic variations.  
1.2 Genetic Variation  
 Genetic variation refers to differences in the DNA nucleotide sequence that occur 
between individuals of a population. Genetic variation encompasses a broad spectrum of 
genetic differences, ranging from modifications affecting single base pairs to those affecting 
megabases (Mbs – 1,000,000 bps) of DNA. The most common variants in the genome are 
single nucleotide polymorphisms (SNPs).
1
 SNPs are single base pair substitutions that occur 
within one percent or more of the individuals within a population. However, the discovery of 
copy number variants (CNVs) has identified a new form of genetic variation that is 
prominent in both healthy and diseased phenotypes.
2,3
 Copy number variants are large 
  2 
segmental duplications or deletions of genomic regions, typically 1 kb or greater, that alter 
the usual ploidy of the genome.  
1.3 The origin of genetic variation: mutations and how they occur 
 Genetic variation results from mutations occurring during the lifespan of an 
individual. These mutations arise as a result of DNA damage that is not repaired upon 
replication.
1
 DNA damage can occur from both endogenous and exogenous factors, and can 
affect both the germline and the soma. When DNA is exposed to mutagenic factors, the 
structure of the DNA is altered. During DNA replication, this altered structure can result in 
the changing of a single nucleotide pair, or facilitate mechanisms that induce large 
modifications. Such mechanisms known to facilitate genomic modifications include single 
strand breaks, double strand breaks, strand slippage, and fork stalling and template switching 
result in the addition or deletion of nucleotides from the DNA sequence.
4
 The additions and 
deletions introduced by these mechanisms can modify single base pairs to many Mbs of 
DNA.  
1.4 The nature of genetic variation 
 Genetic variation can contribute to the distinct differences observed between 
individuals and within populations. Humans from different ancestries often have distinct 
characteristics associated with distinct ancestries. These characteristics are the result of 
mutations becoming fixed within a population. For example, the redheaded phenotype 
prominent in those of Celtic ancestry resulted from a mutation in the melanocortin 1 receptor 
(MCR1) gene.
5
 Such mutations are inherited and are often associated with other distinct 
characteristics of that population such as the association between red hair and fair skin. When 
  3 
specific allelic combinations associated with these characteristics are often inherited together, 
they are known as haplotypes.  
 However, differences contributing to genetic variation may result from the 
accumulation of mutations in somatic tissues.
6
 Mutations occurring in somatic tissues are not 
inherited, but when frequent in the population they are referred to as recurrent mutations.
7,8
 
Recurrent mutations occur at mutational hotspots where the nucleotide sequence or DNA 
conformation is more susceptible to DNA damage in comparison to other locations in the 
genome. Variants resulting from recurrent mutations are often not associated with ancestral 
haplotypes. Recurrent mutations are often linked with specific phenotypes associated with 
health and disease, such as those mutations associated with cancers.  
1.5 Inheritance of genetic variation 
The inheritance of genetic variation was first described by Gregor Mendel in the mid 19
th
 
century. By selecting for different phenotypic traits, namely colour and shape of peas, 
Mendel identified that these traits, each of which were determined by a single gene, were 
passed between parent and offspring in a manner that could be predicted.
9
 Mendel predicted 
for each of the selected traits, whether peas would be yellow or green in colour, and round or 
wrinkled in shape, based on the phenotypes of the parental plants. The predictivity of single 
gene inheritance of binary traits was later coined as Mendelian Genetics. However, not all 
traits follow the principles of Mendelian genetics. 
1.6 Complex Phenotypes 
Rather than a single gene directly impacting a phenotype, complex traits arise as a result 
of many genes contributing small effects, and the interactions between these genes and their 
environment.
1
 Like Mendelian genetics, specific allelic combinations/interactions impact the 
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phenotypic outcome of complex phenotypes. However, because there is no clear cause and 
effect relationship with complex phenotypes, it is difficult to make an association between a 
genetic variant and a specific phenotypic outcome. When you have multiple genes interacting 
to contribute to an overall phenotype, it becomes difficult to dissect out which genetic 
variants contribute to each specific characteristic of that phenotype. The addition of 
environmental variation adds an additional level of complexity to understanding complex 
phenotypes. The environment to which an individual is exposed can impact how substantial 
the effects of the genetic variants are on the observed phenotype. Therefore, when studying 
complex traits it is important to minimize the amount of genetic and environmental variation 
between individuals in order to understand how the interactions between genes and 
environment affect specific complex traits.  
1.7 Genetic variation in human populations 
1.7.1 The genetics of complex phenotypes 
 Studying complex phenotypes in humans has traditionally been accomplished by 
analyzing diseases. By looking at diseases in populations where many individuals are 
affected and disease inheritance can be traced, associations between genetic variants and the 
disease can be identified. Identification of genotype-phenotype associations is easiest in 
populations that contain minimal genetic and environmental variation. In humans, these 
populations are uncommon; however, popular case studies include Amish, Ashkenazi Jewish, 
and Acadian populations. Amish populations have a high prevalence of recessive disorders 
including those associated with dwarfism, anemia, and epilepsy.
10
 Similarly, in Azhkenazis 
Jewish populations, mutations causing diseases such as Gaucher’s, hemophilia, and Tay-
Sachs are common.
11–13
 Acadians also show prevalence for single gene disorders as a result 
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of the founder effect within these populations.
14,15
 The founder effect causes a decrease in 
genetic diversity ultimately increasing the prevalence of single gene disorders like Tay-
Sachs. The limited genetic variation within these populations enables the analysis of 
haplotypes with minimal genetic variation, making them ideal models to study complex 
diseases. Therefore, inbred populations are becoming case studies for complex phenotypes 
because the limited genetic variation simplifies the identification of genotype-phenotype 
interactions.
12,16
   
1.7.2 Single gene detection of genetic variation 
 The identification of genetic variation has traditionally focused on traits following the 
principles of Mendelian genetics. Genotype-phenotype associations were used to study 
medical phenomena by tracing phenotypes through family pedigrees.
17
 Some of the earliest 
association studies completed in humans were conducted to understand the clotting of blood 
during blood transfusions in the early 1900’s.18 This led to the identification of four blood 
groups. These four blood groups were later classified as the ABO blood types, and could be 
used for paternity testing.
19
 In 1940, Landsteiner and Wiener identified the genetic basis of 
the Rh groups which added a positive and negative factor to each of the four blood types, and 
explained the effects of mother-fetus incompatibility.
20
  
1.7.3 Genomic detection of genetic variation 
As research advanced, and studies progressed from single gene analysis towards 
technologies that can query across the genome, the ability to study complex traits became 
increasingly easier. The major improvement in studying complex traits came with the 
development of the Human Genome Project. The Human Genome Project, was a 13-year 
project focused on understanding the human genome and was completed in 2003 with the 
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first full sequence read.
21
 With a goal of identifying all genes as well as decoding the entire 
sequence of the human genome, the Human Genome Project became one of the biggest 
efforts to improve our understanding of human genetics. By 2002, the human genome project 
was nearing completion and the next step was to determine how genetic variation affected the 
genome. This led to the development of the HapMap project that focused on identifying 
variation and mapping haplotypes across human populations.
22
 
Mapping genetic variation across the human population required the participation of 
individuals from a broad range of ancestries. To understand how genetic variation affects the 
human population, researchers focused on identifying haplotypes within each ancestral 
group. By identifying combinations of genes predominant to these populations, researchers 
could associate specific allelic combinations to specific phenotypes. Researchers could also 
speculate as to the accumulation of genetic variants within human populations dependent on 
geographic location and common ancestries. Therefore, when studying complex phenotypes, 
it is important to understand the ancestral origin of genetic variants and how the 
accumulation of these variants affects the genome over time. 
1.7.4 Genomic technologies for studying complex traits 
The rapid discovery of genetic variants from the human genome project and HapMap 
project led to major advances in genomic technologies, namely high-resolution microarrays 
and next-generation sequencing.
1,23–25
 High-resolution microarray technologies from 
Affymetrix
®
 (Affymetrix
®
, Santa Clara, CA) and Illumina
®
 (Illumina
®
, San Diego, CA) 
became available during the late 1990’s. These included a variety of SNP genotyping arrays, 
tiling arrays, and array comparative genomic hybridization (aCGH) technologies. SNP 
genotyping arrays allow for the analysis of allelic variation at hundreds of thousands of 
locations across the genome. Using hybridization technologies, SNP genotyping arrays are 
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used to determine which allele an individual has at specific locations across the genome. 
Tiling arrays are used to intensively investigate whole segments of DNA rather than using 
SNPs that are distributed across the genome.
26
 Tiling arrays contain probe sequences that 
overlap with each other or are spaced closely together so that an entire stretch of DNA can be 
queried by the probes. aCGH is used for the identification of CNVs between samples.
27,28
 
Comparative genomic hybridization relies on the use of a test sample and a reference sample 
labeled with two different dyes to identify variation in copy number. aCGH uses an array to 
determine the relative difference in fluorescence intensities between a reference and 
experimental sample. The differences in fluorescence intensities between the reference and 
sample are then used to determine overall copy number in comparison to the reference.  
However, due to limitations in the amount of variation detectable with microarray 
technologies, researchers are turning to a more comprehensive analysis of the genome.
29
 
Next-generation sequencing technologies allow for the detailed analysis of the whole genome 
sequence. Next-generation sequencing provides the most complete picture of genetic 
variation between and within genomes, and is now the primary technology used in studies 
related to health and disease.
30–32
 As whole genome sequencing becomes the new frontier for 
medical research, rapid advancements in next-generation sequencing technologies have made 
whole genome sequencing to a single base pair resolution financially feasible for most 
laboratories.
25,32
 A variety of techniques have been developed, including synthesis by 
hybridization, nanopore sequencing, and sequencing by synthesis, that have allowed for rapid 
advancements in understanding the human genome.
33–35
 
1.7.5 The Human 6.0 array 
 The most recent and comprehensive microarray technology that is currently available 
for humans is the Affymetrix
®
 Genome-wide Human Array 6.0 (Human 6.0 array).
36
 The 
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Human 6.0 array was released in 2008 and can detect variation at more than 906,000 SNP 
sites across the human genome. The Human 6.0 array also screens over 946,000 locations 
across the genome to assay copy number status. The Human 6.0 array was designed using 
only perfect match probes to maximize the number of variable regions that could be detected 
across the genome. SNPs selected, for inclusion on the Human 6.0 array, were based on the 
performance of SNPs used on the Human 5.0 array and Affymetrix
® 
500K mapping array. 
Additional SNPs identified from the HapMap project were used to supplement the SNPs 
selected from previous Affymetrix
®
 microarrays in order to maximize the SNP coverage 
across the human genome. The Human 6.0 array is bi-allelic for each SNP, meaning that for 
every SNP location queried there is an A and a B allele represented by the SNP probe 
sequences. Copy number probes were also selected to obtain uniform coverage across the 
genome, which when combined with the SNP probes, are used to detect an increase or a 
decrease in copy number from the diploid state of the human genome. Copy number probes 
were not restricted by the location of SNPs across the genome. With the capability to both 
genotype a sample, as well as determine copy number, the Human 6.0 array has been 
implemented in a variety of different research studies focused on the identification of genetic 
variants within the human population.
37–39
 In particular, the Human 6.0 array has been a 
popular choice for studying CNVs in relation to diseases. 
1.7.6 Limitations of studying complex phenotypes in humans 
Understanding complex traits and diseases has been made possible with the 
development of genomic technologies. Genome-wide association studies have made their 
mark on the scientific community, and have been responsible for the identification of many 
genotype-phenotype associations.
40
 Unfortunately, short of identifying these associations, 
humans prove to be poor models to truly elucidate the mechanisms underlying the 
  9 
interactions between genes and their environment. To understand the basics for why specific 
genotypes result in certain characteristics, researchers must be able to limit the amount of 
variation between subjects. The inability to control a human’s environment, therefore, makes 
it difficult to minimize the variation between samples. Similarly, traits affecting specific 
organs become difficult to study, as researchers are limited to non-invasive sampling of 
genetic material. Finally, understanding the inheritance and development of phenotypes, 
especially those associated with diseases, is challenging due to the long generation time of 
the human population.  
An attempt to study complex phenotypes of individual tissues has been made in 
humans with the use of stem cell research.
41,42
 Stem cell research allows for the study of 
individual organs in an in vitro environment. This allows for the analysis of genetic variation 
within a specific tissue. However, when studying complex phenotypes it is important to 
understand how these tissues interact with other organs in the body from a holistic view. 
Stem cell research does not recreate in vivo interactions that would occur within a whole 
organism.
43
 Similarly, the ethical concerns regarding how these stem cells are obtained often 
limit the amount of research conducted using stem cells as a model. Therefore, researchers 
generally turn to model organisms to overcome the limitations of in vivo and in vitro 
experiments on human tissues.  
1.8 Genetic variation in mouse populations 
1.8.1 Mouse as a model for human complex phenotypes 
Mice have been used as a model organism to study complex phenotypes for well over 
a century. The synteny of genome size and composition between mice and humans, make 
mice ideal for studying complex phenotypes and diseases that are observed in the human 
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population. Additionally, mice naturally develop many of the same diseases as humans, 
including cancer, diabetes, glaucoma, addiction, and hearing loss because of their similarity 
in cellular physiology and development.
44
 For diseases that do not naturally affect mice, 
mouse models have been created that mimic these diseases by manipulating the mouse 
genome. Transgenic technologies are used to insert, remove, or modify genes, to induce 
disease characteristics in mice to mimic specific diseases.
44
 Coupled with the short 
generation time of a mouse, and the ability of researchers to control environmental 
conditions, mice prove to be a strong model for studying complex phenotypes. Therefore, 
many researchers examining complex traits choose to use mice as their model organism. 
1.8.2 The origins of the laboratory mouse 
Inbred mouse strains have been in development since the turn of the 20
th
 century. 
With an interest of studying inheritance, the development of inbred mice was initially based 
on selecting for coat colour.
44
 Mice were selected to be homozygous at loci for agouti (a), 
brown (b/Tyrp1) and dilute (d/Myo5a). To select for homozygosity at these loci, offspring 
were brother-sister mated for many generations, ultimately reducing the genetic variation. 
After nearly 20 generations of brother-sister mating, mice no longer contained variation 
between offspring, as all mice were homozygous at every location across the genome. This 
effectively creates mice that were genetically identical and contain the isogenic background 
that is characteristic of an inbred mouse strain. 
By 1909, the first inbred mouse strain known as DBA was created by Dr. C.C. Little, 
the founder of The Jackson Laboratory.
44,45
 The DBA inbred mouse was joined a short time 
later by several other inbred mouse strains, including C57, C3H, CBA, and A. Each of these 
strains contained their own unique genetic background with alleles primarily found in the 
Mus musculus domesticus subspecies. These mouse strains formed the basis from which 
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many of the classical laboratory inbred mouse strains currently used in biological research 
were created. 
The isogenic nature of inbred mouse strains makes them ideal for studies that require 
a large number of replicates that contain as little genetic variation as possible.
46,47
 Because 
inbred mice contain no genetic variation between individuals within a strain, it is possible to 
repeat experiments while keeping the variation between samples at a minimum. By reducing 
the amount of variation between samples, conclusions may be made using a smaller sample 
set as compared to similar studies conducted between samples containing high genetic 
variation.
46
 Inbred mouse strains exist for a variety of different phenotypic characteristics; 
this allows researchers to tailor their strain selection in order to answer specific biological 
questions. 
Some of the first research conducted on complex phenotypes using these inbred 
mouse strains was aimed at understanding the basics of cancer research and immunology. 
One such study, conducted by Haldane in 1933, proposed the alloantigenic hypothesis of 
tumor rejection.
46
 The alloantigenic hypothesis of tumor rejection functions on the premise 
that antigens are produced for an allele within a strain rather than as an immune response that 
is directly targeting the cells. Haldane showed that when tumors were transplanted within 
mice of the same strain, the tumor cells were not rejected. However, when transplanted to 
mice of a different strain, the tumor cells were rejected. The rejection of tumors between 
mouse strains indicates that there is a genetic basis to tumor rejection. The newfound 
understanding for the genetic basis of tumor rejection explained transplant rejection observed 
in human populations. This principle is still used today with respect to blood transfusions and 
organ donations, where blood and tissues are matched based on the patients genome. 
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Therefore, studies relating to complex phenotypes within laboratory mice have been applied 
to human populations.  
1.8.3 The C57BL/6J mouse strain 
One of the most commonly used laboratory strains is the C57BL/6J (B6) mouse. This 
strain was developed in 1921 and quickly became the strain of choice for many researchers. 
The B6 mouse strain was developed by Dr. C.C. Little using a parental line of C57 black 
mice, of which a defining characteristic is their black coat colour.
45
 The B6 mouse strain, in 
particular, has been inbred for over 200 generations. The B6 mouse is also the mouse strain 
from which the mouse genome sequencing project was based.
48
 
1.8.4 Congenic and consomic mice 
 Congenic and consomic mice were created to study the effects of single genes when 
different allelic variants were present on an otherwise isogenic background.
45
 Congenic and 
consomic mice maintain the genetic background of their parental strains; however, they 
contain a single gene (congenic) or a single chromosome (consomic) from a mouse strain that 
is genetically distinct from their parents. The incorporation of a gene or chromosome from a 
different inbred mouse strain increases the genetic variation at a specific location in the 
mouse genome, while the remainder of the genome remains unchanged. Some of the most 
common congenic and consomic mice are on a B6 genetic background. However, these mice 
can be created for any combination of genetic backgrounds from the available mouse strains.  
1.8.5 F1 mice 
 First filial (F1) mice are offspring from two different parental inbred mouse strains. 
These mice contain heterozygosity at all locations in the genome where the maternal and 
paternal inbred strains contain different alleles.
45
 F1 mice display characteristics that result 
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from a combination of two distinct genetic backgrounds. This increases the genetic variation 
within F1 mice in comparison to mice from an isogenic strain. The benefit of F1 mice is that 
studies can be reproduced. Therefore, by continually breeding two mice from two different 
isogenic backgrounds, all offspring contain the same combination of alleles. This allows for 
studies to be reproduced on a genetic background that is not isogenic; however, is 
reproducible. 
1.8.6 Recombinant inbred strains 
Recombinant inbred strains are derived from crossing two genetically distinct founder 
strains.
47
 After breeding the F1 offspring from the original two founder populations, 
recombination occurs at meiosis as a result of homologous chromosomes crossing over. 
When loci are heterozygous, containing two different alleles, recombination can result in the 
creation of different haplotypes. The generation of new haplotypes in recombinant inbred 
strains results in new allelic combinations that are inherited together. After nearly 20 
generations of brother-sister mating, mice are considered inbred and contain homozygosity at 
all locations in the mouse genome. The resulting recombinant inbred strain, contain regions 
of homozygosity derived from the maternal strain as well as regions of homozygosity derived 
from the paternal strain. By incorporating alleles from two different mouse strains into a 
single recombinant inbred mouse strain, the genetic diversity of recombinant inbred strains is 
higher than that of classical inbred strains. Therefore, recombinant inbred strains have all the 
benefits of a classical inbred mouse strain, with the added benefit of increased genetic 
diversity.  
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1.8.7 Wild-derived laboratory mice 
 Wild-derived laboratory mice, are inbred mouse strains that were derived from mice 
caught in the wild.
45
 Wild-derived laboratory mouse strains are created by brother-sister 
mating the offspring from wild caught parents. Wild-derived laboratory mice, are isogenic 
mouse strains; however, the alleles within these strains are derived from different Mus 
musculus subspecies (Mus musculus musculus, and Mus musculus castaneus) in comparison 
to classical laboratory strains (Mus musculus domesticus).
49
 The haplotypes associated with 
each of the founder strains reflect the genetic variation present in the wild caught parental 
mice. Alleles reflect those that are most common based on the subspecies and geographic 
locations of the wild caught parents.
45
  
1.8.8 Mutant mice 
 Mutant mouse strains that display characteristics of diseased phenotypes are also 
available for many of the classical and wild-derived mouse strains. Mutant strains can arise 
from spontaneous mutations occurring during breeding, or from induced mutations using 
chemical or transgenic technologies.
45,50
 Spontaneous mutations arising during breeding may 
result in phenotype changes. When this occurs, a new mouse strain is created when the 
mutation is non-lethal in a homozygous state. This creates a new mouse strain available for 
mutation analysis. Inducing mutations by modifying the genome with transgenic 
technologies or by chemically inducing mutations also creates mutant mouse strains. Mouse 
strains derived from induced mutations are also maintained at a homozygous state. 
Transgenic mutant mice can be created for any non-lethal combination of modifications; this 
allows for a broad spectrum of research on mutant phenotypes.  
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1.8.8.1 The harlequin (hq) mouse as a mutant mouse strain 
The harlequin (hq) mouse is a mouse model for neurodegeneration.
51
 The distinct 
phenotypic characteristics of the hq mouse include low body weight, a patchy coat, and 
severe ataxia. The hq mutation originally arose spontaneously on a CF1 outbred stock and 
was transferred to the current genetic background of B6CBACaA
w-J
/A-Pdcd8
Hq
/J
51
. The hq 
mutation results from a 1 kb proviral insertion into intron 1 of the Apoptosis-inducing factor 
(Aif) gene, resulting in an 80% downregulation of Aif expression.
51,52
 AIF is involved in 
programmed cell death and it functions, in conjunction with complex I of the electron 
transport chain, as a NADH reductase.
53
 The reduction of NADH results in an increase in the 
production of reactive oxygen species (ROS). However, recent studies have shown that hq 
mice do not show an increase in ROS.
54
 AIF also functions as a mitochondrial hydrogen 
peroxide scavenger, which prevents damage caused by ROS.
53,55
 The reduction of AIF in the 
hq mouse is associated with the degeneration of neurons in the cerebellum and retina in 
comparison to age-matched wild-type mice.
51,54,56
 The hq mouse has also displayed a reduced 
level of AIF in the spleen which causes a reduction in neglect-induced death in T-cells.
57
 
Therefore, the hq phenotype not only affects neuronal tissues, but also displays a spleen-
specific phenotype that has implications in immunity. The direct assessment of tissue-
specific degradation in the hq mouse provides an excellent model for studying diseases of 
neurodegeneration affecting the human population. The implications of the cerebellar and 
retinal degeneration make the hq mouse an ideal model to study the effects of tissue-specific 
mutation accumulation in neurodegenerative diseases. By analyzing the accumulation of 
mutations in specific tissues, researchers can gain a better understanding of the mutational 
profiles including the frequency and distribution of mutations affecting specific tissues with 
neurodegenerative disorders.  
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1.8.10 Genetic variation within a mouse 
Genetic variation not only exists between mouse strains, but also within mice as 
somatic mosaicism and germline mosaicism. Some of the most obvious forms of within 
mouse variation are associated with cancers. Cancers display mutator phenotypes that cause 
cells within a tumor to be genetically distinct from those outside of the tumor.
58
 Although 
mutator phenotypes that are associated with cancer typically occur within a single tissue type, 
other research indicates that genetic variation exists between tissue types and within tissues 
as a result of point mutations.
30,59–61
 There is also evidence that mutations accumulate in the 
germline of mice.
60,62,63
  
1.8. 11 Traditional mouse models have minimal genetic variation 
Currently, mouse models are used to study the mechanisms underlying a broad 
spectrum of complex phenotypes; including those associated with development and disease 
progression. Studies on inbred mouse strains have been used to identify the interactions 
between genes and how the interactions contribute to an observable phenotype. However, 
when genetic variation is incorporated into the genome, as seen within human populations, 
the interactions between genes are altered ultimately impacting the observable phenotype. 
64
 
Gene-gene interactions are affected by genetic variation. Inbred mouse strains contain a 
minimal amount of genetic variation, as all mice within a strain are genetically identical. The 
human population is studied globally and contains high amounts of genetic variation because 
humans are typically not inbred. Increasing the variation within the genome, adds an 
additional level of information. Different combinations of genetic variants are now 
interacting to display a wide spectrum of phenotypes. Therefore, the murine model that is 
being used to study these interactions must be modified to mimic the genetic diversity of 
humans.  
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1.8.12 Next-generation recombinant inbred mice 
The first step in developing a mouse model that mimics the genetic diversity of the 
human population was initiated with the development of the Collaborative Cross (CC) 
mouse, a “next-generation recombinant inbred strain”.65 The CC mouse contains the genetic 
diversity of eight founder populations rather than the traditional two used in recombinant 
inbred strains. The eight founder populations include five classical laboratory strains (A/J, 
C57BL/6J, 129/SvImJ, NOD/LtJ, and NZO/H1LtJ) as well as three wild-derived laboratory 
mouse strains (CAST/EiJ, PWK/PhJ, and WSB/EiJ).
66
 By breeding these eight founder 
strains together, mice were generated that contain alleles from each of the eight genetic 
backgrounds.
67
 Currently, there are 160 CC mouse lines available, all of which contain 
different combinations of haplotypes derived from alleles from each of the founder strains. 
However, being an inbred mouse strain, each of these individual lines is homozygous at 
every locus in the genome. The CC mouse contains all the benefits of an inbred mouse strain 
with the addition of increased genetic variation. Although increasing the genetic variation 
across the genome is a step in the right direction, the next-generation recombinant inbred 
mouse still does not capture the heterozygosity observed within human populations. 
1.8.13 The Diversity Outbred mouse 
Developing a mouse model that mimics the human population requires the mouse to 
be heterozygous at many locations across the genome. The Diversity Outbred (DO) mouse 
was produced using a novel outbreeding strategy in order to maximize the allelic variation 
within a mouse strain.
68
 This breeding strategy was derived from the idea of heterogeneous 
stock populations.
69,70
 The unique feature of these mice, in comparison to classical inbred, 
recombinant, and next-generation recombinant inbred strains, is that they maintain a level of 
heterozygosity across the genome that replicates the levels of heterozygosity found within the 
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human population. The 160 CC mouse lines were used to generate the DO mouse. Each line 
contains the genetic diversity from eight founder populations, therefore in the resulting DO 
mouse, there are various allelic representations from these eight founder strains. Because 
these mice need to maintain a high level of heterozygosity, the standard brother-sister mating 
technique is not applied. Rather, mice are bred using a random mating strategy, to generate 
mice that are genetically unique.
71
 Therefore, each DO mouse that is bought and bred will 
have its own combination of founder alleles. Because each mouse is unique, the 
heterozygosity and recombination makes tracking genetic background using breeding records 
challenging, studies conducted with DO mice require genotyping at all loci across the 
genome to identify allelic origin. 
1.8.14 The origins of somatic mosaicism with development  
Mammalian development begins with a single cell, which during development 
replicates to form each of the tissue types within an organism. As this cell divides and 
organogenesis begins, each tissue will follow a unique developmental history with respect to 
proliferation, differentiation, cell type, apoptosis, and mutagen exposure. As an embryo 
develops it undergoes gastrulation, a process that divides the embryo into the three germ 
layers; the ectoderm, the mesoderm, and the endoderm. After gastrulation, organogenesis 
initiates and the primordial cells for each tissue begin to differentiate. Each of these 
primordial tissues begins differentiation at a distinct embryonic day at which point the 
primordial tissues are subjected to replication rates, apoptosis, and mutagen exposure specific 
to their tissue type. Therefore as tissues differentiate, they begin to accumulate genetic 
differences that reflect their developmental histories. The accumulation of these genetic 
differences results in somatic mosaicism, as tissues within the mouse are no longer 
genetically identical. Three candidate tissues for the study of somatic mosaicism, that 
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represent each of the three germ layers, are the spleen, the cerebellum, and the liver. Each of 
these tissues has shown different rates of accumulation of spontaneous mutations over the 
lifespan of a mouse that are unique to the developmental and functional histories of each 
tissue.
59–61,72–78
 
The spleen is a mesodermal tissue that begins development at gestational day 12.5.
79
 
It is divided into two distinct compartments, the red pulp and the white pulp. The cell types 
found within the spleen include lymphocytes, hematopoietic cells, granulocytes, and circular 
mononuclear cells in the red pulp, and lymphocytes, macrophages, dendritic cells, and 
plasma cells in the white pulp. In the mouse, the spleen accounts for about 0.2% of the 
weight of the mouse and acts as a blood filter. The spleen also provides hematopoietic 
functions beginning at gestational day 17, as it is involved in the production of blood cells. 
Therefore, the spleen plays an intricate role in the immune system of the mouse. The 
replication rate of cells within the adult spleen ranges between 1 and 21 days depending on 
cell type.
80
 Within the spleen there is evidence of somatic mosaicism associated with 
immunology and the hematopoietic function of the tissue.
81,82
 
The cerebellum is an ectodermal tissue that develops at embryonic day 10.5. The 
cerebellum is 90% neurons, including granular neurons, Purkinjie cells, and oligodendrytes.
83
 
Other non-neuronal cell types within the cerebellum include parvalbumin-positive fast-
spiking basket cells, somatostatin-positive regular-spiking bipolar and multipolar cells, and 
cholecystokinin-positive irregular-spiking bipolar and multipolar cells.
84
 The cerebellum is a 
post-mitotic tissue meaning that cells are no longer dividing in adult mice, resulting in little 
cell turnover in this tissue. It contributes to roughly 2% of the body weight of a mouse and 
the primary function is the regulation of motor control and balance. Previous research in 
humans has identified chromosomal aneuploidy in the developing fetal brains.
85
 In mice, 
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mobile elements in the brain have been identified during development and in granular 
neurons of adult brain tissues that contribute to somatic mosaicism within the cerebellum.
86,87
 
The cerebellum is also prone to genomic modifications as a result of circular DNA occurring 
early in development around embryonic day 16-17.
88
 The presence of circular DNA 
molecules facilitates somatic recombination within cells of the developing embryonic brain 
leading to genomic alterations.  
The liver develops from endodermal tissues at embryonic day 9.5 and contributes to 
about 7% of the overall body weight. It is composed of nearly 70% hepatocytes 
(parenchymal cells), which replicate every 480-620 days.
80,89
 Hepatocytes are involved in the 
synthesis and storage of proteins. The liver also contains non-parenchymal cells including 
Stellate and Kupffer cells.
90
 The liver is also responsible for the removal of cellular waste. 
Previous reports of somatic mosaicism in the liver has been associated with highly unstable 
minisatellites early in development.
91
 There is also evidence for somatic mutations occurring 
during the processing of metabolites,
92
 and recent literature has identified CNVs associated 
with metabolic stress.
93,94
  
1.8.15 Tissue-specific mutation frequency 
Studies of tissue-specific mutation frequency using transgenic mice have reported the 
different rates at which tissues accumulate mutations throughout development.
60,61,73,78,95
 
Beginning as a zygote containing no mutations, mutations have been reported to accumulate 
as early as the fetal stage.
60,61,73
 By post-natal day 10, mutation frequency has been shown to 
be tissue-specific.
60
 As mice mature into late adulthood, tissue-specific mutation frequencies 
become more distinct.
60,73,78
 Neuronal and germ tissues maintain a constant mutation 
frequency after 3 months of age, whereas mutation frequency in the liver, spleen, and adipose 
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tissues increases as the mouse ages.
60
 The extent to which spontaneous mutations accumulate 
in a tissue depends upon the development of the tissue and how they are affected by aging.   
1.8.16 Genome-wide mutation detection 
Genome-wide mutation detection is the gold standard for mutation studies. In 
humans, high-density microarray technologies such as the human 6.0 array (Affymetrix
®
), 
array Comparative Genomic Hybridization (aCGH), and the cytoscan HD array 
(Affymetrix
®
) incorporate probes that represent regions across the genome to detect both 
small and large genomic modifications.
28,96
 Next-generation sequencing technologies also 
provide affordable genome-wide screening of the entire genome to identify genomic 
modifications.
32
 Unfortunately in mice, the cost of sequencing the genome is far from 
affordable for most laboratories, transgenic mice screen limited genomic areas, and 
microarray technologies lack genome-wide coverage compared to human microarray 
standards.
97
 Therefore, a high-resolution, genome-wide mutation detection technology is in 
high demand for the mouse. 
1.8.17 Analysis of complex traits by single gene mutation detection 
Traditionally, complex traits in mice are studied using mutation detection approaches, 
as many of these traits are related to aging and disease progression. Since mutations are 
known to cause aging and disease progression, research on mouse models focused on the 
identification and characterization of mutations.
98–100
 Conventional mutation detection 
systems in the mouse rely on the use of single gene analyses to study the frequency and 
nature of mutation accumulation. Single gene mutation studies allow for in vitro examination 
of mutations and can be conducted using either endogenous genes, like HPRT, or transgenes 
such as cII, lacI, and lacZ.
101
 Mutations are identified by packaging the isolated genes into a 
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vector, infecting these vectors into Escherichia coli and screening for mutant colonies or 
plaques. 
Transgenic mice, namely Muta
TM
 Mouse and the BigBlue
®
 mouse have been 
developed to study mutations using transgenes. These mice contain copies of the 48 kb 
lambda genome which contains the cII, lacI, and lacZ genes.
102,103
 Muta
TM
 Mouse was 
developed on a BALB/C X DBA/2J genetic background and contains 40 copies of the 
lambda phage genome on chromosome 3. Muta
TM
 Mouse was traditionally used to study the 
lacZ transgene; however more recently has been used for the cII assay as well.
102,104,105
 The 
BigBlue
®
 mouse is a transgenic mouse model that contains 40 copies of the lambda genome 
on chromosome 4. This mouse was developed on a B6 genetic background and is 
traditionally used to study the lacI and cII transgenes.
103,105
 Although these transgenic mouse 
models prove to be effective at identifying the frequency and type of mutation accumulation 
throughout development, these mutation assays lack the ability to detect mutation 
accumulation outside the region of these exogenous genes. 
1.8.18 Genomic technologies for the mouse 
Unfortunately, genomic technologies for the mouse are limited in comparison to 
humans, in their ability to detect genome-wide allelic differences. Genomic technologies for 
the mouse include microarrays and next-generation sequencing. However, the advancement 
in genomic technologies specific to the mouse lags behind those that are available for 
humans. The lack of demand for mouse specific genomic technologies resulted in poor 
technological advancement and a much higher price tag for genome-wide studies in 
comparison to humans. As a result, microarrays, the predominant genomic technology for the 
mouse, were limited in the number of locations that could be studied across the genome. 
Until as recently as 2006, microarray technologies could detect only 14,000 SNPs across the 
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mouse genome.
106
 Next-generation sequencing technologies, although available for the 
mouse, are cost prohibitive for most laboratories costing approximately $35,000 to sequence 
a single mouse genome. Traditional methods used to identify allelic variation, including 
polymerize chain reaction (PCR), although effective, are inefficient as a genome-wide 
strategy.  Currently, mouse models for studying complex diseases, namely the DO mouse, 
would require PCR amplification for hundreds of thousands of locations across the genome 
in order to determine the genetic background of each allele. Therefore, a high-resolution 
technology for the mouse that is efficient and cost effective was developed. 
1.8.19 The Mouse Diversity Genotyping Array 
In 2009, the highest resolution, genome-wide microarray was developed by The 
Jackson Laboratory in collaboration with Affymetrix
®
.
107
 Modeled after the Human 6.0 
array, the Mouse Diversity Genotyping Array (MDGA) was designed to capture as much 
genetic variation as possible within the mouse population. The MDGA incorporates probes 
for 623,124 single nucleotide polymorphisms (SNPs) identified from inbred and wild-derived 
mouse strains (Table 1-1). This is also the first mouse array capable of detecting large 
structural variants with an additional 916,296 invariant genomic probes (IGPs), conserved 
across mouse subspecies. All probes are distributed across each chromosome of the mouse 
genome to give the highest-resolution microarray technology for the mouse to date. 
Probes for SNPs and IGPs have two distinct designs. SNP probes were designed in 
sets of eight (probe set), where all eight of these probes are required to detect the genotype at 
a single SNP location and must meet the strict criteria outlined in Table 1-2. These eight 
probe sequences were designed to detect two possible alleles on the array, four detecting 
Allele A and four detecting Allele B (Figure 1-1). Two probes for each allele detect a sense 
(forward/+) target sequence and two probes for each allele detect an antisense (reverse/-) 
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target sequence. The four sequences on the forward strand only differ in the allele that is 
detected, meaning that the two sequences detecting Allele A are identical and only differ 
from the two sequences detecting Allele B by a single nucleotide. Likewise, the four 
sequences representing the reverse strand are identical with the exception of the SNP 
detected. Although probes for the forward and reverse strand of DNA detect the same SNP, 
they may be offset up to 10 bps. Probes representing Allele A and Allele B of the forward 
strand are printed on the array in pairs at two separate locations on the array to account for 
the duplication of the probe sequences. Probes for the reverse strand are printed in the same 
manner. 
Using strict criteria for probe design is essential for accurate genotyping. A 
combination of fluorescence intensities from eight probe sequences is used to determine a 
genotype call.
108,109
 By incorporating two identical probe sequences for each strand and for 
each allele on the microarray, redundancy is created and SNP genotype calling becomes 
more accurate. However, when inconsistencies occur in the design of these probe sequences, 
they manifest as technical errors in genotyping calls. Because microarrays are designed to 
detect genotype calls over hundreds of thousands of locations across the genome, probes 
detecting these locations are designed using a strict set of criteria. Probes are designed so that 
each probe sequence on the microarray works at an optimal hybridization temperature, 
ideally for allele specificity. Therefore, for probes that do not meet basic design criteria, such 
as probe length and sequence context, the genotyping calls determined using these probe sets 
are unreliable.  
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Table 1-1: The total number of SNPs in the original SNP list annotation by strategy 
of SNP identification 
Mouse 
Chromosome 
Probe identification strategies
a 
Classical
b 
NIEHS
c 
B6
d 
Wild
e 
MSM
f 
Mt
g 
Y
h 
Total 
1 12246 35799 278 46 2882 0 0 51251 
2 11313 27968 112 30 2825 0 0 42248 
3 9845 26298 203 22 2498 0 0 38866 
4 9369 24908 192 17 2262 0 0 36748 
5 9039 25896 169 14 2393 0 0 37511 
6 9097 25707 156 19 2158 0 0 37137 
7 8249 24573 199 70 1891 0 0 34982 
8 7982 22226 152 21 1726 0 0 32107 
9 7755 21202 164 87 1948 0 0 31156 
10 7970 19084 144 46 2112 0 0 29356 
11 7660 18709 144 41 1966 0 0 28520 
12 7049 21616 155 48 1639 0 0 30507 
13 7125 20597 97 36 1797 0 0 29652 
14 7288 17456 117 56 1525 0 0 26442 
15 6448 18119 102 55 1555 0 0 26279 
16 6093 15335 121 28 1593 0 0 23170 
17 5710 18224 122 50 1368 0 0 25474 
18 5544 16437 55 13 1550 0 0 23599 
19 3633 11513 86 40 907 0 0 16179 
X 8238 12565 5 60 1002 0 0 21870 
Y 0 0 0 0 0 0 51 51 
Mitochondrial 0 0 0 0 0 19 0 19 
Total 157653 424232 2773 799 37597 19 51 623124 
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a 
how the SNPs used on the MDGA were identified. Grouped by the type of laboratory 
strain, chromosome, or project that identified the SNPs.  
b
 SNPs identified from classical laboratory strains 
c
 SNPs identified from studies conducted by the National Institute of Environmental 
Health Sciences (NIEHS) 
d
 SNPs identified in the B6 mouse that are absent from the NIEHS  
e 
SNPs that are not shared with A/J, DBA/2J, 129S1, and MSM/Ms strains. 
f
 SNPs identified in Mus macedonicus, Mus spretus, Mus spicilegus, and Mus musculus  
g
 SNPs identified that are on the mitochondrial chromosome 
h
 SNPs identified that are on the Y chromosome 
  27 
 
 
 
 
 
 
Table 1-2: Criteria outlined by Yang et al, 2009 to define a “chippable probe” on the 
Mouse Diversity Genotyping Array 
Criteria
a
 probes must meet to be chippable 
1. SNP must be located on a NspI or StyI fragmentb between 50 bps and 1 kb 
2. SNPs should be at least 10 bps away from a NspI and StyI cut site 
3. No other SNP ± 12 bps of the target SNP 
4. 33 mer centered on the SNP must BLATc as unique 
a
 All probe selection criteria are based on the C57BL/6J mouse reference genome 
sequence build 36 (NCBI, mm8:Ensembl) and build 37 (NCBI, mm9:Ensembl) 
b 
NspI and StyI are the restriction enzymes used to digest the genomic DNA 
c
 sequence alignment tool in Ensembl 
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Figure 1-1: Design of Single Nucleotide Polymorphism (SNP) probes on the Mouse 
Diversity Genotyping Array (MDGA). A) Each SNP selected for the array is detected 
using a combination of 8 probes that are represented on the array.  The 8 probes consist of a 
combination of 4 unique probe sequences (outlined in purple, yellow, red, and blue), each 
represented twice on the array.  Two sequences (purple and yellow) detect sense DNA and 
two sequences (red and blue) detect antisense DNA.  The two sequences on the sense strand 
differ by a single base pair (SNP in bold), for Allele A (yellow) or Allele B (purple).  Two 
sequences on the antisense strand differ by a single base pair (SNP in bold), for Allele A 
(red) or Allele B (blue).  Probes detecting sense and antisense sequences can be shifted up to 
10 bps from each other. B) Each probe sequence (purple, yellow, red, and blue) is 
represented on two separate features of the array that are printed in pairs.  C) Probes 
detecting sense alleles are paired together and probes detecting antisense alleles are paired 
together.  With each separate sequence represented twice on the array, each pairing occurs at 
two separate locations on the MDGA. 
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Technical error resulting from flaws in probe design can affect genotyping accuracy 
because the probes no longer perform under the “optimal conditions” to which they were 
designed. Probes that are not 25 nucleotides long do not match the optimal hybridization 
temperature calculated for the microarray.
109
 Shortened probe lengths are also more 
susceptible to mismatch alignment causing a reduction in the genotyping accuracy of the 
microarray. Probes that align to more than one location in the mouse genome will determine 
the genotype of a SNP based on hybridization to multiple locations across the genome. 
Therefore, genotype calls, are no longer indicative of the SNP for which the probe set was 
designed to detect. Probes containing recognition sequences for the digestion enzymes used 
to prepare the samples for hybridization cannot detect genotypes because their target DNA 
will have been digested. SNPs detected by multiple probe sets on the array potentially double 
the amount of genetic variation detected within a sample. This is because when a SNP is 
detected by its assigned probe set, as well another probe set that is associated with a different 
SNP, it causes an “off target” variant in this second probe set (Figure 1-2). Because the SNP 
is detected twice on the array any differences detected will be double counted. This results in 
an overestimate of the number of NoCalls (no genotype call determined) or the genetic 
distance values, when the SNP contains an allele that contributes to a genetic difference 
between samples.   
Design of the IGPs is slightly simpler than the SNPs, with only two probes querying 
each invariant genomic site represented on the array. Invariant genomic probes were 
designed to be within the exons of all genes in the mouse genome. Probe sequences selected 
in each of the exons for representation on the array, had to be invariant within the mouse 
genome (containing no SNPs) and occur only once in order to be used for copy number 
detection. Each exon that was selected contains a total of 6 probes, two detecting a proximal 
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site within the exon, two detecting a medial site within the exon, and two detecting a distal 
site within the exon. Ideally the proximal, medial, and distal probe sequences do not overlap, 
however, constraints based on sequence context of the mouse genome may result in 
overlapping probe sequences. 
The MDGA was designed with the intent of detecting genetic variation between mice 
of different genetic backgrounds. To date, the MDGA has been used primarily by The 
Jackson Laboratory to detect variation and map quantitative traits within outbred mouse 
strains, the DO mice, and the CC lines.
67,68,110,111
 Researchers have also been using the 
MDGA to detect CNVs across the mouse genome.
112,113
 The MDGA has been used to study 
quantitative traits and determine genetic variation across the genome between different 
mouse strains. However, the MDGA has the potential to be the first high-resolution 
technology for studying genetic variants underlying complex phenotypes and the potential to 
be the first high-resolution mutation detection assay for the mouse.   
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Figure 1-2: Overestimate of the number of genotype differences when SNPs are 
detected by multiple probe sets. The genotype call for any given probe set will be affected 
by “off target” variants, variants that occur in the probe sequence other than the SNP for 
which that probe was designed. SNPs, such as the mutated SNP in probe set 1, will affect the 
genotyping calls of both probe set 1 and probe set 2. When interpreting genotype calls, the 
first probe set was correctly identified as a variant, as the SNP that the probe set was 
designed contains a mutation. However, probe set 2 was designed for a SNP that did not 
contain a mutation and should therefore have had a genotype different from a NoCall. The 
off target variant in the second probe set, however, caused a mutation in the target sequence 
for the probe which caused the incorrect genotyping of the second SNP.  
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1.8.20 Genetic distance as a measure of genetic diversity detected using genotyping 
microarray technologies 
The most advanced microarray technologies have been designed to capture genetic 
variation at a high-resolution across the genome. The ability to capture genetic variation at 
the genomic level has enabled researchers to analyze phylogenetic and genealogical 
relationships within a variety of species. To date, genotyping microarrays have been used to 
recreate representations of phylogenies for many species including humans, horses, dogs, 
mice, plants, and viruses.
112,114–119
 Phylogenetic representations of the relationships are 
created using neighbour-joining algorithms with data taken from either similarity matrices 
(total number of genotype calls that are the same between two samples divided by the total 
number of genotypes compared with the differences between the two samples subtracted) or 
distance matrices (the total number of different genotype calls between two samples divided 
by the total number of genotypes compared between the samples). These matrices are then 
used to create phylogenetic trees describing how distant or closely related samples are within 
a species or subspecies.  
1.8.21 Mutation detection with the Mouse Diversity Genotyping Array 
The MDGA was designed as the mouse equivalent of the Human 6.0 array. It is an 
affordable high-resolution technology for the mouse that bridges the gap in genomic 
technologies between mice and humans. Because the design on the MDGA was based off of 
the Human 6.0 array, it should have the capability to be used as a mutation detection system. 
With the ability to screen more than 1.5 million locations across the mouse genome, the 
MDGA has the potential to be the first high-resolution mutation detection assay for the 
mouse. Probes associated with each SNP can detect both “on target” and “off target” 
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mutations as either differences at the SNP location itself or differences within nucleotides 
surrounding the SNP. It also provides the first genotyping microarray for the mouse that 
combines SNP probes and copy number probes for the identification of CNVs. Ultimately, 
the development of the MDGA fills the gap in technological advances between humans and 
mouse. This allows for mouse models to be used to study complex phenotypes such as aging 
and disease progression with a comparable technology to that available for humans. 
To determine if the MDGA can be used as a next-generation mutation detection 
system, we must first determine the ability of the microarray to detect genetic variation 
between and within laboratory mice. By determining how effective the microarray is at 
detecting genetic diversity, we can conclude whether or not the microarray is sensitive and 
specific enough to be used for detecting somatic mutations. Comparisons of mutation 
frequency and distribution of mutations between tissues of the same mouse will allow me to 
compare genome-wide mutation accumulation in tissues that have different developmental 
origins and timelines. Analysis of mutation accumulation in tissues with such different 
developmental histories, will allow me to establish a genome-wide mutation signature for 
each tissue during development and aging. 
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1.9 Central Hypothesis and Specific Aims 
 Given that SNP-based genotyping microarrays have high-resolution for assessing 
genetic diversity, the Mouse Diversity Genotyping Array can be used to investigate genetic 
distance not only between different mice but also between tissues of the same mouse and 
within a single tissue. 
Specific Aim 1: To assess if all probes on the MDGA have an optimal design for 
hybridization and genotyping. 
Specific Aim 2: To measure genetic distance using the MDGA to distinguish between 
distantly and closely related mice.  
Specific Aim 3: To measure genetic distance using the MDGA to distinguish between 
mice ranging in genetic background from 100% B6 to 100% CBA/CaJ genetic 
backgrounds.  
Specific Aim 4: To assay tissue-specific genotypes to distinguish between the spleen, 
cerebellum, and liver within a mouse. 
Specific Aim 5: To assay intra-tissue genotype variation using replicates for the spleen 
and cerebellum of a B6 mouse. 
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Chapter 2 : Materials and Methods 
2.1 Generating a SNP probe list 
2.1.1 Understanding probe design 
 A SNP is a site within the genome that contains variation at a single nucleotide within 
at least one percent of the population. Variants at these single nucleotide positions are known 
as alleles. On the MDGA, each SNP is detected by a set of eight probe sequences, also 
known as a probe set. These probe sets contain probe sequences that can detect the forward 
strand of DNA and probe sequences that can detect the reverse strand of DNA. These 
sequences also have the capability to bind to DNA containing one of two alleles, an A allele 
or a B allele. To create a list of probe sets that are most effective at genotyping, each probe 
within a probe set was filtered using a strict set of design criteria. The identification of probes 
that fail to meet these design criteria resulted in the removal of the entire probe set from 
analysis. Removal of a SNP, results in the removal of the associated probe set from 
genotyping analysis.  
2.1.2 Making a consensus list 
Two separate genotyping lists were released with “poorly preforming SNPs” removed 
from the original 623,124 SNPs that are printed on the array. The first list released by The 
Jackson Laboratory
 contained 549,683 SNPs after removal of all “poorly performing SNPs” 
and the second list released by Genotyping Console (Affymetrix
®
, Santa Clara, CA) 
contained 584,726 SNPs after removal of all “poorly performing SNPs”. Both of the updated 
lists were compared to determine all SNPs present in both The Jackson Laboratory list and 
the Genotyping Console list. The overlap between the two lists was used to generate a 
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consensus list of SNPs. Probe filtering was performed on this consensus list, where SNPs 
were removed based on their probe design.  
2.1.3 SNP filtering by probe design  
SNPs in the consensus list were subjected to strict probe design analysis. In addition 
to the original guidelines for creating “chippable probes” outlined by Yang et al, 2009, each 
SNP probe was tested against seven parameters (Table 2-1). SNPs with one or more of their 
8 corresponding probes failing to meet these criteria were removed from the final SNP list 
used for genotyping (Figure 2-1). 
Probe sequences obtained from the Didion et al, 2012 annotation file were checked 
against the CDF library file (Affymetrix
®
), which provides the coordinates for each of the 
probes (623,124 SNPs * 8 probe sequences each) on the MDGA. Annotations from the 
Didion et al, 2012 file were determined to be correct by comparison with locations checked 
by Fadista et al, 2012 and were used as the final annotations for the chromosome and 
chromosome position in the remainder of the analysis.
117,120
   
1) Probe lengths were checked for both the forward and reverse probe sequences for 
the A and the B alleles. Sequences were taken from the CDF file available from The Jackson 
Laboratory. Probe lengths were calculated in Microsoft Excel
TM
 (Microsoft, Redmond, 
Washington) by determining the number of characters in the string that denoted the probe 
sequence. For inclusion in the genotyping list, all eight probes representing a single SNP 
were 25 nucleotides long. If one or more of the eight probe sequences did not meet this 
criterion, the SNP was removed from genotyping analysis.   
2) The alignment scores for forward and reverse probes were checked for each SNP.  
Alignment scores were taken from the most recent publication of MDGA  
 
  39 
 
 
 
 
Table 2-1: Criteria SNP probes must meet for inclusion in the final genotyping list 
Inclusion criteria for SNP probes in genotyping list
a 
1. Probe length must be 25 nucleotides  
2. Alignment score must be 2, “Perfect match” b 
3. SNPs must be present in the mouse SNP database (Mouse Phenome Database) 
4. Probes must not be cut with NspI and StyI 
5. 10 bps upstream and downstream of the probe must not be cut with NspI and StyI 
6. SNPs must be at least 12 bps apart 
7. SNPs must not be detected with more than one probe set 
a
 All probe selection criteria are based on the sequence of the C57BL/6J mouse reference 
genome build 37 (NCBI, mm9:Ensembl) 
b
 sequences that align to a single location in the mouse reference genome build 37 
  
  40 
 
 
 
 
 
 
 
Figure 2-1: Probe removal criteria when filtering the original SNP list. All probe 
sequences on the array must be 25 bps in length, and align as a perfect match to the mouse 
reference genome. They cannot be cut with both NspI and StyI restriction enzymes within the 
sequence of the probe or the 10 bps flanking the probe. Consecutive SNPs must be at least 12 
bps away from each other and any SNP that was detected by multiple probe sets on the 
MDGA was removed.  
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Annotations.
117
 Probes were given a score of -3, -2, -1, 1, or 2 depending on their alignment 
to GRCm37 (build 37) of the mouse reference genome.
117
 These alignment scores were 
determined using Burrows-Wheeler Aligner (BWA).
121
 A score of -3 indicates that the probe 
set (all probes pertaining to a particular SNP) was not uniquely aligned to the reference 
genome. A score of -2 indicates that the probe sequence did not align to the reference 
genome. A score of -1 indicates that the probe sequence was not unique to the reference 
genome. A score of 1 indicates that the probe aligned to another location in the genome with 
a single mismatch. Finally, a score of 2 indicates that the probe sequence aligned to a single 
location in the genome with no off target alignments. All probes for the forward and reverse 
orientation of a SNP must be “2” for inclusion in the final genotyping list.  
3) Genotyping output using the MOUSEDIVm520650 library file (Affymetrix
®
) 
identified SNP probes that did not have a chromosome location associated with them. SNP 
probes were then checked for inclusion in the Mouse Phenome Database (MPD) using the 
chromosome and chromosome base pair location. If the location in the genome was not 
available, the rsNumber was used to search for the SNP. SNPs that were not included in the 
MPD were removed from analysis.   
 4) Forward and reverse sequences for each SNP were checked for the full NspI and 
StyI restriction enzyme recognition sites. NspI cuts at 5’ RCATGY 3’ (5’ ACATGT 3’ and 5’ 
GCATGC 3’) and StyI cuts at 5’ CCWWGG 3’ (5’ CCATGG 3’ and 5’ CCTAGG 3’). 
Probes were searched for all possible cut sites of NspI and StyI in the CDF file and SNPs 
were removed if any of the eight sequences were cut by both restriction enzymes.  
 5) Sequences 10 bps upstream and downstream of the forward and reverse probe 
sequences for each SNP were checked for the full NspI and StyI restriction enzyme 
recognition sites. Additional sequences were obtained using an in-house shell script which 
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extracted 50 bps before and after the SNP using its chromosome and base pair location from 
build 37 of the mouse reference genome (NCBI). Probe start and end positions taken from 
Didion et al, 2012 were used to determine the 10 bps before the start of the probe and the 10 
bps after the end of the probe.  SNPs where any probe contained a cut site in these additional 
20 bps of sequence for both NspI and StyI were removed from genotyping.  
 6) The nucleotide spacing between consecutive SNPs, or inter-SNP distance, 
represented on the array was determined using the chromosome positions provided in the 
reannotation by Didion et al, 2012. Probes that had an inter-SNP distance of less than 12 bps 
were removed from the SNP list for genotyping. 
7) Forward and reverse probe sequences were checked to determine if there was 
overlap with more than one SNP represented on the array. SNPs were ordered by 
chromosome and chromosome position (bps). Consecutive SNP probes were checked to 
determine if the SNP directly before or directly after could be detected within the range of 
the probe for the SNP of interest. If the SNP fell between the probe start and end positions of 
the previous or subsequent probe sequences, the SNP detected by multiple probe sets was 
removed.  
2.2 Annotating the filtered SNP list 
Annotations from the MOUSEDIVm520650 library file were cross-referenced with 
the most recent annotation of SNP probes for the MDGA.
117
 Chromosome location and base 
pair position were compared between these two files to identify any discrepancies.  
Differences to chromosome or chromosome position (bps) had the reference sequence ID 
numbers searched in dbSNP (NCBI) against build 37 of the mouse reference genome. 
Chromosome and chromosome position (bps) were corrected according to the NCBI 
database, build 37 of the mouse reference genome. Genomic locations were checked against 
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the Fadista et al, 2012 SNP locations, where SNPs were identified to contain incorrect 
annotations in the original annotation file.
120
 All SNPs were then plotted on a karyotype of 
the mouse genome to visualize the distribution of SNPs across the genome using Circos 
(Canada’s Michael Smith Genomic Sciences Centre, Vancouver, BC, Canada).122 
Chromosome and chromosome position (bps) were used to compare the distribution of SNPs 
across the genome and the interSNP distances between the original SNP list and the filtered 
SNP list.  
Chromosome location was also checked for each SNP using the Mouse Phenome 
Database (MPD), a publically available database maintained by The Jackson Laboratory
®
.
123
 
A SNP/variation query was performed for each SNP within the CGD-MGA1 dataset (MDGA 
dataset) which includes over 546,000 SNPs for 151 mouse strains.
124
 At each SNP, the alleles 
for two commonly used laboratory strains, the C57BL/6J (B6) mouse strain and the CBA/CaJ 
mouse strain were recorded. The SNP for the Mus musculus molossinus (MSM) strain from 
Japan was also determined to be used as a possible control. MSM probes can be used as 
controls to determine the accuracy of genotyping because mice containing a B6 and a 
CBA/CaJ genetic background should not genotype with the MSM allele. The A allele and the 
B allele for each SNP on the array was identified as either a B6 allele, a CBA/CaJ allele, or a 
MSM allele using MPD. If the allele was not B6, CBA/CaJ, or MSM, the annotation was left 
blank. Each SNP was then assigned a “B6:CBA/CaJ annotation” based on their capability to 
detect the genetic backgrounds of the B6 and CBA/CaJ mouse strains. SNPs where only the 
B6 allele was detected were annotated as “B6”, where only the CBA/CaJ allele was detected 
as “CBA”, where both the B6 and CBA/CaJ alleles were detected as “Heterozygous”, and 
where neither the B6 nor CBA/CaJ alleles were detected as “negative”.  SNPs where neither 
the B6 nor CBA/CaJ alleles were detected were annotated as negative because mice used in 
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the somatic mosaicism study only contained the genetic backgrounds for a B6 and CBA 
mouse and would therefore be expected to have NoCalls at these negative control probes. 
Chromosome number and chromosome position were used to identify whether a SNP 
was located within the region of a gene. Two databases were downloaded from UCSC, the 
first containing all known genes (reference genes) and the second containing putative genes 
(known genes) in build mm9 (Ensembl) of the mouse reference genome. All genes, known 
and putative, that span the genomic location of the SNP were recorded.  
 Probe sequences for the forward and reverse probes were taken from the CDF file and 
included in the final annotation, along with the chromosome, chromosome position (bps), 
SNP, alternate SNP, start position of the forward probe sequence, end position of the forward 
probe sequence, start position of the reverse probe sequence, end position of the reverse 
probe sequence, and the target sequences for the forward and reverse probes taken from the 
Didion et al, 2012 annotation. All additional information from the Didion et al, 2012 
annotation file was included in the corrected annotations. This additional information was not 
checked given that the focus of SNP list filtering and reannotation was based on probe 
design.  
2.3 Genotyping of the Mouse Diversity Genotyping Array CEL files 
 Genotyping was performed using Affymetrix
®
 Genotyping Console (4.1.2) 
(Affymetrix
®
, Santa Clara, CA), a publically available program which can be downloaded 
from Affymetrix
®
 (http://www.affymetrix.com/estore/browse/level_seven_software_ 
products_only.jsp?productId=131535#1_1). Genotyping Console runs using the Mouse 
Diversity Array, AGCC library files (CD_MOUSEDIVm520650_rev2) which can also be 
downloaded from the Affymetrix
®
 website or directly through the Genotyping Console 
program. A project file was created defining the location of the library and the type of array 
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that is being used, MOUSEDIVm520650 (MDGA). Genotyping results were generated for a 
total of 384 samples (351 samples downloaded from Centre for Genome Dynamics and 33 
samples from in-house experiments). Each genotyping run was completed by loading all 
CEL files into Genotyping Console; along with a list denoting the gender for each sample 
and a specific SNP list to be used for genotyping. The algorithm used to genotype the 
MDGA is the BRLMM-P algorithm, which is specific to perfect match probes, with default 
settings and a score threshold of 0.1.
108
 Using this algorithm, one of four genotypes is 
assigned to each SNP in the genotyping list for every sample (Figure 2-2). The first two 
genotype calls are homozygous genotypes, one homozygous for the A allele denoted in the 
genotyping results as “AA”, and the other homozygous for the B allele denoted as “BB” in 
the genotyping results. The third possible genotype call is the presence of both the A and the 
B alleles and is annotated as “AB”. Finally, the fourth possible genotype call is when no 
genotype can be determined and is shown as a “NoCall” in the genotyping results.  After one 
round of genotyping, all samples that failed to pass a minimum threshold of 97% overall call 
rate were considered to have failed genotyping. Overall, genotype call rate is the total 
number of SNPs with an identified genotype; the total number of AA, AB, and BB calls. All 
failed samples were identified and removed from analysis. A second round of genotyping 
was performed on all samples that passed this 97% cutoff, a threshold recommended in the 
Genotyping Console users guide. Results from the second round of genotyping again yielded 
an AA, AB, BB, or NoCall for each SNP in the genotyping list. Genotypes for each sample 
were exported into Microsoft Office Excel
®
 2007 (Microsoft, Redmond, Washington) and 
cross-referenced with the annotated SNP list of filtered SNP probes to determine the 
corresponding chromosome and locus. These genotyping results were used for analysis of 
genetic distance, genetic background, and somatic mosaicism.  
  47 
 
 
 
 
 
 
 
 
Figure 2-2: Possible genotype calls from the Mouse Diversity Genotyping Array. The 
four possible genotype calls are listed. a) The first two possibilities are homozygous 
genotypes which include either homozygous A (AA) or homozygous B (BB) genotypes. b) 
the third possible genotype is heterozygous (AB). c) the fourth possibility is the failure of a 
genotype to be determined, or unknown genotype (NoCall).    
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2.4 Post-genotype filtering 
 Each SNP in the genotyping list was given an overall genotyping call rate. Overall 
genotype call rate is defined as the total number of AA, AB, and BB genotypes associated 
with a SNP across all samples that were genotyped. SNPs that failed to meet an overall SNP 
call rate of 97% were removed from the analysis after the second round of genotyping as 
recommended by the Genotype Console analysis guide. Samples were not regenotyped after 
removing SNPs that did not meet this overall call rate. All passing SNPs were carried 
through for further analyses of genetic distance, genetic background, and somatic mosaicism. 
For comparisons made using samples from The Jackson Laboratory dataset, only autosomal 
SNPs were used. This is because the dataset contains both male and female samples and the 
inclusion of SNPs from the X and Y chromosomes will make samples appear more different 
based on gender rather than genetic background. For genetic background comparisons of the 
Hill laboratory samples, the unknown origin of the X chromosome from the maternal founder 
mouse resulted in the removal of the X chromosome from these analyses. Comparisons for 
somatic mosaicism detection included the X chromosome in analysis because comparisons 
were made only between male mice (Figure 2-3).  
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Figure 2-3: Lists of SNP probes generated to be used before and after genotyping. The 
original SNP list contains all SNPs that were printed on the array (Yang et al, 2009). This 
original SNP list was filtered by The Jackson Laboratory and Genotyping Console to 
generate two separate lists that had poorly performing probes removed. From The Jackson 
Laboratory 2011 list and the Genotyping Console 2011 list a consensus list was generated 
taking all probes that overlapped between the two lists. Probes were removed based on 
specific probe design criteria to generate a filtered SNP list. Twenty randomly filtered SNP 
lists were also created, each containing the same number of SNPs as the filtered SNP list that 
had been removed from the original SNP list. After genotyping, two lists were created, one 
removing all SNPs that contained a genotyping call rate of less than 97% “post-genotyping 
filtered SNP list”, and a second removing all SNPs that contained a genotyping call rate of 
less than 97% as well as the sex and mitochondrial chromosomes “autosomal post-
genotyping filtered SNP list”.  
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2.5 Comparing genotyping accuracy 
 Genotyping accuracy, defined as the total number of CEL files that passed the 
genotyping threshold of 97% after one round of genotyping, was compared between the 
original SNP list, the Genotyping Console SNP list, and the filtered SNP list. All 351 CEL 
files, each representing a different mouse, from The Jackson Laboratory dataset of CEL files 
from the MDGA were used to test the genotyping accuracy of the three SNP lists. Genotype 
analysis was completed three separate times, one time for each of the SNP lists. After 
genotyping, the total number of samples that failed to meet the overall call rate of 97% was 
compared between the original SNP list, the Genotyping Console SNP list, and the filtered 
SNP list.  
2.6 Testing genotyping accuracy 
 The genotyping accuracy of the filtered SNP list was tested against 20 lists where 
probes were removed at random. These 20 lists all contained the same number of SNPs as the 
filtered list; however, removal of SNP probes was completely random. These 20 randomly 
generated SNP lists had probes removed at random using a random number assignment in 
Excel.  Numbers were randomly assigned to each SNP between a range of 1 and 623,124, 
they were then sorted based on the random number assignments, and the first 523,322 SNPs 
were included in the random filtered SNP list. Each random filtered SNP list was then 
imported into Genotyping Console and 20 rounds of genotyping were preformed, one round 
with each list. Each list was used to genotype 351 samples and had a gender file denoting the 
gender for each sample. The total number of samples that failed to pass the 97% genotyping 
threshold was counted for each of the randomly generated lists. This number was compared 
to the total number of samples that failed to pass the 97% genotyping threshold with the 
filtered SNP list after a single round of genotyping.   
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2.7 Animal Care 
All protocols were approved by The Canadian Council on Animal Care 2009-033 
(Appendix A). Mice selected for the study were 8-month and 15-month-old males 
hemizygous for the harlequin (hq) mutation (X
hq
Y), 11-month-old female carriers 
hemizygous for the hq mutation (X
hq
X), and 8-month-old  male mice that carry the wild-type 
allele for the Apoptosis-inducing factor (Aif) genotype (XY) (mixed genetic background: 
B6CBACaA
w-J
/A-Pdcd8
Hq
/J) (Jackson Laboratories, Bar Harbour, ME). Mice on a pure 
C57BL/6J (B6) (Taconic Farms, Germantown, NY) genetic background were also selected at 
10 months-of-age and carried the wild-type allele for the Aif gene (XY). Mice were housed at 
21±1
o
C on a 14/10 hour light/dark cycle. Diets provided ad libitum for all mice were 
standard (PMI Foods, St. Louis, MO) with water provided ad libitum.   
2.8 Genotyping for the Apoptosis-inducing factor gene 
Mice were ear notched at 10-12 days of age for identification purposes. Tail clippings 
or ear pieces were used to determine the genotype at the Aif locus in all samples to determine 
the presence of the mutated allele of samples as Aif-proficient WT mice or Aif-deficient hq 
mice. Genotyping was completed using the Terra-PCR kit (Qiagen, Valencia, CA) with crude 
tissue extracts and a tri-primer mixture to amplify a portion of both the WT Aif sequence and 
the proviral insertion responsible for the hq phenotype.
51
 Primers included an exonic forward 
primer, Aif 3468 5’ AGT GTC CAG TCA AAG TAC CGG G 3’and reverse Aif 4000 5’ CTA 
TGC CCT TCT CCA TGT AGT T 3’ primer. A third primer hqLTR2 5’ GAA CAA GGA 
AGT ACA GAG AGG C 3’was used to amplify the long terminal repeat of the murine C-
type ecotropic virus inserted into Aif intron one of mice hemizygous for the Aif insertion. 
Cycling conditions included an initial denaturing step at 98
o
C for 2 minutes, followed by 38 
cycles of 98
o
C for 10 seconds, 60
o
C for 15 seconds, and 68
o
C for 30 seconds (GeneAmp 
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PCR System 9600, Applied Biosystems, Foster City, CA). Amplicons were electrophoresed 
through a 1.5% agarose gel stained with SYBR
®
 Safe (Invitrogen, Life Technologies, 
Burlington, ON, Canada) for visualization of amplicons indicative of Aif genotypes.   
2.9 Tissue harvesting  
 Mice were euthanized at 8, 10, or 15 months-of-age with carbon dioxide (CO2) 
inhalation according to Animal Care and Veterinary Services (ACVS standard operating 
procedure (SOP)) 320-02 in an enclosed chamber prior to harvesting tissues. After 
euthanization, the spleen, cerebellum, and liver were harvested and snap-frozen in liquid 
nitrogen to prevent the degradation of DNA. Tissues were later transferred to a -80
o
C freezer 
for long-term storage.   
2.10 DNA extractions 
 Harvested tissues were subjected to one of two high molecular weight DNA 
extraction procedures at The Jackson Laboratory (Bar Harbour, MA), London Regional 
Genomics Center (LRGC) (Robarts Research Institute, London, ON, Canada), or in-house 
(Table 2-2). Samples that were extracted at The Jackson Laboratory used the Wizard
®
 
Genomic DNA Purification Kit (Promega, Madison, WI) for 40-70 mg of animal tissues. 
London Regional Genomics Center isolated tissues with both the Gentra
®
 Puregene
®
 Kit 
(Qiagen, Mississauga, ON) and the Wizard
®
 Genomic DNA Purification Kit, both with 7-11 
mg of tissue. In-house DNA extractions were completed using the Wizard
®
 Genomic DNA 
Purification Kit by homogenizing 6-10 mg of thawed tissues. In-house modifications made to 
the Wizard
®
 Genomic DNA Purification Kit protocol include two additional centrifugations 
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Table 2-2: Summary table of the 27 samples from the Hill laboratory 
Mouse 
ID
a 
Tissue 
Type
b 
Age 
(months)
c 
Sex
d 
Aif 
genotype
e 
DNA Extraction 
Protocol
f 
Amount of Tissue 
(mg)
g 
Processing Location
h 
911.143 Cl 15.2 M X
hq
Y Wizard 40.0 JAX 
911.148 Cl 15.2 M X
hq
Y Wizard 40.0 JAX 
911.50 Sp 8.7 M XY Wizard 30.0 JAX 
911.50 Cl 8.7 M XY Wizard 70.0 JAX 
911.49 Sp 8.7 M XY Wizard 30.0 JAX 
911.49 Cl 8.7 M XY Wizard 60.0 JAX 
904.9 Sp 7.7 M X
hq
Y Wizard 50.0 JAX 
904.9 Cl 7.7 M X
hq
Y Wizard 60.0 JAX 
904.11 Sp 7.7 M X
hq
Y Wizard 30.0 JAX 
904.11 Cl 7.7 M X
hq
Y Wizard 40.0 JAX 
300.6 Cl 10.4 M XY Gentra 42.0 LRGC 
900.3 Sp 11.3 F X
hq
X
i
 Gentra 10.0 LRGC 
900.3 Li 11.3 F X
hq
X
i
 Gentra 9.4 LRGC 
911.50 Sp-2 8.7 M XY Gentra 8.6 LRGC 
911.50 Cl-2 8.7 M XY Gentra 11.0 LRGC 
911.50 Li 8.7 M XY Wizard 10.0 LRGC 
300.7 Cl-1 10.4 M XY Wizard
j
  7.0 LRGC 
300.7  Cl-2 10.4 M XY Wizard
j
 9.0 LRGC 
300.7  Cl-3 10.4 M XY Wizard
j
 8.5 LRGC 
300.7  Sp-1 10.4 M XY Wizard
j
 6.7 LRGC 
300.7  Sp-2 10.4 M XY Wizard
j
 8.8 LRGC 
300.7  Sp-3 10.4 M XY Wizard
j
 7.0 LRGC 
911.17  Sp 8.9 M XY Wizard
j
 7.5 LRGC 
911.17  Li 8.9 M XY Wizard
j
 8.8 LRGC 
911.17  Cl 8.9 M XY Wizard
j
 6.6 LRGC 
911.49  Li 8.7 M XY Wizard
j
 8.8 LRGC 
911.50  Li-2 8.7 M XY Wizard
j
 7.0 LRGC 
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a
 the specific identifier that was assigned to each of the mice 
b
 the tissue samples analyzed using the MDGA (Sp = Spleen, Cl = Cerebellum, Li = Liver), replicates are indicated in by “- #” 
c
 the age of the mouse at euthanization and tissue harvest 
d
 M=male, F= female 
e
 refers to the presence or absence of the harlequin mutation 
f
 the method of DNA extraction. Wizard refers to Wizard
® 
Genomic DNA Purification Kit (Promega, Madison, WI) and Gentra 
refers to the Gentra
®
 Puregene
®
 Kit (Qiagen, Mississauga, ON). 
g
 mass of tissue (mg) that was used for the high molecular weight DNA extraction  
h
 where the genomic DNA was processed, hybridized to the array, and scanned. The Jackson Laboratory (JAX) and London 
Regional Genomics Centre (LRGC) .  
i
 indicates a carrier for the harlequin mutation 
j 
refers to extractions performed in house 
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of DNA samples during the protein precipitation step, one at 16,000xg for 4 minutes and one 
at 16,000xg for 8 minutes. Pellets were dried overnight and resuspended at room temperature 
for 8 hours before refrigerating (4
o
C) until use. All samples were electrophoresed through a 
1.5% agarose gel with a 1 kb ladder (Invitrogen, Life Technologies, Burlington, ON, Canada) 
to verify high-molecular weight DNA extraction. DNA quality ratios, 260/280 and 260/230, 
and quantity were also tested using a Nanodrop ND-1000 spectrophotometer (Thermo 
Scientific, Ottawa, ON, Canada). CEL files obtained from The Jackson Laboratory dataset 
were tail DNA samples isolated at The Jackson Laboratory using the Wizard
®
 Genome DNA 
purification Kit for animal tissues.   
2.11 Preparation of extracted DNA 
DNA extractions completed at The Jackson Laboratory were prepared for microarray 
hybridization and scanned at the same location. DNA extractions completed at the LRGC or 
in-house were prepared for microarray hybridization and microarrays were scanned at 
LRGC.  Scanning of the microarrays using the GeneChip
®
 Scanner 3000 7G (Affymetrix
®
, 
Santa Clara, CA) generated a CEL file containing the fluorescence intensities for each of the 
features on the array. 
All samples were prepared for microarray hybridization following the protocol 
outlined for the Affymetrix
®
 Genome-Wide Human SNP Nsp/Sty 6.0 Assay Kit 5.0/6.0 
(Figure 2-4).
125
 High-molecular weight DNA was digested in two separate restriction enzyme 
digests, one with NspI and the second with StyI. Adaptors recognizing the overhangs 
produced by the restriction enzymes were then ligated to the ends of the digested DNA 
fragments. Primers that recognize the adaptor sequences were used to PCR amplify 
fragments ranging between 200-1100 bps. Amplicons from each of the digests were then 
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pooled together and fragmented using a fragmentation buffer and reagent (DNase 1). This 
generated an average fragment size smaller than 180 bps. These fragments were end labeled 
using biotin at the 3’ end of the DNA fragment and denatured at 95 oC for 10 minutes. After 
denaturation the DNA was hybridized to the MDGA at 50
 o
C for 16 to 18 hours before 
scanning.  
 Microarrays were they stained so that a fluorescence signal was generated for each of 
the SNPs to be used for genotyping (Figure 2-5). Staining of the MDGA involves a three step 
process. The first staining is performed using streptavidin-phycoerythrin (SAPE). 
Phycoerythin is a chromophor which emits light at 578 nm. The emission of light by 
phycoerythin is used to produce the CEL image of fluorescence intensities. The second step 
in staining uses an anti-streptavidin antibody that is bound to a biotin molecule. This anti-
streptavidin antibody recognizes the streptavidin in SAPE and provides additional binding 
sites for a second round of staining with SAPE. The third step in the staining process is the 
second round of staining with SAPE. The addition of SAPE a second time amplifies the 
initial signal that was created with the binding of SAPE directly to the DNA molecule. 
Microarrays were then scanned with the GeneChip
®
 Scanner 3000 7G to generate a CEL file.  
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Figure 2-4: Overview of genomic DNA preparation for the array. DNA was digested in 
two separate restriction enzyme digests (NspI and StyI) to produce fragments for PCR 
amplification. Adaptors were ligated to the ends of the digested DNA fragments that were 
recognized by PCR primers. PCR amplicons from each of the digests were then pooled 
together, fragmented with DNase 1, and 3’ end labeled with biotin. Labeled fragments were 
then denatured and hybridized to the MDGA. After hybridization, microarrays were scanned 
and fluorescence intensities were interpreted into genotype calls.  
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Figure 2-5: The staining process for the Mouse Diversity Genotyping Array. Digested 
DNA fragments are biotin labeled and hybridized to the MDGA. This is followed by three 
rounds of staining. Staining steps are highlighted in red. The first stain is with Streptavidine 
phycoerythin (SAPE). SAPE contains the phycoerythin chromophore. An anti-streptavidin 
antibody stain is then applied which recognized the streptavidin component of SAPE. The 
antibody stain contains another biotin molecule which is recognized a second time by SAPE 
in the third staining step.   
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2.12 Experimental Design  
2.12.1 Genetic Distance 
The genotyping capability of the MDGA was tested using a set of 351 publically 
available CEL files. These 351 CEL files represent samples genotyped using the MDGA by 
The Jackson Laboratory and are available from the Centre for Genome Dynamics 
(http://cgd.jax.org/datasets/diversityarray/CELfiles.shtml). The samples used in this dataset 
represent mice that are similar to classical laboratory mouse strains, primarily derived from 
the Mus musculus domesticus subspecies to more distantly related subspecies of mice, 
including Mus musculus musculus, Mus musculus molossinus, and Mus musculus castaneus. 
Each sample was grouped into one of eight categories depending on genetic background 
(Table 2-3). These samples were used to determine if the array was capable of differentiating 
between mouse strains that are genetically similar and genetically distant by comparison of 
genetic distance measures. Genetic distance measures were calculated in two ways, first as a 
comparison to a reference genotype and second through pairwise comparisons between each 
sample (Figure 2-6).  
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Table 2-3: Summary of sample types for the 351 CEL files 
available from The Jackson Laboratory 
Type
a 
Number of CEL files 
Classical Laboratory Strain
b 120 
Congenic
c 1 
Consomic
d 10 
BXD
e 44 
Wild-Derived Laboratory Strains
f 58 
F1 Hybrid
g 55 
CC-UNC G2:F1
h
 40 
Wild Caught
i 23 
a
 Samples are ordered based on their potential to be divergent from 
the reference genome 
b
 Mouse strains traditionally used in the laboratory such as the B6 
mouse 
c
 inbred strains that contain a single gene with a genetic background 
different from the rest of the genome 
 
d
 inbred strains that contain a single chromosome with a genetic 
background different from the rest of the genome 
e
 BXD mice inbred mouse strains that are derived from a B6 mouse 
crossed with a DBA mouse  
f
 inbred mouse strains that were derived from wild caught mice 
g
  the first generation of offspring from parents that are from two 
different mouse strains 
h 
collaborative cross mouse strain developed to include the genetic 
diversity of 8 inbred mouse strains 
i
 mice that were captured from fields across Europe and Asia 
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Figure 2-6: Predicted relative genetic distance between the mouse strains from The 
Jackson Laboratory dataset. Predicted relative genetic distance between the 351 samples 
available from The Jackson Laboratory. a) shows the genetic distance as compared to a 
reference of all homozygous (AA) genotypes. b) shows the genetic distance as a phylogenetic 
tree resulting from pairwise comparisons between each sample.   
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2.12.2 Genetic Background 
Twenty-seven additional samples ranging in genetic background from pure B6 to 
varying degrees of B6 and CBA/CaJ genetic background ratios (B6:CBA), along with eight 
B6 mice and one CBA/CaJ mouse from The Jackson Laboratory dataset were analyzed to 
determine the sensitivity of the MDGA in distinguishing a spectrum of genotypes (Figure 
2-7). Genetic diversity was measured as the genetic distance between the mouse samples 
ranging across a spectrum of genetic backgrounds from a pure B6 genetic background to pure 
CBA/CaJ genetic background. Genetic distance measures were determined as a comparison 
to a reference genotype of all homozygous A calls, as well as with pairwise comparisons 
between each of the samples. The additional 27 samples (Table C-1), include a total of 10 
mice, with tissues taken from the spleen (Sp) (n=10), liver (Li) (n=5), and cerebellum (Cl) 
(n=12). Mice with two or more different tissue types were used to determine if genetic 
differences can be detected between tissues of a single mouse. Replicates of the same tissue 
sample from the same mouse were used to determine the variation in genotype within a 
single tissue for samples 300.7 Sp, 300.7 Cl, 911.50 Sp, and 911.50 Cl.    
2.12.3 Somatic Mosaicism 
Somatic mosaicism was measured for the 27 additional samples by analyzing the 
genetic differences detected between tissues of the same mouse (Figure 2-8). The distribution 
of differences for each tissue was compared across chromosomes to determine if there was a 
tissue-specific profile to the accumulation of differences. Tissue-specific profile refers to the 
overall number of differences as well as the distribution of differences across the mouse 
genome in reference to specific tissues.  
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Figure 2-7: Experimental design for detecting the genetic distance between samples 
ranging from 100% C57Bl/6J mouse strain to 100 % CBA/CaJ mouse strain. The 
experimental design used to determine the range of genetic backgrounds from samples 
prepared in-house. a) Comparison of genotypes to a reference of all homozygous A (AA) 
genotypes to determine genetic distance measures. Genetic distance measures were used to 
determine the distance for mixed genetic backgrounds that ranged from 100% C57Bl/6J (B6) 
and 100% CBA/CaJ (CBA) mouse strains. Samples highlighted in blue indicate they are 
from the database of 351 Jackson Laboratory samples. Pure B6 genotypes were used to 
determine the sensitivity to detect genetic differences between tissues of the same mouse, and 
three replicates of the spleen (Sp) and three replicates of the cerebellum (Cl) were used to 
determine intra-tissue variation.  b) Pairwise comparisons of genotype were used to generate 
a phylogenetic tree for the samples ranging in genetic backgrounds from pure B6 to pure 
CBA/CaJ.    
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Figure 2-8: Experimental design for the comparison of somatic mosaicism between the 
spleen, liver, and cerebellum of wild-type and harlequin mice. The experimental design 
used to infer estimates of somatic mosaicism between the spleen (dark shade), cerebellum 
(medium shade), and liver (light shade). Mice used in this study were wild-type (WT) 
(yellow) or harlequin (hq) (purple). Carrier mice are denoted as half purple and half yellow.  
Tissues were harvested from mice at 8 months-of-age, 10 months-of-age, and 15 months-of-
age. Two replicates (totaling three samples per tissue) were included for one WT B6 mouse 
10 months-of-age as well as a single replicate (totaling two samples per tissue) for one WT 
mouse 8 months-of-age. The second WT mouse at 10 months-of-age has only one tissue 
sample for the spleen and no sample for the cerebellum. 
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2.13 Determining genetic distance 
2.13.1 Genetic distance measures from a reference 
 Genetic distance was calculated for each sample using genotypes determined after the 
second round of genotyping for the autosomal post-genotyping original SNP list and the 
autosomal post-genotyping filtered SNP list. Genetic distance was calculated as the total 
number of genotype differences from a reference containing homozygous A (AA) genotypes 
for all SNPs. Genotype calls contributing to a homozygous A genotype were based off the B6 
reference mouse strain. Measures were taken for all autosomal SNPs that passed the 97% 
post-genotype filtering threshold. Genotype differences were identified as anything deviating 
from the homozygous A reference genotype (Homozygous B (BB), Heterozygous (AB), and 
NoCalls). The total number of differences from an AA reference was counted for each 
sample, and divided by the total number of autosomal SNPs that were compared to the 
reference. This generated a genetic distance value between 0 and 1 for each sample. For 
specific aims 2 and 3, genetic distance values were calculated using the autosomal post-
genotyping filtered SNP list.  
2.13.2 Pairwise genetic distance measures 
 Genetic distance measures were then calculated by pairwise comparisons for all 
samples using an iterative process in which each sample was set as a reference and compared 
to all remaining samples in the dataset. Again, genetic distance measures were calculated by 
determining the number of differences from the reference sample for all autosomal SNPs 
passing the 97% post-genotype filtering threshold. Any SNPs containing different genotype 
calls (AA, AB, BB, or NoCall) between two samples for all pairwise sample comparisons 
were identified as differences. In addition, SNPs where a “NoCall” was shared between the 
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reference and the sample were also counted as differences in genotype. NoCalls are not 
informative as to why no genotype call was determined; therefore, an overestimate of 
genotype differences was determined by including shared NoCalls as genotype differences. 
The total number of differences, including shared NoCalls, was then divided by the total 
number of autosomal SNPs that were compared. This generated a genetic distance value for 
each sample between 0 and 1. This was repeated until each sample served as a reference. 
Genetic distances were compared between all mouse strains to create a distance matrix. This 
distance matrix was used to create a phylogenetic tree using the modified neighbour-joining 
algorithm, bionj function from the analysis of phylogenetics and evolution (APE) package in 
R.
126,127
 Phylogenetic trees were saved in the Newick format and visualized using FigTree 
(http://tree.bio.ed.ac.uk/software/figtree/).
128
 A comparison between the matrices was made 
using a Mantel Test to determine if the underlying matrices used to build the trees were 
globally different between the autosomal post-genotyping original SNP list and the 
autosomal post-genotyping filtered SNP list. 
A second set of genetic distance measures was calculated using pairwise comparisons 
of genetic differences between samples; however, this time excluding shared NoCalls. 
Excluding shared NoCalls from the differences gave a conservative estimate for genetic 
distance between the samples. Therefore, genetic distance was calculated as all differences 
between two samples divided by the total number of SNPs that were compared. Again, a 
Mantel Test was used to determine if the structure of the trees between the autosomal post-
genotyping original and filtered lists was statistically different. This second type of pairwise 
comparison is what was used for the remainder of the determinations of genetic distance in 
specific aims 2 and 3.   
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2.14 Comparing genotyping accuracy using genetic distance measures from a reference 
Genetic distance measures compared to a reference of all homozygous A genotypes 
were calculated using the autosomal post-genotyping original SNP list as well as the 
autosomal post-genotyping filtered SNP list. Genetic distance values were separated by strain 
type and compared to determine if there was a significant difference between values 
calculated with each of the SNP lists. Genetic distance values for each strain type were tested 
using the Shapiro-Wilk test (Cytel
®
, Cambridge, MA) to determine if genetic distance values 
for each of the genotyping lists was normally distributed. Strain types were then compared 
between the original and filtered SNP lists to determine if genetic distance values shifted 
significantly using a Mann-Whitney U test because samples were not normally distributed 
(Wilcoxon-Mann-Whitney test) (R, Vienna, Austria).  
2.15 Percentage of genetic variation detectable 
 The percentage of genetic variation detectable using the list of filtered SNPs was 
determined for all samples passing the first round of genotyping. The percentage of genetic 
variation detectable was calculated using the autosomal post-genotyping filtered SNP list. 
Percent genetic variation was determined as the total number of SNPs from this list that 
could detect a difference in genotype in at least one of the samples divided by the total 
number of SNPs queried. The percentage of genetic variation was then compared for each of 
the sample types to determine the amount of genetic variation captured within each group. 
For each sample type, all SNPs with one or more samples varying in genotype call were 
added. These values were then divided by the total number of SNPs capable of detecting 
variation within all of the samples regardless of sample type. 
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2.16 Analysis of genetic variation for C57BL/6J mice 
2.16.1 Percentage C57Bl/6J genetic background 
 In the available set of 351 CEL files, there were tail samples from eight B6 mice. 
Genetic differences between these eight mice were measured using the autosomal post-
genotyping filtered SNP list after two rounds of genotyping (Table 2-4). The total percentage 
of genotypes that are B6, as annotated in the SNP list, was calculated for each mouse. Only 
SNPs that were capable of detecting a B6 genotype as determined in the reannotations were 
included in the analysis.    
2.16.2 Genetic variation within C57Bl/6J mice 
Genotype calls were compared between the eight B6 samples for each SNP to 
determine the total number of genotype differences between the mice. Differences in 
genotype calls were then attributed to each sample by determining which mouse contained 
the “different” genotype call. The total number of differences observed between each mouse 
was compared as a ratio of the total number of genotype differences to the total number of 
SNPs queried using and compared as an average ± SEM. Each genotype difference is 
associated with a SNP, and therefore a chromosome and chromosome position. The total 
number of genotype differences for each of the samples was divided among the 
chromosomes based on the known chromosome location within the mouse reference genome. 
The observed number of genotype differences on each of the chromosomes was then 
compared between samples with a Fisher’s Exact Test with Monte Carle Simulation (MCS) 
(Cytel
®
, Cambridge, MA). The distribution of differences across each of the autosomes was 
recorded and graphed using Circos for each of the eight samples to determine if the 
differences were localized to specific regions across each of the chromosomes.  
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Table 2-4: B6 samples from the 351 publically available 
CEL files from the Center for Genome Dynamics 
Cel file identifier Sample Identifier 
SNP_mDIV_A7-7_081308 B6 (1) 
SNP_mDIV_A1-SNP08_001_103008 B6 (2) 
SNP_mDIV_A2-SNP08_001_103008 B6 (3) 
SNP_mDIV_A3-SNP08_001_103008 B6 (4) 
SNP_mDIV_A4-SNP08_002_103008 B6 (5) 
SNP_mDIV_A6-SNP08_002_103008 B6 (6) 
SNP_mDIV_A5-SNP08_002_103008 B6 (7) 
SNP_mDIV_A5-378_121608 B6 (8) 
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Samples containing a genotype call that was shared between less than four samples 
were considered to have a “genotype difference”. In cases where there was an even split 
containing four B6 mice with one genotype and four B6 mice of another genotype, the four 
samples containing NoCalls were determined to contain the genotype difference. All 
differences detected between the eight B6 samples were analyzed to determine SNPs where 
mice were divided between two genotypes in ratios of 4:4 (4 mice with one genotype : 4 
mice with a second), 4:3 (4 mice with one genotype : 3 mice with a second), or 5:3 (5 mice 
with one genotype : 3 mice with a second). The distribution of these SNPs across the 
autosomes was visualized with Circos to determine if they were localized to specific regions 
across the genome. 
2.17 Analysis of genetic variation for wild caught mice 
 Nineteen wild caught mice from The Jackson Laboratory dataset that passed the first 
round of genotyping were compared to identify all SNPs with genotype differences. SNPs 
that contained differences in genotype calls between any of the wild caught samples were 
identified as containing genotype differences. The total number of SNPs on each 
chromosome that detected a genotype difference was totaled. These differences were not 
attributed to any particular samples because all of the wild caught mice were from different 
locations across Europe and Asia (Figure 2-9).  
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Figure 2-9: The geographic location where wild caught mice included in The Jackson 
Laboratory database were caught. Samples in yellow indicate Mus musculus domesticus 
and samples in purple indicate Mus musculus musculus (Center for Genome Dynamics; 
Google Maps).  
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2.18 Comparison of C57BL/6J genotyping differences to wild caught genotyping 
differences 
 Differences identified between the eight B6 mice as well as the wild caught mice 
were compared to determine SNPs that were different between isogenic mice and wild 
caught mice.  The list of genetic differences identified between B6 mice at ratios of 4:4, 4:3, 
and 5:3 was also compared against the list of differences identified between wild caught 
mice.  All SNPs in common between the two lists were identified and analyzed for genomic 
position and genic regions.   
2.19 Distinguishing mixed C57Bl/6J and CBA/CaJ genetic backgrounds 
 The genotype calls for each SNP were used to identify whether an allele was derived 
from a B6 or a CBA/CaJ mouse strain for samples ranging from pure B6 to pure CBA/CaJ 
genetic backgrounds. Samples ranging in genetic background between these two strains 
include the 27 samples from the Hill laboratory, the eight B6 samples from The Jackson 
Laboratory dataset, and the one CBA/CaJ sample also from The Jackson Laboratory
 
dataset.  
Annotations from the list of filtered SNPs were used to identify the percentage of B6 and 
CBA/CaJ genotypes for each mouse for the post-genotyping filtered SNP list. This 
percentage was then compared to the expected genetic background identified from breeding 
records (Figure 2-10). Mice were ordered by percentage B6 to percentage CBA/CaJ to 
determine the range of genetic diversity between the two mice strains.  Pairwise comparisons 
were also made to generate a phylogenetic tree of the 27 samples from the Hill laboratory, 
the eight B6 samples from The Jackson Laboratory dataset, and the one CBA/CaJ sample 
from The Jackson Laboratory dataset to determine if genotype could be used to accurately 
discriminate between a spectrum of mixed genetic backgrounds.   
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Figure 2-10: Mouse pedigree of samples from the Hill laboratory. Samples are labeled 
with their specific identifier number. Samples are coloured based on Aif phenotype, with 
yellow representing WT and purple representing hq. Samples that are carriers for the hq 
mutation (X
hq
X) are half yellow, half purple.  Samples that are underlined have been selected 
for analysis in this study. Samples that are outlined with dashes indicate isogenic 
backgrounds, large dashes are pure C57BL/6J (B6) and small dashes are pure CBA/CaJ 
(CBA). Remaining samples have a range in their mixture of B6:CBA genetic background.   
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2.20 Genetic diversity and tissue type 
 Samples from the Hill laboratory include multiple tissues from the same mouse, 
which were compared to determine if the array was sensitive enough to detect genetic 
diversity between tissues. The sensitivity to detect differences between tissues of the same 
mouse was analyzed using the genetic distance measures and pairwise comparisons described 
previously by comparing the ranking of samples based on percentage B6 genetic background.  
2.21 Genetic variation within tissues 
 Three replicates from the spleen and three replicates from the cerebellum of a pure B6 
mouse were compared to determine the variation within each tissue. Differences were 
assigned to a single replicate by determining which of the three samples contained a 
genotype different from the other replicates. Replicates were compared using Fisher’s Exact 
Test with Monte Carlo Simulation (MCS; 10,000 simulations), to determine if the total 
number of differences attributed to each sample (average ± SEM) and distribution of 
differences across the autosomes and X chromosome were significantly different. The 
distribution of differences for each replicate was then compared to a random distribution, in 
which differences were distributed at random across the genome, proportional to the length 
of the chromosome. Significance from a random distribution was determined using a Fisher’s 
Exact Test with MCS.  
2.22 Genetic variation between tissues 
Comparisons were made between all combinations of spleen and cerebellum 
replicates, resulting in a total of nine pairwise comparisons (Sp-1 vs Cl-1, Sp-2 vs Cl-1, Sp-3 
vs Cl-1, Sp-2 vs Cl-1, Sp-2 vs Cl-2, Sp-2 vs Cl-3, Sp-3 vs Cl-1, Sp-3 vs Cl-2, and Sp-3 vs Cl-
3). For each of the nine pairwise comparisons, differences were then divided by tissue type, 
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by determining which of the tissues contained a different genotype call (Table 2-5). When an 
AA, AB, or BB genotype of one tissue is compared to a NoCall in a second tissue, the tissue 
containing the NoCall contains the difference. When a homozygous genotype is compared to 
a heterozygous genotype, the tissue containing the heterozygous genotype contains the 
difference. Finally, when a homozygous A was compared to a homozygous B, the tissue 
containing the homozygous B genotype contained the difference. For each comparison, the 
total number of differences between the spleen and the cerebellum was compared to 
determine if there was a significant difference between the tissues (average ± SEM). The 
distribution of differences was also compared across all autosomes and the X chromosome, 
to determine if there was a significant difference between the tissues (Fisher’s Exact Test 
with MCS).  
2.23 Somatic Mosaicism  
 Genotype comparisons were made between the spleen, cerebellum, and/or liver tissue 
of each mouse. Differences in genotype between the tissues were identified for all autosomes 
and the X chromosome using the post-genotyping filtered SNP list, after the second round of 
genotyping. Genotypes were analyzed to identify locations where tissues did not share the 
same genotype calls. Differences in genotype calling were scored, and the tissue containing 
the unexpected genotype call was determined. The total number of differences that were 
attributed to each tissue was then compared to determine differences in frequency (average ± 
SEM) and distribution across the mouse genome (Fisher’s Exact Test with MCS). 
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Table 2-5: Comparison of genotypes used to determine somatic 
mosaicism between pairs of tissues
a 
Tissue 1 genotype Tissue 2 genotype Genotype Difference 
AA AA No difference 
AA AB AB 
AA NoCall NoCall 
NoCall AB NoCall 
a
 Two tissues of the same mouse should contain the same genotype 
calls. The tissue containing the difference contains the genotype that 
is not expected. Samples used for somatic mosaicism studies are on 
a B6 or mixed B6/CBA/CaJ genetic background and should 
therefore contain AA genotypes. When a NoCall occurs in only one 
tissue it is likely due to the failure of hybridization on the array due 
to a genetic variant. 
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Two-tissue and three-tissue comparisons were made depending on the mouse. All hq 
mice 8 months of age had the spleen and cerebellum tissues compared and all WT mice 8 
months of age had the spleen, cerebellum, and liver compared. In two tissue comparisons, the 
genotypes of each tissue were compared to determine which tissue contained the different 
genotype call. The tissue containing the difference was identified as the tissue that contained 
the NoCall or non-homozygous AA genotype. For tissue triads of spleen, cerebellum, and 
liver genotype calls were compared to identify any differences between the three tissues 
(Table 2-6). Differences in tissue triad comparisons were assigned to the tissue containing the 
“one off” genotype. Where two tissues shared the same genotype call, and the third tissue 
differed from the other two. Any cases where all three tissues contained a different genotype 
call, a difference was counted for each of the three tissues. Total differences and the 
distribution of differences across the autosomes and the X chromosome were compared 
between tissues.  
2.23.1 Comparisons between WT mice 
 The total number of differences within a tissue was compared between the spleen 
samples, between the cerebellum samples, and between the liver samples for the three WT 
mice. The distribution of differences across the autosomes and the X chromosome was 
compared between samples as well as in comparison to a random (or expected) distribution.  
A random distribution of differences was calculated for each separate sample, as the total 
number of observed differences divided by the total number of SNPs compared and 
multiplied by the length of each chromosome. This gives the expected number of SNP 
differences for each chromosome proportional to the number of SNPs on that chromosome.   
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Table 2-6: Comparison of genotypes used to determine somatic mosaicism studies 
between tissue triads
a 
Tissue 1 genotype Tissue 2 genotype Tissue 3 genotype Genotype Difference
 
AA AA AA No difference 
AA AB AA AB 
AA NoCall NoCall AA 
NoCall AB AB NoCall 
a
 Three tissues of the same mouse are expected to have the same genotype calls. When 
these genotype calls are different the genotype call that is in the majority of tissues is the 
expected genotype. Therefore, the tissue containing the genotype not shared between the 
other tissues contains a difference.  
 
  
  88 
2.23.2 Comparison of WT replicates 
 The total number of genotype differences between the spleen, cerebellum, and liver 
was compared for a replicate tissue sample of one WT mouse. The total number of 
differences between these three tissues (average ± SEM), as well as their distribution was 
compared using a Fisher’s Exact Test with MCS. The distribution of the observed differences 
for each tissue was also compared to a random distribution (Fisher’s Exact Test with MCS). 
Values for a random distribution in each of the three tissues were calculated as described 
above.  
 Tissue replicates were also compared to determine the variation within each of the 
tissues of a single mouse. Replicates for the spleen, cerebellum, and liver were compared to 
determine the number of differences between two samples of the same tissue. The 
distribution of these differences was also compared across the autosomes and the X 
chromosome to identify any significant differences in distribution.   
2.23.3 Comparisons of hq mice 
 The total number of differences observed in the spleen of the two hq mice and 
between the cerebellum of the two hq mice was compared. The distribution of these 
differences across the autosomes and X chromosome was compared. The distribution of the 
observed differences was also compared for each sample to a random distribution as 
described previously.  
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Chapter 3 : Results 
3.1 The filtered SNP list contains 523,322 SNPs 
A consensus list of 530,035 SNPs was generated by taking the overlap between the 
list of 549,683 SNPs provided by The Jackson Laboratory and the list of 584,729 SNPs 
provided by Genotyping Console (Affymetrix
®
). This consensus list was used to filter SNPs 
based on the seven probe criteria used for filtering probe sets. 
A total of 74 SNPs were removed in the final filtered SNP list that had a probe length 
other than 25 bps. Another 2,736 SNPs had to be removed based on alignment and 417 SNPs 
were identified and removed as they were no longer present in dbSNP. Additionally, 16 
SNPs were removed because their probe sequences contained a recognition sequence for both 
NspI and StyI restriction enzymes. Another 28 SNPs were removed that contained 
recognition sequences for both enzymes within 10 bps surrounding the probe sequence. A 
total of 3,442 SNPs were removed because probe sequences detected more than one SNP 
represented on the array.  A final SNP list containing 523,322 SNPs was generated which 
represents regions distributed across each of the chromosomes in the mouse genome (Figure 
3-1; Appendix B). The 523,322 SNP list is the final list that should be used for genotyping.  
3.2 Nearly all SNPs in the reannotated filtered SNP list can detect a B6 genotype 
Overall, removal of SNPs was evenly distributed across the genome. No one 
chromosome showed a disproportionately high number of SNP removed (Figure 3-2). Each 
chromosome is represented proportionately on the array. The number of SNPs for each 
chromosome is proportional to chromosome length (Table 3-1). The average interSNP 
distance for the filtered SNP list increases from 4 kb to 4.9 kb from the original SNP list; 
however, the overall range remains similar (Figure 3-3).  
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Figure 3-1: The distribution of SNPs across the mouse genome for the filtered SNP list. 
SNP frequency is graphed alongside each of the chromosomes in blue. Regions where there 
are gaps in SNP coverage can be seen as areas with no colouring in the blue inner circle.   
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Figure 3-2: Total number of SNPs representing each chromosome in the mouse genome. 
Grey plus black bars indicate the number of additional SNPs that are in the original SNP list. 
The filtered SNP list is represented by grey bars with a blue outline. The black bars represent 
the number of SNPs that have been removed during filtering.  
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Table 3-1: Overall representation of SNPs from each chromosome for the filtered SNP list 
Mouse 
Chromosome 
Chromosome Length 
(bp) 
Number of SNPs % coverage
a 
First SNP 
position (bp)
b 
Last SNP 
position (bp)
c 
1 197,195,432 43381 0.0220 3013441 197191885 
2 181,748,087 35467 0.0195 3010110 181731538 
3 159,599,783 32975 0.0207 3032787 159598996 
4 155,630,120 30222 0.0194 3013031 155559551 
5 152,537,259 31258 0.0205 3060235 152527863 
6 149,517,037 30950 0.0207 3001551 149505351 
7 152,524,553 28592 0.0187 3099583 152510110 
8 131,738,871 27194 0.0206 3083611 131706890 
9 124,076,172 26328 0.0212 3084105 124029861 
10 129,993,255 24802 0.0191 3009197 129982856 
11 121,843,856 23745 0.0195 3005934 121829163 
12 121,257,530 24938 0.0206 3109153 121256667 
13 120,284,312 24979 0.0208 3006383 120259651 
14 125,194,864 22259 0.0178 6074266 125150241 
15 103,494,974 22224 0.0215 3090615 103458457 
16 98,319,150 19669 0.0200 3282623 98290818 
17 95,272,651 20903 0.0219 3059769 95264893 
18 90,772,031 20058 0.0221 3012495 90766409 
19 61,342,430 13685 0.0223 3125547 61337203 
X 166,650,296 19652 0.0118 4990476 166416379 
Y 15,902,555 34 0.0002 37027 2634903 
Mitochondrial 16,299 7 0.0429 2525 3443 
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a
 the total percentage of the chromosome that is represented by SNPs on the MDGA 
b
 the chromosomal position of the first SNP on the array for each chromosome 
c
 the chromosomal position of the last SNP on the array for each chromosome 
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Figure 3-3: InterSNP distance distribution for SNPs on the MDGA on a log scale. The 
black represents interSNP distances (bps) determined using the original SNP list. The grey 
with blue borders represents interSNP distances in the filtered SNP list. Each bar indicates an 
increment of 150 bps.  
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The average interSNP distance for each chromosome varies depending on the 
chromosome (Table 3-2). The minimum average interSNP distance is 153 bps for the 
mitochondrial genome and maximum average interSNP distance is 787 kb for the Y 
chromosome. For autosomes, the minimum average interSNP distance is 4.2 kb and the 
maximum average genetic distance is 5.3 kb. The smallest interSNP distance is 12 bps and 
the largest interSNP distance is 7.3 Mb. The total number of SNPs representing each of the 
strategies used to identify the SNP has been broken down by chromosome for the filtered 
SNP list (Table 3-3). The number of SNPs that can detect a B6 allele, a CBA/CaJ allele, both 
a B6 and a CBA/CaJ allele, or neither a B6 or CBA/CaJ allele according to the B6:CBA/CaJ 
Annotations for each chromosome is listed in Table 3-4. The number of SNPs located in 
genic regions on each of the chromosomes ranges from 32% to 100% of SNPs detectable on 
the chromosome (Table 3-5). The proportion of SNPs capable of detecting a B6 allele differs 
with each chromosome and ranges from 99.10% to100% (Table 3-6). 
3.3 Fewer samples fail when genotyping with the filtered SNP list 
 The total number of samples failing after one round of genotyping for the original 
SNP list, Genotyping Console SNP list, and filtered SNP list was 50, 29, and 15 respectively. 
The 20 randomly filtered SNP lists resulted in between 53 to 56 samples failing after one 
round of genotyping (Figure 3-4). The samples that failed using the filtered SNP list include 
classical laboratory mice, wild-derived laboratory mice, and wild caught mice (Table 3-7).  
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Table 3-2: InterSNP distance for each chromosome in the mouse genome for the filtered SNP list. 
Mouse 
Chromosome 
Average inter-SNP 
distance (bp) ± SEM 
Smallest inter-SNP 
distance (bp) 
Largest inter-SNP 
distance (bp) 
Number of SNPs 
above average 
% of SNPs above 
average + SEM 
1 4476 ± 69 12 2610728 12573 28.98 
2 5039 ± 83 12 2484127 10206 28.78 
3 4748 ± 44 12 365224 9660 29.29 
4 5048 ± 78 12 1170016 8693 28.76 
5 4782 ± 87 12 2101102 9131 29.21 
6 4734 ± 45 12 249605 9031 29.18 
7 5226 ± 289 12 7268520 7218 25.24 
8 4730 ± 109 12 2050016 7845 28.85 
9 4594 ± 45 12 405837 7845 29.80 
10 5120 ± 51 12 385400 7602 30.65 
11 5004 ± 50 12 155954 6929 29.18 
12 4738 ± 115 12 1751470 6854 27.48 
13 4694 ± 73 12 905392 7176 28.73 
14 5350 ± 130 12 1687052 6447 28.96 
15 4516 ± 45 12 81398 6683 30.07 
16 4831 ± 54 12 247483 5966 30.33 
17 4411 ± 67 12 709221 5778 27.64 
18 4375 ± 47 12 142451 5952 29.67 
19 4254 ± 63 12 279160 3937 28.77 
X 8215 ± 402 12 7033330 5632 28.66 
Y 78724 ± 25825 47 606537 7 20.59 
Mitochondrial 153 ± 58 12 435 1 14.29 
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Table 3-3: Summary of SNPs in the filtered SNP list by strategy used to identify each 
SNP 
Mouse 
Chromosome 
Probe identification strategies 
Classical
a 
NIEHS
b 
B6
c 
Wild
d 
MSM
e 
Y
f 
Mt
g 
Total 
1 10483 30598 188 13 2099 0 0 43381 
2 9768 23521 91 9 2078 0 0 35467 
3 8356 22655 116 7 1841 0 0 32975 
4 7937 20530 121 9 1625 0 0 30222 
5 7545 21929 83 8 1693 0 0 31258 
6 7631 21711 88 4 1516 0 0 30950 
7 6844 20323 139 31 1255 0 0 28592 
8 6824 19075 87 8 1200 0 0 27194 
9 6667 18085 107 25 1444 0 0 26328 
10 6730 16433 73 19 1547 0 0 24802 
11 6593 15672 92 6 1382 0 0 23745 
12 5859 17785 82 16 1196 0 0 24938 
13 6100 17512 77 10 1280 0 0 24979 
14 6323 14792 72 20 1052 0 0 22259 
15 5488 15500 64 20 1152 0 0 22224 
16 5112 13266 59 6 1226 0 0 19669 
17 4793 15035 82 15 978 0 0 20903 
18 4696 14178 39 6 1139 0 0 20058 
19 3120 9826 55 11 673 0 0 13685 
X 0 0 0 0 0 0 0 0 
Y 0 0 0 0 0 7 0 7 
Mitochondrial 7510 11294 3 25 820 0 34 19686 
Total 134379 359720 1718 268 27196 7 34 523322 
a
 SNPs identified from classical laboratory strains 
b
 SNPs identified from studies conducted by the National Institute of Environmental Health 
Sciences (NIEHS) 
c
 SNPs identified in the B6 mouse that are absent from the NIEHS SNPs that were not shared 
with A/J, DBA/2J, 129S1, and MSM/Ms strains. 
d
 SNPs identified in Mus macedonicus, Mus spretus, Mus spicilegus, and Mus musculus  
e
 SNPs identified in Mus musculus molossinus  
f
 SNPs identified that are on the Y chromosome  
g 
SNPs identified that are on the mitochondrial chromosome 
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Table 3-4: Summary of B6:CBA/CaJ annotations for the filtered SNP 
list 
Chromosome B6
a 
CBA
b 
Heterozygous
c 
Negative
d 
Total 
1 33320 315 9738 8 43381 
2 28962 250 6254 1 35467 
3 25293 262 7417 3 32975 
4 24445 211 5561 5 30222 
5 24845 213 6198 2 31258 
6 24694 239 6016 1 30950 
7 22479 196 5913 4 28592 
8 21226 224 5740 4 27194 
9 20911 189 5226 2 26328 
10 21504 217 3076 5 24802 
11 18459 159 5124 3 23745 
12 19121 170 5644 3 24938 
13 19740 210 5024 5 24979 
14 15853 188 6216 2 22259 
15 17932 171 4119 2 22224 
16 15383 140 4144 2 19669 
17 15766 157 4978 2 20903 
18 16661 155 3241 1 20058 
19 10323 117 3245 0 13685 
X 31 0 3 0 34 
Y 7 0 0 0 7 
Mitochondrial 17330 46 2273 3 19652 
Total 414285 3829 105150 58 523322 
a
 either the A allele or the B allele is present in the C57BL/6J (B6) mouse 
strain 
b
 either the A allele or B allele is present in the CBA/CaJ mouse strain 
c
 the A allele or B allele is present in the C57BL/6J (B6) mouse strain and 
the non-B6 allele is present in the CBA/CaJ mouse strain 
d
 cannot detect the C57BL/6J allele or CBA/CaJ allele  
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Table 3-5: Summary of SNPs in genic regions in the filtered 
SNP list 
Mouse 
Chromosome 
Number of SNPs in 
Genes 
% of SNPs in genes 
1 18996 43.79 
2 17637 49.73 
3 12972 39.34 
4 14120 46.72 
5 15716 50.28 
6 15526 50.16 
7 14117 49.37 
8 11851 43.58 
9 13068 49.64 
10 11326 45.67 
11 12080 50.87 
12 10799 43.30 
13 10596 42.42 
14 10074 45.26 
15 9908 44.58 
16 8815 44.82 
17 10540 50.42 
18 9079 45.26 
19 7434 54.32 
X 7020 35.72 
Y 11 32.35 
Mitochondrial 7 100.00 
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Table 3-6: The proportion of SNPs on each chromosome 
capable of detecting an allele that is present in the B6 genetic 
background. 
Chromosome Number of SNPs that 
genotype a B6 mouse 
%  of SNPs that  
genotype a B6 mouse 
1 43058 99.26 
2 35216 99.29 
3 32710 99.20 
4 30006 99.29 
5 31043 99.31 
6 30710 99.22 
7 28392 99.30 
8 26966 99.16 
9 26137 99.27 
10 24580 99.10 
11 23583 99.32 
12 24765 99.31 
13 24764 99.14 
14 22069 99.15 
15 22051 99.22 
16 19527 99.28 
17 20744 99.24 
18 19902 99.22 
19 13568 99.15 
X 19603 99.75 
Y 34 100.00 
Mitochondrial 7 100.00 
Total 519435 99.26 
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Figure 3-4: Number of samples that failed after one round of genotyping for randomly 
generated SNP lists of 523,322 SNP probes. A total of 351 CEL files from the publically 
available Jackson Laboratory dataset were used to determine the genotyping accuracy of the 
filtered SNP list. The total number of samples that failed after one round of genotyping for 
the filtered SNP list is shown in red. The total number of samples that failed after one round 
of genotyping for the 20 randomly generated SNP lists is shown in black.   
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Table 3-7: Samples that failed round one of genotyping from the 351 publically available CEL files from The 
Jackson Laboratory dataset using the filtered SNP list 
MDGA CEL file identifier Mouse 
Gender 
Overall 
call rate
a
 
Sample Type Mouse Strain 
SNP_mDIV_A9-9_081308 Male 92.51 Wild-derived laboratory strain CAST/EiJ 
SNP_mDIV_D4-470_012209 Male 95.17 Wild-derived laboratory strain MDGI 
SNP_mDIV_B6-390_012709 Male 95.49 Classical laboratory strain A/HeJ 
SNP_mDIV_C10-121_090908 Male 95.98 Classical laboratory strain ATEB/LeJ 
SNP_mDIV_C11-35_081308 Male 96.29 Wild-derived laboratory strain PWK/PhJ 
SNP_mDIV_D6-133_090908 Male 96.31 Classical laboratory strain MA/MyJ 
SNP_mDIV_A6-54_082108 Male 96.32 Wild-derived laboratory strain MSM/Ms 
SNP_mDIV_B6-450_012209 Male 96.38 Wild-derived laboratory strain PWK hybrid 
SNP_mDIV_A4-157_091708 Female 96.52 Wild caught RDS10105 
SNP_mDIV_A7-55_082108 Male 96.60 Wild-derived laboratory strain SKIVE/EiJ 
SNP_mDIV_B4-191_082108 Female 96.69 Wild caught BAG94 
SNP_mDIV_B10-491_022709 Female 96.73 Wild caught Yu2120f 
SNP_mDIV_C10-405_012709 Male 96.87 Classical laboratory strain NONcNZO10/LtJ 
SNP_mDIV_B6-188_103008_3 Female 96.94 Wild caught BAG102 
SNP_mDIV_B2-446_012209 Male 96.96 Wild-derived laboratory strain MPB 
a 
overall call rate refers to the total number of AA, AB, and BB genotypes determined for each sample using all SNP 
probes included in the 523,322 SNP list used for genotyping. 
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3.4 There is little variation between genetic distance measures calculated for the 
original and filtered SNP lists 
Genetic distance measures for the autosomal post-genotyping filtered SNP list are 
similar to those calculated for the autosomal post-genotyping original SNP list (Table 3-8). 
However, using the filtered SNP list, genetic distance values increase or decrease depending 
on their sample type. For wild caught mice the minimum genetic distance measure remained 
the same; however the maximum and average genetic distance measures increased. The 
minimum, maximum, and average genetic distance measures for collaborative cross mice and 
F1 hybrid mice increased. The genetic distance range for wild-derived laboratory mice 
broadens, with the minimum value decreasing and the maximum value increasing. The 
average genetic distance value for wild-derived laboratory strains also increased. The 
minimum and maximum genetic distance measures, as well as the average genetic distance 
value for both consomic and BXD mice decreased. The genetic distance of the congenic 
mouse sample also increased. The range of genetic distance values for classical laboratory 
strains decreased for the minimum genetic distance value. The maximum genetic distance 
value remained the same for classical laboratory strains; however, the average genetic 
distance value decreased. Genetic distances for both the collaborative cross mice and F1 
hybrid mice were significantly different between the original and filtered SNP lists (p<0.01, 
p<0.01 respectively; Mann-Whitney U Test). The remaining sample types showed no 
significant difference between genetic distance values calculated with the original SNP list 
and those calculated with the filtered SNP list.  
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Table 3-8: Genetic distance measures determined for samples compared to a homozygous A reference using autosomal post-
genotyping lists 
Sample Type
a 
 Original SNP list
b 
 Filtered SNP list
cd 
 Min
e 
Max
f 
Mean
g 
SEM
h 
Min
e 
Max
f 
Mean
g
 SEM
h 
Classical laboratory strains (114, 116) 0.010 0.226 0.157 0.007 0.000 0.226 0.153 0.007 
congenic (1, 1)   0.237    0.241  
consomic (10, 10) 0.011 0.237 0.174 0.018 0.001 0.209 0.036 0.019 
BXD (44, 44) 0.089 0.168 0.110 0.002 0.083 0.167 0.106 0.002 
Wild-derived laboratory strains (42, 51) 0.136 0.521 0.339 0.017 0.133 0.529 0.354 0.017 
F1 Hybrid (37, 55)
i 0.190 0.587 0.462 0.022 0.191 0.646 0.495 0.019 
CC-UNC G2:F1 (37, 40)
i
 0.363 0.456 0.411 0.003 0.374 0.473 0.428 0.003 
Wild Caught  (12, 19) 0.271 0.511 0.361 0.026 0.271 0.519 0.409 0.029 
a 
Samples are ordered based on their potential to be divergent from the reference genome 
b
 521,841 SNPs used in genetic distance measure determinations 
c
 450,927 SNPs used in genetic distance measure determinations     
d
 red values indicate a decrease in genetic distance towards 0 and blue values indicate an increase genetic distance towards1 
e
 the minimum genetic distance values for each of the sample types 
f
 the maximum genetic distance values for each of the sample types 
g
 the average genetic distance values for each of the sample types 
h
 standard error of the mean for each of the sample types 
i 
significantly different distribution of genetic distance values between the original and filtered SNP lists (Mann-Whitney U test). 
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Genetic distance measures were then calculated for all samples that passed the first 
round of genotyping after all samples were regenotyped for both the original SNP list and the 
filtered SNP list to determine if there was a significant difference in phylogenetic trees 
(Figure 3-5; Figure 3-6). Only samples that appeared in both lists were compared and no 
significant difference was seen between the ordering of the nodes when genetic distance was 
calculated when NoCalls shared between samples were included as differences (Mantel 
score=0.9995; p<0.001; Mantel Test). When NoCalls shared between samples were excluded 
as genetic differences, the genetic distance values were also the same between the two 
genotyping lists (Mantel score=0.9995; p<0.001; Mantel Test) (Figure 3-7; Figure 3-8).     
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Figure 3-5: Phylogenetic tree for 301 samples created using genetic distance values 
determined with the autosomal post-genotyping original SNP list. The colours for each of 
the mouse samples indicate which sample type they are according to their mouse strain. 
NoCalls shared between samples were counted as differences when calculating the genetic 
distances used to create this tree. 
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Figure 3-6: Phylogenetic tree for 336 samples created using genetic distance values 
determined with the autosomal post-genotyping filtered SNP list. The colours for each of 
the mouse samples indicate which sample type they are according to their mouse strain. 
NoCalls shared between samples were counted as differences when calculating the genetic 
distances used to create this tree.  
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Figure 3-7: Phylogenetic tree for 301 samples created using genetic distance values 
determined with the autosomal post-genotyping original SNP list. The colours for each of 
the mouse samples indicate which sample type they are according to their mouse strain. 
Shared NoCalls between samples were not counted as differences in the genetic distance 
measures used to create this tree. 
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Figure 3-8: Phylogenetic tree for 336 samples created using genetic distance values 
determined with the autosomal post-genotyping filtered SNP list. The colours for each of 
the mouse samples indicate which sample type they are according to their mouse strain. 
Shared NoCalls between samples were not counted as differences in the genetic distance 
values used to create this tree. 
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3.5 Genetic Distance 
3.5.1 Genetic distance measures can distinguish between samples as compared to a 
reference genome homozygous for the A allele at all loci  
 After one round of genotyping, 15 samples were identified as having failed to pass 
the genotyping threshold of 97% (Table 3-7). The remaining 336 samples were subjected to a 
second round of genotyping with the filtered SNP list and the genotyping call rate for each 
sample is listed (Table C-2). Genetic distance was calculated for the 336 samples using the 
autosomal post-genotyping filtered SNP list (450,927 SNPs) to obtain a genetic distance 
measure for each of the samples compared to a reference genome homozygous for the A 
allele at all loci (Figure 3-9). The mouse strains in the 336 samples have been divided by 
sample type; wild caught, collaborative cross, F1 hybrid, wild-derived laboratory, BXD, 
consomic, congenic, and classical laboratory.  Mice that are more genetically distant from the 
homozygous A reference have a genetic distance closer to 1, such as the wild-derived 
laboratory strains, the collaborative cross mice, and the wild caught mice. Mice that are more 
genetically similar to the reference AA genotype (modified from a B6 mouse) have a genetic 
distance closest to 0, such as the BXD and classical laboratory strains. The highest genetic 
distance was 0.64601 for the F1 hybrid of CAST/EiJxPWK/PhJ (Mus musculus castaneus x 
Mus musculus musculus). The smallest genetic distance determined using this method was a 
pure B6 (Mus musculus domesticus) mouse with a distance of 0.00049 from the reference 
sample.   
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Figure 3-9: Genetic diversity of 336 samples from The Jackson Laboratory in 
comparison to a homozygous A reference. Colours in order from left to right across the 
graph represent BXD (light blue), collaborative cross (light purple), classical laboratory 
strains (dark blue), congenic (black), consomic (grey), F1 hybrid (dark purple), wild caught 
(pink), and wild-derived mouse strains (teal).  
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3.5.2 Genetic distance measures from pairwise comparisons can distinguish between 
distantly and closely related samples 
Genetic distances were calculated to generate a genetic distance matrix for all 336 
passing samples from The Jackson Laboratory database using the autosomal post-genotyping 
filtered SNP list (Table D-1). Samples were given a genetic distance value between 0 and 1. 
Samples with the highest genetic distance measures were from Mus musculus musculus and 
Mus musculus castaneus substrains and include wild-derived laboratory mice, CC, F1 
hybrids, and wild caught mice. Samples that were most similar to the reference of all 
homozygous A genotypes had genetic distances closest to 0. Samples with genotypes closest 
to the reference include Mus musculus domesticus samples for classical laboratory strains, 
BXD strains, and consomic mice that are on a B6 genetic background with a single 
chromosome replacement from the PWD/PhJ-ForeJ mouse strain. Phylogenetic trees were 
created using this distance matrix and mouse strain types were colour coded to distinguish a 
pattern among the phylogeny based on strain type (Figure 3-8).  Each strain type groups 
closely together within the phylogenetic tree. Genetic distance measures calculated for the 
eight B6 mice, could differentiate between each of the samples (Figure 3-10; Table D-2). 
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Figure 3-10: Genetic distance values calculated for the eight B6 samples using the 
autosomal post-genotyping filtered SNP list. Genetic distance values were calculated after 
genotyping with 336 samples. All samples are part of the classical laboratory strain set 
(blue).  
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3.5.3 Nearly all SNPs on the array can detect genetic variation 
 Of the 450,927 SNPs in the autosomal post-genotyping filtered SNP list that were 
used for genetic distance comparisons, a total of 448,174 SNPs were capable of detecting 
genetic variation between 336 samples. This is attributed to 99.4% of SNPs used in the 
analysis.  A total of 2,753 SNPs did not detect any genotype differences between the 336 
samples. The percentage of genetic variation detectable for each sample varies depending on 
the sample type (Table 3-9). B6 mice detect the least amount of genetic variation and wild-
derived laboratory strains detect the most amount of genetic variation. 
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Table 3-9: Percentage of genetic variation detectable within each sample 
type using the Mouse Diversity Genotyping Array. 
Sample Type
a 
Number of 
CEL files 
% of SNPs that detect 
genetic variation 
Classical Laboratory Strain 116 71.4 
C57Bl/6J
b
 8 1.7 
Congenic
c
 1  
Consomic
 10 32.1 
BXD 44 24.7 
Wild-Derived Laboratory Strains
 51 96.5 
F1 Hybrid 55 91.9 
CC-UNC G2:F1 40 87.7 
Wild Caught 19 82.0 
a 
Samples are ordered based on their potential to be divergent from the 
reference genome 
b 
the samples included in C57BL/6J are part of the 116 samples in classical 
laboratory strains 
c 
only contains one sample therefore could not detect the amount of genetic 
variation within group 
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3.5.4 Genetic variation can be detected among C57BL/6J mice 
 Overall, the eight B6 samples genotyped with a genetic background over 98% B6 
(Table 3-10). The range of genetic distance values for B6 mice is between 0.0005 and 0.0103 
(SEM 0.0011). A total of 7,793 SNPs detected genotype differences between the eight B6 
mice. These differences include 2% of the genetic variation detectable on the array from the 
448,174 informative SNPs that detect differences between 336 samples. When separated by 
sample, there was a significant difference in the total number of differences between the eight 
mice (average 1044 ± 504 genotype differences) (p<0.001; Fisher’s Exact Test MCS) (Figure 
3-11). When mouse eight is removed from analysis the average number of genetic 
differences is 557  ± 152. When looking at how differences accumulated across autosomes of 
the mouse genome, all eight mice were not significantly different from each other. The 
distribution of observed differences in genotype as an over- or under-representation of 
differences from the expected random distribution was compared by subtracting the expected 
(the number of differences in genotype calls calculated from the observed value in proportion 
to the number of SNPs on each chromosome) from the total number of differences observed 
on each chromosome. The distribution for all eight mice was not significantly different from 
a random distribution. The distribution of differences based on position along each of the 
chromosomes for all eight mice does not show any obvious regions that preferentially 
accumulate or lack differences for any of the mice (Figure 3-12). Of the differences detected 
between the eight mice, a total of 47 have two major genotype calls represented among the 
samples in ratios of 4:4, 4:3, and 5:3 genotype differences; where a minimum of three mice 
genotype with one call and three mice genotype with a second genotype call. The few 
differences between two major genotypes were divided among all but one of the mouse 
chromosomes, chromosome 16.  
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Table 3-10: Percentage of SNPs that genotyped as B6
a
 for the eight B6 mice in The 
Jackson Laboratory dataset using the autosomal post-genotyping filtered SNP list. 
Sample B6 genotypes non-B6 genotypes % B6 Genetic distance value 
B6 (1) 448124 2803 99.38 0.0015 
B6 (2) 448386 2541 99.44 0.0009 
B6 (3) 447340 3587 99.20 0.0033 
B6 (4) 448143 2784 99.38 0.0014 
B6 (5) 448555 2372 99.47 0.0005 
B6 (6) 447853 3074 99.32 0.0017 
B6 (7) 448017 2910 99.35 0.0021 
B6 (8) 445230 5697 98.74 0.0103 
a 
450,927 SNPs from the autosomal post-genotyping filtered SNP list were capable of 
detecting a B6 genotype and were used to calculate the percentage of B6 genotypes for 
each sample
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Figure 3-11: Differences attributed to each of the eight B6 mice from The Jackson 
Laboratory dataset. A) The total number of genotype differences associated with each of 
the eight samples (average 1044 ± 504 genotype differences). B) The distribution of 
observed differences in genotype graphed to show instances of over- and under-
representation from a random occurrence based on the number of genotype calls per 
chromosome. 
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Figure 3-12: The distribution of differences across the autosomes for each of the eight 
B6 mice from The Jackson Laboratory dataset. Each of the differences attributed to the 
eight mice is shown in its own track inside the ring of chromosomes. Mouse 1 in blue is 
closest to the karyotypes, and mouse 8 the second inner-most ring in orange. The remaining 
colours correspond in the following order, mouse 2 in yellow, mouse 3 in purple, mouse 4 in 
green, mouse 5 in light blue, mouse 6 in red, and mouse 7 in dark purple. The distribution of 
differences across the autosomes for the differences detected between the “majority” of B6 
mice from The Jackson Laboratory dataset is the inner-most ring. The number of differences 
detected when B6 mice were divided evenly into two distinct genotype calls in ratios of (4:4, 
4:3, and 5:3). The location of the SNP affected is plotted in purple on the inside track for 
each chromosome.  
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3.5.5 Genetic variation can be detected between wild caught mice 
 The total number of SNPs where differences were detected between 19 wild caught 
mice was 367,695 SNPs (Figure 3-13). These differences include 82% of the genetic 
variation detectable on the array from the 450,927 informative SNPs that detect differences 
between 336 samples. Of these 367,695 SNP differences, 6,671 SNP differences are shared 
between the wild caught mice and the eight B6 mice from the previous analysis (Figure 
3-14). Of the 47 SNPs that were represented in the majority of samples genotyping 
differently, 41 of the SNPs were also present in the 6,671 SNPs detecting differences in both 
the B6 and wild caught mice. Of the 41 SNPs where differences occur between both wild 
caught and the eight B6 mice, 14 are located in regions affecting genes (Table 3-11).  
3.6 Apoptosis-inducing factor genotyping  
Mice that genotyped as WT were 911.17, 911.49, 911.50, 300.6, and 300.7. Mice that 
genotyped with the hq mutation were 904.9, 904.11, 911.143, and 911.148. Mouse 900.3 
genotyped as a hq carrier.  
3.7 DNA quality for DNA extractions 
The concentration, 260/280 ratio, and 260/230 ratio for each of the 33 samples from 
the Hill laboratory are shown in Table 3-12. The DNA extracted for the 33 samples was of 
high molecular weight (Figure 3-15).  
3.8 Samples failed genotyping because of poor DNA quality 
 A total of six samples from the Hill laboratory failed genotyping. DNA quality ratios 
indicate that the 260/280 ratios and 260/230 ratios were below the optimum 1.8 and 2.0, 
respectively (Table 3-13). 
 
 
  133 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-13: Total number of differences across each of the chromosomes detected 
between 19 wild caught mice. The total number of SNPs detected using the filtered SNP list 
is shown by the maximum height of the black bar. The total number of differences detected 
between the 19 wild caught mice is shown in grey bars with blue borders.  
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Figure 3-14: The number of SNPs that detected differences between the eight B6 mice 
and between 19 wild caught mice from The Jackson Laboratory dataset. Differences 
identified between the B6 mice are indicated by the red circle. The purple circle indicates 
differences identified between the wild caught mice. The overlap between the circles is the 
number of SNPs in common between the two lists of differences. The numbers are associated 
with differences specific to the B6 mice, shared between the B6 and wild caught mice, and 
specific to the wild caught mice when moving from left to right across the figure. 
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Table 3-11: SNPs affecting genes where differences occur in both B6 and wild caught mice 
Chromosome Chromosome position (bps) Gene Name Gene Symbol
a 
2 132520778 RIKEN cDNA 1110034G24 gene 1110034G24Rik 
4 21780030 Serine/arginine-rich splicing factor 18 Sfrs18 
5 28705949 RNA binding motif protein 33 Rbm33 
6 32800650 Coiled-coil-helix-coiled-coil-helix domain containing Chchd3 
8 83952230 Inositol polyphosphate-4-phosphatase, type II Inpp4b 
9 67134475 Talin 2 Tln2 
12 25588806 Membrane bound O-acyltransferase domain containing 2 Mboat2 
12 67752382 MAM domain containing glycosylphosphatidylinositol anchor 2 Mdga2 
13 71689784 RIKEN cDNA 1700112M02 gene AK007185 
14 120680516 Muscleblind-like 2 Mbnl2 
14 28152097 Rho guanine nucleotide exchange factor (GEF) 3 Arhgef3 
18 67392407 Metallophosphoesterase 1 Mppe1 
19 6009147 Calpain 1 Capn1 
19 21907126 Transmembrane protein 2 Tmem2 
a 
Gene Symbol was taken from MGI 
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Table 3-12: Quality control data for DNA extractions 
Mouse 
ID 
Tissue DNA Concentration 
(µg/µl) 
Total DNA 
Yield (µg) 
260/280 
ratio 
260/230 
ratio 
Electrophoretic 
assessment
a 
DNA Extraction 
location 
904.9 Sp 1.35 134.6 1.85 2.16 √ JAX 
904.11 Sp 1.69 169.4 1.82 2.23 √ JAX 
911.49 Sp 1.84 184.3 1.84 2.23 √ JAX 
911.50 Sp 1.53 153.4 1.83 2.28 √ JAX 
904.9 Cl 0.27 13.6 1.74 1.31 √ JAX 
904.11 Cl 0.37 18.46 1.76 1.34 √ JAX 
911.49 Cl 0.28 13.81 1.73 1.27 √ JAX 
911.50 Cl 0.30 14.97 1.76 1.33 √ JAX 
911.143 Cl 0.19 9.27 1.73 1.16 √ JAX 
911.148 Cl 0.19 9.46 1.72 1.13 √ JAX 
300.6 Cl 0.10 9.96 1.81 1.43 √ LRGC 
300.6
 b
 Sp 0.26 26.13 1.9 2.44 √ LRGC 
900.3 Li 0.22 22.12 1.82 1.44 √ LRGC 
900.3 Sp 0.48 48.00 1.87 2.42 √ LRGC 
911.50 Cl-2 0.10 9.73 1.88 2.34 √ LRGC 
911.50 Sp-2 0.25 24.83 1.88 2.33 √ LRGC 
904.9
b 
Li 0.93 928.60 1.72 1.3 √ LRGC 
904.11
b
 Li 1.97 1967.07 1.75 1.39 √ LRGC 
904.12
b
 Li 1.28 1279.87 1.75 1.4 √ LRGC 
911.49
b
 Li 2.82 2822.40 1.75 1.65 √ LRGC 
911.47
b
 Li 1.93 1934.30 1.74 1.39 √ LRGC 
911.50 Li 1.15 1151.46 1.8 1.93 √ LRGC 
300.7 Cl-2 0.10 9.76 1.84 2.17 √ Hill Laboratory 
300.7 Cl-3 0.10 9.60 1.81 1.96 √ Hill Laboratory 
300.7 
300.7 
Sp-1 
Sp-2 
0.10 
0.17 
9.79 
17.41 
1.89 
1.88 
2.26 
2.24 
√ 
√ 
Hill Laboratory 
Hill Laboratory 
300.7 Sp-3 0.09 9.17 1.86 2.44 √ Hill Laboratory 
911.17 Sp 0.10 10.07 1.9 2.23 √ Hill Laboratory 
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Mouse 
ID 
Tissue DNA Concentration 
(µg/µl) 
Total DNA 
Yield (µg) 
260/280 
ratio 
260/230 
ratio 
Electrophoretic 
assessment
a
 
DNA Extraction 
location 
911.17 Cl 0.08 8.44 1.86 2.24 √ Hill Laboratory 
911.17 Li 0.25 24.68 1.87 1.94 √ Hill Laboratory 
911.49 Li 0.10 9.72 1.88 2.13 √ Hill Laboratory 
911.50 Li-2 0.19 19.462 1.89 2.11 √ Hill Laboratory 
a
 indicates whether samples were electrophoresed through an agarose gel to determine if the DNA extraction was high  
molecular weight 
b  
samples that failed to pass the first round of genotyping threshold of 97% overall genotype call 
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Figure 3-15: 1.5% agarose gel of high molecular weight DNA extractions. This gel shows 
the quality for samples isolated in the Hill Laboratory. This is a representation of all 
extractions for DNA quality. Lane 1 contains a 1 kb ladder. Lanes 2-4 contain DNA isolated 
from samples 300.7 Cl-1, Cl-2, and Cl-3 respectively. Lanes 5-7 contain DNA isolated from 
samples 300.7 Sp-1, Sp-2, and Sp-3 respectively. Lane 8-10 contain DNA isolated from 
911.17 Sp, Cl, and Li respectively. Lane 11 contains 911.49 Li and lane 12 contains 911.50 
Li-2. Samples were stained with SYBR Safe for visualization.  
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Table 3-13: DNA quality for failing Hill laboratory samples and their 
genotyping call rates 
Mouse ID Tissue
a 
260/280 
ratio 
260/230 
ratio 
Genotyping call 
rate
 
300.6 Sp 1.81 1.43 96.34 
904.9 Li 1.72 1.30 84.75 
904.11 Li 1.75 1.39 94.80 
904.12 Li 1.75 1.40 78.23 
911.49 Li 1.75 1.65 95.64 
911.47 Li 1.74 1.39 95.00 
a 
Tissue from which the DNA was extracted. Tissue types include the spleen (Sp) and 
liver (Li). 
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3.9 Genetic Background 
3.9.1 Genetic distance measures can distinguish between samples when determined 
from a homozygous A reference 
 A total of 384 samples were genotyped in round one of genotyping using the filtered 
SNP list. Of these samples, 22 failed genotyping (Table 3-14). Sixteen of these 22 samples 
were from The Jackson Laboratory database, and six samples were from the Hill laboratory. 
Genotype results from the remaining 362 passing samples were obtained after a second round 
of genotyping using the filtered SNP list (Table C-2). 
3.9.2 Genetic background comparisons can distinguish between samples that range in 
genetic background from pure C57BL/6J to pure CBA/CaJ 
 The percentage of B6, CBA/CaJ, and heterozygous genotypes was compared between 
the eight B6 mice from The Jackson Laboratory database, 27 passing samples from the Hill 
laboratory, and the CBA/CaJ sample from The Jackson Laboratory (Table 3-15). Samples 
can be distinguished based on the percentage of B6 genotype calls. Pure B6 samples 
genotype with the highest percentage of B6 genotypes. Pure CBA/CaJ samples genotyped 
with the highest percentage of CBA/CaJ genotypes calls. Samples that contain high levels of 
heterozygosity (50% B6:50% CBA/CaJ) genotyped with the highest number of heterozygous 
genotype calls. Overall, the B6 genotype decreases as the genetic background of a mouse 
becomes more CBA/CaJ. Mice will never genotype 100% CBA/CaJ because a B6 mouse and 
a CBA/CaJ mouse genotype the same for 369,597 SNPs. Multiple tissue samples from the 
same mice tend to group together.  
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Table 3-14: Samples that failed 1
st
 round genotyping out of the 384 provided samples using the filtered SNP list 
MDGA CEL file identifier Mouse 
Gender 
Overall 
call rate
a
 
Sample Type Mouse Strain 
DNA3255
b
 Male 78.23 Classical laboratory strain C57BL/6J/ CBA/CaJ 
DNA3253
b
 Male 84.75 Classical laboratory strain C57BL/6J/ CBA/CaJ 
SNP_mDIV_A9-9_081308 Male 92.45 Wild-derived laboratory strain CAST/EiJ 
DNA3254
b
 Male 94.80 Classical laboratory strain C57BL/6J/ CBA/CaJ 
DNA3257
b
 Male 95.00 Classical laboratory strain C57BL/6J/ CBA/CaJ 
SNP_mDIV_D4-470_012209 Male 95.10 Wild-derived laboratory strain MDGI 
SNP_mDIV_B6-390_012709 Male 95.37 Classical laboratory strain A/HeJ 
DNA3256
b
 Male 95.64 Classical laboratory strain C57BL/6J/ CBA/CaJ 
SNP_mDIV_C10-121_090908 Male 95.85 Classical laboratory strain ATEB/LeJ 
SNP_mDIV_C11-35_081308 Male 96.19 Wild-derived laboratory strain PWK/PhJ 
SNP_mDIV_D6-133_090908 Male 96.20 Classical laboratory strain MA/MyJ 
SNP_mDIV_A6-54_082108 Male 96.25 Wild-derived laboratory strain MSM/Ms 
SNP_mDIV_B6-450_012209 Male 96.32 Wild-derived laboratory strain PWK hybrid 
DNA3159
b
 Male 96.34 Classical laboratory strain C57BL/6J/CBA/CaJ 
SNP_mDIV_A4-157_091708 Female 96.46 Wild caught RDS10105 
SNP_mDIV_A7-55_082108 Male 96.52 Wild-derived laboratory strain SKIVE/EiJ 
SNP_mDIV_B4-191_082108
 
Female 96.62 Wild caught BAG94 
SNP_mDIV_B10-491_022709 Female 96.64 Wild caught Yu2120f 
SNP_mDIV_C10-405_012709 Male 96.78 Classical laboratory strain NONcNZO10/LtJ 
SNP_mDIV_B6-188_103008_3 Female 96.86 Wild caught BAG102 
SNP_mDIV_B2-446_012209 Male 96.90 Wild-derived laboratory strain MPB 
SNP_mDIV_C9-464_012209 Male 96.97 Wild-derived laboratory strain DDO 
a
 overall call rate refers to the total number of genotypes determined as AA, AB, or BB for each sample 
b
 are Hill laboratory samples 
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Table 3-15: Percentage of B6 and CBA genetic background
a
 for all of the Hill 
laboratory plus B6 and CBA/CaJ samples from The Jackson Laboratory dataset
b 
Sample ID 
and tissue
 
Expected  
%B6 genotypes 
% B6 
genotypes 
% CBA 
genotypes 
% Heterozygous 
genotypes 
% 
other 
B6 (5)  100 99.49 0.39 0.00 0.13 
B6 (2) 100 99.44 0.38 0.00 0.18 
B6 (1)  100 99.40 0.38 0.00 0.21 
B6 (7) 100 99.37 0.38 0.00 0.24 
B6 (4) 100 99.37 0.38 0.01 0.24 
300.7 Cl-3 100 99.37 0.40 0.01 0.22 
B6 (6) 100 99.34 0.38 0.00 0.27 
300.7 Sp-2 100 99.30 0.40 0.01 0.29 
300.7 Sp-3 100 99.29 0.40 0.01 0.30 
300.7 Sp-1 100 99.18 0.40 0.01 0.40 
B6 (3) 100 99.18 0.38 0.01 0.43 
300.7 Cl-1 100 99.14 0.40 0.01 0.45 
300.7 Cl-2 100 99.13 0.40 0.02 0.45 
B6 (8) 100 98.77 0.21 0.02 1.00 
300.6 Cl 100 98.65 0.39 0.04 0.92 
904.11 Cl 75 87.67 0.41 11.70 0.21 
904.11 Sp 75 87.67 0.41 11.72 0.20 
904.9 Sp 75 86.68 0.42 12.69 0.21 
904.9 Cl 75 86.66 0.42 12.71 0.21 
900.3 Sp 50 82.09 6.62 10.21 1.08 
900.3 Li 50 82.06 6.59 10.19 1.16 
911.143 Cl 7 79.67 13.14 7.01 0.18 
911.148 Cl 7 79.66 12.97 7.19 0.18 
911.50 Sp 7 79.25 14.36 6.23 0.16 
911.49 Cl 7 79.24 12.93 7.63 0.20 
911.49 Sp 7 79.24 12.93 7.64 0.19 
CBA/CaJ 0 79.21 20.60 0.00 0.19 
911.50 Cl 7 79.18 14.32 6.23 0.27 
911.50 Sp-2 7 79.14 14.32 6.20 0.34 
911.17 Cl 7 79.11 15.04 5.50 0.34 
911.50 Cl-2 7 79.03 14.28 6.21 0.48 
911.50 Li-2 7 79.01 14.29 6.21 0.48 
911.17 Sp 7 79.01 15.00 5.48 0.51 
911.17 Li 7 78.85 14.99 5.48 0.68 
911.49 Li 7 78.56 12.80 7.40 1.24 
911.50 Li 7 77.83 14.04 6.10 2.03 
a
 Samples are ordered from the highest to the lowest percentage of B6 genotypes 
b
 Samples highlighted in red are the pure B6 and CBA/CaJ samples from The Jackson 
Laboratory dataset 
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Comparison of each sample to a reference of all homozygous A genotypes determined the 
genetic distance for each of the 362 samples (Figure 3-16). Genetic distance values were 
compared between the eight B6 mice from The Jackson Laboratory database, 27 passing 
samples from the Hill laboratory, and the CBA/CaJ sample from The Jackson Laboratory 
(Table 3-16). Genetic distance values could be used to distinguish between mice that were 
pure B6 to pure CBA/CaJ genetic backgrounds. Ordering of values showed mice mostly B6 
in genetic background had a genetic distance closest to 0 and mice more CBA/CaJ had a 
genetic distance further from 0. Samples that were half B6 and half CBA/CaJ had genetic 
distance values falling in the middle of samples that were primarily B6 and those primarily 
CBA/CaJ. When two tissue samples were available for the mouse, both tissue samples 
grouped together. Mice with three tissue samples did not have all three tissues group 
together. Liver samples consistently showed the higher genetic distance measure when there 
are multiple tissue types available for a single mouse.  
 Pairwise comparisons were used to calculate genetic distance measures between all 
362 samples (Figure 3-17) (Table D-3, Table D-4). These genetic distance measures were 
used to generate a phylogenetic tree. Genetic distance measures between the eight B6 mice 
and one CBA/CaJ mouse from The Jackson Laboratory, and the passing 27 samples from the 
Hill laboratory can distinguish between a spectrum of B6 to CBA/CaJ genotypes (Figure 
3-18). Tissue samples from the same mouse group together. Mice group together in the 
phylogenetic tree as expected based on breeding relationships.  
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Figure 3-16: Genetic distance from pairwise comparisons between 362 Mouse Diversity 
Genotyping Array samples. Colours in order from left to right across the graph represent 
BXD (light blue), collaborative cross (light purple), classical laboratory strains (dark blue), 
congenic (black), consomic (grey), F1 hybrid (dark purple), wild caught (pink), wild-derived 
mouse strains (teal), and Hill samples (mint).  
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Table 3-16: Genetic distance measures
a
 for the 27 Hill 
laboratory samples, eight B6 samples, and one CBA/CaJ 
sample from The Jackson Laboratory dataset. 
Sample Identifier Genetic Distance Mouse Strain
b 
B6 (5) 0.0005 B6 
B6 (2) 0.0008 B6 
B6 (1) 0.0014 B6 
B6 (4) 0.0015 B6 
300.7 Cl-3 0.0017 B6 
B6 (7) 0.0017 B6 
B6 (6) 0.0021 B6 
300.7 Sp-2 0.0024 B6 
300.7 Sp-3 0.0025 B6 
B6 (3) 0.0032 B6 
300.7 Sp-1 0.0036 B6 
300.7 Cl-1 0.0041 B6 
300.7 Cl-2 0.0042 B6 
300.6 Cl 0.0093 B6 
B6 (8) 0.0101 B6 
904.11 Cl 0.1239 <B6 
904.11 Sp 0.1239 <B6 
904.9 Sp 0.1342 <B6 
904.9 Cl 0.1344 <B6 
900.3 Sp 0.1793 B6/CBA 
900.3 Li 0.1813 B6/CBA 
911.50 Sp 0.2071 <CBA 
911.143 Cl 0.2071 <CBA 
911.148 Cl 0.2071 <CBA 
911.49 Cl 0.2071 <CBA 
911.49 Sp 0.2072 <CBA 
CBA/CaJ 0.2075 CBA 
911.50 Cl 0.2078 <CBA 
911.50 Sp-2 0.2082 <CBA 
911.17 Cl 0.2085 <CBA 
911.50 Cl-2 0.2094 <CBA 
911.50 Li-2 0.2096 <CBA 
911.17 Sp 0.2096 <CBA 
911.17 Li 0.2112 <CBA 
911.49 Li 0.2142 <CBA 
911.50 Li 0.2218 <CBA 
a
 Samples are ordered from smallest to highest genetic distance 
b 
Pure B6 and CBA samples are indicated in red. Samples more 
B6 than CBA are in blue. Samples half B6 and half CBA are in 
black. Samples more CBA than B6 are in purple. 
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Figure 3-17: Phylogenetic tree for 362 samples created using genetic distance values 
determined with the autosomal post-genotyping filtered SNP list.  The colours for each of 
the mouse samples indicate which sample type they are according to their mouse strain (see 
legend). 
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Figure 3-18: Genetic distance measures for samples ranging from 100% B6 genetic 
background to 100% CBA/CaJ genetic background. Samples from the Hill laboratory are 
shown in black and those from The Jackson Laboratory dataset are classical laboratory 
strains in blue. The genetic distance values were determined using the autosomal post-
genotyping filtered SNP list generated from genotyping of the 362 samples.  
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3.9.3 Tissue replicates for the spleen and the cerebellum of a C57BL/6J mouse show 
genotype differences within a tissue 
The average number of genotype differences identified between replicates of the 
spleen was 959 ± 158 standard error of the mean (SEM) (Figure 3-19). Of the differences 
identified within each of the three replicates, a total of 0.60% of SNPs (2,780 SNPs) detected 
at least one genotype differences between the three tissues. The distribution of these 
genotype differences across the autosomes and the X chromosome was significantly different 
from random (p<0.001 for spleen, p<0.01 for cerebellum; Fisher’s Exact Test MCS) and all 
three samples showed an under-representation of genotype differences on the X 
chromosome. When the X chromosome was removed from analysis, all samples had a 
random distribution of genotype differences across the autosomes.  
The average number of genotype differences detected between three replicates of the 
cerebellum was 1,150 ± 287 (SEM). A total of 0.70% of SNPs (3,288 SNPs) detected at least 
one genotype difference between the three cerebellum replicates. The distribution of 
differences across the autosomes and the X chromosome was not significantly different 
between replicates. Two of the tissue replicates had a distribution of genotype differences 
that was significantly different from a random distribution (p<0.001, p<0.01; Fisher’s Exact 
Test MCS). All replicates of the cerebellum showed an under-representation of genotype 
differences on the X chromosome. When the X chromosome was removed, all samples had a 
random distribution across the autosomes.  
Of the probes that detected genotype differences between spleen replicates and 
between cerebellum replicates, 622 (0.16 % of genotypes) detected differences in both the 
spleen and cerebellum. The differences for all tissue replicates of the spleen and cerebellum 
appear to be uniformly distributed along each of the chromosomes (Figure 3-20).  
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Figure 3-19: The total number of genotype differences within each B6 spleen replicate 
and cerebellum replicate, and the over- or under-representation of differences across 
the genome. 300.7 is the specific mouse identifier. Sp refers to the spleen, and the replicate 
number is indicated after the dash. A) The total number of differences specific to each of the 
spleen replicates (959 ± 158 genotype differences). B) The total number of differences 
specific to each of the cerebellum replicates (1,150 ± 287 genotype differences). C) The 
distribution of observed differences in genotype graphed to show instances of over- and 
under-representation from a random occurrence based on the number of genotype calls per 
chromosome. * indicates samples with a distribution significantly different from the expected 
random distribution (p<0.005; Fisher’s Exact Test MCS). 
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Figure 3-20: The distribution of genotype differences along the chromosomes for spleen 
and cerebellum replicates of mouse 300.7. The differences in genotype calls determined 
between the spleen replicates are the three outer rings (grey). The differences in genotype 
calls determined between the cerebellum replicates are the inner three rings (light grey). Each 
ring is ordered for the tissue types with the outer-most of the three representing replicate 1 
(red for spleen, pink for cerebellum), the middle representing replicate 2 (dark blue for 
spleen, light blue for cerebellum), and the inner representing replicate 3 (dark orange for 
spleen, light orange for cerebellum).   
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3.9.4 Tissue comparisons between the spleen and cerebellum of a C57BL/6J mouse show 
genotype differences between tissues 
 Both the spleen and cerebellum are similar in having a high degree of variation in the 
genotype differences between the three replicate samples (959 ±158 and 1,150 ± 287, 
respectively). The distribution of differences between the spleen and cerebellum of a B6 
mouse was not significantly different (Figure 3-19). The distribution for each of these 
differences across the genome for the spleen and cerebellum was not significantly different in 
all nine possible pairwise comparisons. The distribution of these differences was significantly 
different from a random distribution in all comparisons where the 300.7 Sp-1, Sp-2, Cl-1, and 
Cl-2 were used (p<0.05; Fisher’s Exact Test MCS).  
3.10 Genotype differences between tissues 
3.10.1 Tissue triads show genotype differences between the spleen, cerebellum, and liver 
of wild-type mice 
The total number of genotype differences determined between the spleen, cerebellum, 
and liver for mouse 911.17 showed an average of 1,721 ± 483 genotype differences (Figure 
3-21). The distribution of differences across the autosomes and X chromosome between 
these three tissues was not significantly different. The pattern of observed differences across 
different chromosomes for each of the three tissues was similar to the pattern of total 
genotype differences observed with cerebellum having the least number of differences 
consistently and the liver having the most.  
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Figure 3-21: Differences specific to the spleen, cerebellum, and liver of mouse 911.17. A) 
The total number of differences observed in the spleen (Sp), cerebellum (Cl) and liver (Li) of 
mouse 911.17 detected using the post-genotyping filtered SNP list (1,721 ± 483 genotype 
differences). B) Tissue-specific differences detected using the post-genotyping filtered SNP 
list.   
X 
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The average number of genotype differences observed between the spleen, 
cerebellum, and liver for mouse 911.49 was 1,949 ± 1,718 (Figure 3-22).  The distribution of 
tissue-specific genotype differences across the autosomes and the X chromosome was 
significantly different between the spleen, cerebellum, and liver (p<0.001; Fisher’s Exact 
Test MCS). The significance observed between the three tissues was due to a difference in 
the distribution of genotype differences between the cerebellum and the liver (p<0.001; 
Fisher’s Exact Test MCS). When the X chromosome was removed from analysis and the 
distribution across the autosomes was compared, tissues still showed a significant difference 
in the distribution of genotype differences across the autosomes (p<0.001; Fisher’s Exact 
Test MCS).  
For mouse 911.50, the average number of genotype differences between the spleen, 
cerebellum, and liver was 800 ± 469 (SEM) (Figure 3-23). The distribution of genotype 
differences across the autosomes and X chromosome between the three tissues was 
significantly different (p<0.001; Fisher’s Exact Test MCS). Pairwise comparisons between 
each of the tissues showed that the spleen was significantly different from the cerebellum 
(p<0.05; Fisher’s Exact Test MCS), the cerebellum was significantly different from the liver 
(p<0.05; Fisher’s Exact Test MCS), and the spleen was significantly different from the liver 
(p<0.05; Fisher’s Exact Test MCS). When the X chromosome was removed from analysis, 
the distribution of genotype differences between the three tissues was significantly different 
across the autosomes (p<0.005; Fisher’s Exact Test MCS). Pairwise comparisons between 
the spleen and cerebellum, spleen and liver, and cerebellum and liver all showed a significant 
difference in the distribution of genotype differences across the autosomes (p<0.05; Fisher’s 
Exact Test MCS). 
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Figure 3-22: Differences specific to the spleen, cerebellum, and liver of mouse 911.49. A) 
The total number of differences observed in the spleen (Sp), cerebellum (Cl) and liver (Li) of 
mouse 911.49 detected using the post-genotyping filtered SNP list (1,949 ± 1,718 genotype 
differences). B) Tissue-specific differences detected using the post-genotyping filtered SNP 
list. Distributions that are significantly different between tissues are (p<0.05; Fisher’s Exact 
Test MCS) are indicated with an *. 
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Figure 3-23: Differences specific to the spleen, cerebellum, and liver of mouse 911.50. A) 
The total number of differences observed in the spleen (Sp), cerebellum (Cl) and liver (Li) of 
mouse 911.50 detected using the post-genotyping filtered SNP list (800 ± 469 genotype 
differences). B) Tissue-specific differences detected using the post-genotyping filtered SNP 
list. Distributions that are significantly different between tissues are (p<0.05; Fisher’s Exact 
Test MCS) are indicated with an *. 
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The average number of genotype differences identified in the spleen (determined 
from comparisons against the cerebellum and liver) was 646 ± 489 (Figure 3-24). The 
distribution of these genotype differences compared between mouse 911.17, 911.49, and 
911.50 was significantly different (p<0.001; Fisher’s Exact Test MCS). The distribution of 
differences compared to a random distribution was significantly different for sample 911.17 
(p<0.001; Fisher’s Exact Test MCS), however, was randomly distributed for samples 911.49 
and 911.50. The number of differences on the X chromosome was under-represented for 
mouse 911.17 and 911.49 and over-represented for mouse 911.50. When the X chromosome 
was removed from analysis, the distribution of genotype differences across the autosomes 
was significantly different between the three mice (p<0.05; Fisher’s Exact Test MCS). The 
distribution of genotype differences across the autosomes was not significantly different from 
random for all mice.   
The average number of cerebellum-specific differences detected for mouse 911.17, 911.49, 
and 911.50 in comparison to the spleen and liver was 597 ± 197 (Figure 3-25). The 
distribution of these genotype differences across the autosomes and X chromosome was 
significantly different between the three mice (p<0.001; Fisher’s Exact Test MCS). 
Compared to a random distribution of genotype differences, sample 911.17 and 911.50 were 
not different. However, sample 911.49 was significantly different from a random distribution 
(p<0.001; Fisher’s Exact Test MCS). The number of genotype differences on the X 
chromosome was over-represented for mouse 911.17, and under-represented for mouse 
911.49 and 911.50.  When the X chromosome was removed from analysis, the distribution of 
genotype differences across the autosomes was significantly different between the three mice 
(p<0.05; Fisher’s Exact Test MCS). In comparison to a random distribution of genotype 
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Figure 3-24: Spleen-specific differences observed for the three wild-type mice. A) The 
total number of spleen-specific differences determined in comparison to the cerebellum and 
liver for each WT mouse. (646 ± 489 genotype differences) B) The distribution of observed 
spleen-specific differences in genotype graphed to show instances of over- and under-
representation from a random occurrence based on the number of genotype calls per 
chromosome for three WT mice. * indicates samples with a distribution significantly 
different from the expected random distribution (p<0.005; Fisher’s Exact Test MCS). 
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Figure 3-25: Cerebellum-specific differences between the three wild-type mice. A) The 
total number of cerebellum-specific differences determined in comparison to the spleen and 
the liver for each WT mouse (597 ± 197 genotype differences). B) The distribution of 
observed cerebellum-specific differences in genotype graphed to show instances of over- and 
under-representation from a random occurrence based on the number of genotype calls per 
chromosome for three WT mice. * indicates samples with a distribution significantly 
different from the expected random distribution (p<0.005; Fisher’s Exact Test MCS). 
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differences across the autosomes, only mouse 911.49 showed a significant difference (p<0.05 
Fisher’s Exact Test MCS). 
In the liver, an average of 3,227 ± 1,110 genotype differences was detected for mouse 
911.17, 911.49, and 911.50 when samples were compared to the spleen and cerebellum 
(Figure 3-26). The distribution of these genotype differences across the autosomes and X 
chromosome was significantly different between the three mice (p<0.001; Fisher’s Exact 
Test MCS). All samples had a distribution of genotype differences that was significantly 
different from a random distribution of differences (p<0.01; Fisher’s Exact Test MCS). The 
number of genotype differences on the X chromosome was over-represented for mouse 
911.17, and under-represented for mouse 911.49 and 911.50. When the X chromosome was 
removed from analysis, the distribution of genotype differences across the autosomes was 
significantly different between the three mice (p<0.001; Fisher’s Exact Test MCS). In 
comparison to a random distribution of genotype differences across the autosomes, only 
mouse 911.49 showed a significantly different distribution from random (p<0.001; Fisher’s 
Exact Test MCS).  
The distribution of genotype differences for each mouse was graphed for the spleen, 
cerebellum, and liver using Circos to determine the distribution of genotype differences 
along each of the chromosomes (Figure 3-27). The small number of differences for the 
spleen, cerebellum, and liver did not appear to cluster along the chromosomes.  
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Figure 3-26: Liver-specific differences between the three wild-type mice. A) The total 
number of liver-specific differences determined in comparison to the spleen and the 
cerebellum for each WT mouse (3,227 ± 1,110 genotype differences). B) The distribution of 
observed liver-specific differences in genotype graphed to show instances of over- and 
under-representation from a random occurrence based on the number of genotype calls per 
chromosome for three WT mice. * indicates samples with a distribution significantly 
different from the expected random distribution (p<0.005; Fisher’s Exact Test MCS). 
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Figure 3-27: The distribution of differences along each of the chromosomes for the 
spleen, cerebellum, and liver of mouse 911.17, 911.49, and 911.50. The spleen-specific 
differences are indicated in the three outer-most rings (dark grey) in red, the cerebellum-
specific differences are indicated in the middle three rings (light grey) in blue, and the liver-
specific differences are indicated in the three inner-most rings (very light grey) in orange. 
The groups of three rings for the spleen, cerebellum, and liver samples each represent a 
different mouse and are ordered with the outer-most ring as mouse 911.17, middle ring as 
911.49 and inner-most ring as 911.50.    
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3.10.2 Replicates of tissue triads in a wild-type mouse show high amounts of genetic 
variation within and between tissues 
  The replicate of tissue triads for mouse 911.50 showed an average of 12,255 ± 
10,862 (SEM) genotype differences between the spleen, cerebellum, and liver (Figure 3-28). 
The distribution of these genotype differences was significantly different across the 
autosomes and X chromosome between the spleen, cerebellum, and liver (p<0.001; Fisher’s 
Exact Test MCS). There was a significant difference in the distribution of genotype 
differences between the spleen and liver, and cerebellum and liver (p<0.001, p<0.001 
respectively; Fisher’s Exact Test MCS); however, there was no significant difference 
between the spleen and cerebellum. The distribution of differences in the spleen, cerebellum, 
and liver were all significantly different from a random distribution (p<0.001, p<0.001, 
p<0.001 respectively; Fisher’s Exact Test MCS). On the X chromosome, all three tissues 
showed an under-representation of genotype differences. When the X chromosome was 
removed from analysis, the distribution of genotype differences between the three tissues was 
significantly different (p<0.001; Fisher’s Exact Test MCS). In comparison to a random 
distribution of genotype differences across the autosomes, only the liver was significantly 
different from a random distribution of differences. The distribution of differences for each 
of the tissues is shown along each of the chromosomes (Figure 3-29).  
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Figure 3-28: Tissue-specific differences for the spleen, cerebellum, and liver of the 
replicates for mouse 911.50. A) The total number of tissue-specific differences in the 
spleen, cerebellum, and liver for mouse 911.50. B) The distribution of observed differences 
in genotype graphed to show instances of over- and under-representation from a random 
occurrence based on the number of genotype calls per chromosome. * indicates samples with 
a distribution significantly different from the expected random distribution and when tissues 
have a different distribution from each other (p<0.005; Fisher’s Exact Test MCS).  
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Figure 3-29: The distribution of differences in the spleen, cerebellum, and liver 
replicates for mouse 911.50. The outer-most circle shows spleen-specific differences in red, 
the middle displays cerebellum-specific differences in blue, and the inner-most circle shows 
the liver-specific differences in yellow. The replicate liver for mouse 911.50 is an outlier in 
the sample set. Clusters of colour indicate regions that are prone to the detection of 
differences.   
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The total number of genotype differences varied between the spleen, cerebellum, and 
liver replicates (Figure 3-30). The distribution of genotype differences across the autosomes 
and X chromosome observed between replicates was significantly different for the spleen and 
the liver, but not the cerebellum (p<0.05, p<0.001 respectively; Fisher’s Exact Test MCS). 
When the X chromosome was removed from analysis, the distribution of genotype 
differences across the autosomes between tissue replicates was only significantly different 
for the liver (p<0.001; Fisher’s Exact Test MCS). The replicate for the liver had far more 
genotype differences in comparison to any other tissue sample from mouse 911.50. The 
distribution of these differences when graphed along each of the chromosomes clustered to 
specific regions on all chromosomes except for chromosome 15, 16, and X (Figure 3-29).  
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Figure 3-30: Differences specific to the spleen, cerebellum, and liver between replicates 
of mouse 911.50. A) The total number of differences observed in the spleen (Sp), cerebellum 
(Cl) and liver (Li) of mouse 911.50 detected using the post-genotyping filtered SNP list. B) 
Tissue-specific differences detected using the post-genotyping filtered SNP list. * indicates a 
significant difference between replicates of a tissue type (p<0.05).  
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3.10.3 Tissue pairs show genotype differences between tissues of a wild-type mouse and 
tissues of a harlequin mouse 
 The total number of genotype differences in the spleen and the liver of mouse 900.3 
was 3,859 and 3,982 respectively (Figure 3-31). The distribution of genotype differences 
across the autosomes and X chromosome for the spleen and the liver was significantly 
different (p<0.001; Fisher’s Exact Test MCS). In comparison to a random distribution of 
genotype differences across the autosomes and X chromosome, both the spleen and the liver 
were significantly different (p<0.001, p<0.001 respectively; Fisher’s Exact Test MCS). Both 
the spleen and the liver showed an over-representation of differences on the X-chromosome 
(Figure 3-32). When the X chromosome was removed from analysis, there was no significant 
difference in the distribution of genotype differences across the autosomes. When compared 
to a random distribution of genotype differences across the autosomes, neither the spleen nor 
the liver was significantly different from a random distribution.  
 The total number of differences in the spleen and cerebellum for mouse 904.9 was 
246 and 244 respectively (Figure 3-33). The distribution of differences between the spleen 
and cerebellum across the autosomes and the X chromosome was significantly different 
(p<0.001; Fisher’s Exact Test MCS). When the X chromosome was removed from analysis, 
the distribution of genotype differences across the autosomes was significantly different 
between the spleen and the cerebellum (p<0.001; Fisher’s Exact Test MCS). 
For mouse 904.11, a total of 225 genotype differences were detected in the spleen and 
299 genotype differences were detected in the cerebellum (Figure 3-34). The distribution of 
these differences across the autosomes and X chromosome was not significantly different.  
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Figure 3-31: Tissue-specific differences detected between the spleen and liver of mouse 
900.3. A) The total number of differences between the spleen and the liver. B) The 
distribution of observed differences in genotype graphed to show instances of over- and 
under-representation from a random occurrence based on the number of genotype calls per 
chromosome. * indicates samples with a distribution significantly different from expected 
(p<0.005; Fisher’s Exact Test MCS). 
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Figure 3-32: The distribution of tissue-specific differences across the chromosomes for 
mouse 900.3. Spleen specific differences are plotted in red and liver specific differences are 
plotted in blue. The distribution of differences does not cluster along any of the 
chromosomes. Chromosome X does show a high proportion of differences in comparison to 
the remainder of the genome.   
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Figure 3-33: Tissue-specific differences detected between the spleen and cerebellum of 
mouse 904.9. A) The total number of differences between the spleen and the cerebellum. B) 
Tissue-specific differences detected using the post-genotyping filtered SNP list. The 
distribution of differences in the spleen was significantly different from the distribution of 
differences in the cerebellum across chromosomes (p<0.001; Fisher’s Exact Test MCS).  
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Figure 3-34: Tissue-specific differences detected between the spleen and cerebellum of 
mouse 904.11. A) The total number of differences between the spleen and the cerebellum. B) 
Tissue-specific differences detected using the post-genotyping filtered SNP list. The 
distribution of differences across chromosomes for the spleen and the cerebellum was not 
significantly different. 
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The total number of spleen-specific differences, in comparison to the cerebellum, 
between the two hq mice 904.9 and 904.11 was 246 and 225 respectively (Figure 3-35). The 
distribution of differences in each of the spleen samples was not significantly different across 
the autosomes and X chromosome. The distribution of differences across the autosomes and 
X chromosome was significantly different from a random distribution of genotype 
differences for both mice (p<0.001, p<0.05; Fisher’s Exact Test MCS). Both mice showed an 
under-representation of genotype differences on the X chromosome. When the X 
chromosome was removed from analysis, the distribution of genotype differences across the 
autosomes was not significantly different between mice. The distribution of genotype 
differences across the autosomes in comparison to a random distribution of genotype 
differences was significantly different from random for mouse 904.9 and mouse 904.11 
(p<0.001, p<0.01 respectively; Fisher’s Exact Test MCS).  
The total number of cerebellum-specific differences, detected in comparison to the 
spleen, between mouse 904.9 and 904.11 was 244 and 299 respectively (Figure 3-36). The 
distribution of genotype differences between the two cerebellum samples across the 
autosomes and X chromosome was significantly different (p<0.001; Fisher’s Exact Test 
MCS). When compared to a random distribution across the autosomes and X chromosome, 
the distribution of cerebellum-specific differences in mouse 904.9 was not different from 
random; however, mouse 904.11 did have a significantly different distribution from random 
(p<0.001; Fisher’s Exact Test MCS). Both mice showed an under-representation of genotype 
differences on the X chromosome. When the X chromosome was removed from analysis, the 
distribution of genotype differences across the autosomes was significantly different between 
mice (p<0.001; Fisher’s Exact Test MCS). The distribution of genotype differences across 
the autosomes in comparison to a random distribution of genotype differences was  
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Figure 3-35: Spleen-specific differences between the two harlequin mice. A) The total 
number of spleen-specific differences in the cerebellum for the two hq mice. B) The 
distribution of observed spleen-specific differences in genotype graphed to show instances of 
over- and under-representation from a random occurrence based on the number of genotype 
calls per chromosome in two hq mice. * indicates samples with a distribution significantly 
different from the expected random distribution (p<0.005; Fisher’s Exact Test MCS). 
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Figure 3-36: Cerebellum-specific differences between the two harlequin mice. A) The 
total number of cerebellum-specific differences in the cerebellum for the two hq mice. B) 
The distribution of observed cerebellum-specific differences in genotype graphed to show 
instances of over- and under-representation from a random occurrence based on the number 
of genotype calls per chromosome for two hq mice. * indicates samples with a distribution 
significantly different from the expected random distribution (p<0.005).
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significantly different from random for mouse 904.9 and mouse 904.11 (p<0.001, p<0.01 
respectively; Fisher’s Exact Test MCS). There are too few spleen-specific and cerebellum-
specific differences for mouse 904.9 and 904.11 to identify any regions prone to accumulate 
genotype differences (Figure 3-37).   
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Figure 3-37: The distribution of spleen-specific and cerebellum-specific differences in 
the harlequin mouse across the chromosomes. Spleen-specific differences are shown in the 
outer-most rings (grey) and cerebellum-specific differences are shown in the inner-most rings 
(light grey).  Mouse 904.9 is shown in dark red (spleen) and dark blue (cerebellum). Mouse 
904.11 is shown in light red (spleen) and light blue (cerebellum).  
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Chapter 4 : Discussion 
4.1 General Discussion 
The MDGA can detect genetic variation from the global perspective of known 
diversity existing between different Mus musculus subspecies, to the fine scale detection of 
genetic variation within a single tissue (Figure 4-1). The MDGA can accurately distinguish 
between samples containing high levels of genetic diversity. However, when applied to 
samples that contain little genetic variation, the MDGA falls short. Currently, the small 
sample sizes and high variation in SNP differences between samples result in low power for 
interpreting the extent of variability within tissues of the same mouse. To determine the 
sensitivity of the array, and identify to what scale genetic variation can accurately be 
detected, the error rate for the array must be empirically determined to identify all sources of 
variation.  
4.2 The 99,802 probe sets with design flaws in the original SNP list caused technical 
errors in genotyping calls 
 Through the filtering process, a total of 99,802 SNPs were removed that either 
performed poorly as identified by The Jackson Laboratory or Genotyping Console, or that 
fail to meet basic design criteria. The removal of probe sets that did not meet basic design 
criteria increased the overall genotyping accuracy (number of samples passing a specified 
genotyping threshold, such as 97%) of the microarray. Probe sets that are not designed 
according to specific criteria introduce technical error into the genotyping results. By 
removing probes that do not meet optimal design criteria, technical errors (specifically false 
positives) can be reduced. False positive genotypes occur when a SNP is assigned a 
genotyping call that is different from its true genotype. For example, a false positive occurs  
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Figure 4-1: The amount of genetic variation detectable using the Mouse Diversity 
Genotyping Array between distantly related samples to replicates within a single tissue. 
The amount of genetic variation detectable using the MDGA in terms of the total number of 
SNPs from distantly to closely related samples. Genetic variation is detected between 
samples ranging in genetic diversity between distantly related samples to ranging in genetic 
diversity within a single mouse as between tissues and within a single tissue. The average 
number of genotype differences ± the standard error of the mean is indicated on the far right. 
The average number of genetic differences between mice, between tissues, and within a 
tissue is shown in red. Numbers in blue indicate the average number of genetic differences 
determined from tissue replicates of a B6 mouse.   
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when a sample has a homozygous A genotype and the array determines the genotype of that 
samples is a NoCall. 
4.3 Accuracy of the filtered SNP list causes more samples to pass the genotyping 
threshold of 97% 
 The number of samples that pass the genotyping threshold of 97% increased with the 
use of the filtered SNP list.  An additional 35 samples that failed using the original SNP list 
can be used for further analysis when genotyping is performed with the filtered SNP list.  
This increase in sample size indicates that the majority of samples failing when genotyped 
with the original SNP list did so as a result of technical error on the array rather than true 
biological variation between samples. Samples fail when three percent or more of the 
genotyping calls are NoCalls. Probe sets that were designed poorly caused samples to 
accumulate more NoCalls. NoCalls caused by poor probe design resulted in the detection of 
false positives. Therefore, removing probes that do not meet design standards reduces the 
number of false positives detected using the MDGA. The removal of false positive genotype 
calls reduces the noise on the microarray and improves the genotyping ability.   
 The 35 additional samples that failed when genotyped with the original SNP list did 
so as a result of technical error introduced from probe design flaws. To test if probe design 
resulted in these additional failures between the original and filtered SNP lists, twenty 
randomly filtered SNP lists were used to genotype the dataset. Using these randomly filtered 
SNP lists, more than 50 samples failed the first round of genotyping. Because the same 
number of samples failed when the dataset was genotyped with the original and randomly 
filtered SNP lists, the reduced number of failures when using the filtered SNP list was not 
due to a reduction in the number of SNPs used when genotyping. The increase in the number 
of passing samples was caused by the removal of over 99,000 probe sets that were flawed in 
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their design. The SNPs removed contributed to false positives that were detected when 
genotyping with the original SNP list and resulted in the failure of the additional 35 samples.  
4.4 High genetic variation caused samples to fail when using the filtered SNP list 
 Samples that failed using the filtered SNP list included samples from classical 
laboratory strains, wild-derived strains, and wild caught mice. The majority of samples 
failing were those that are very distantly related to a B6 mouse. These strains include alleles 
from different subspecies of Mus musculus. Since alleles from subspecies other than Mus 
musculus domesticus are poorly represented on the array, it is likely that the alleles within 
each of the failed samples were not detectable. When genotyping calls are made, a minimum 
of 97% of the calls must be an AA, AB, or BB genotype. However, when the alleles that are 
present in a sample cannot be detected by either allele that is represented on the MDGA, this 
minimum of 97% genotype calling may not be reached. When few alleles present in a sample 
are detectable on the array, the sample is too genetically diverse from a B6 mouse to be 
included in analyses when the genotyping cutoff has been set so high. Because the samples 
that likely failed due to high levels of genetic diversity had genetic distance values greater 
than 90%, when studying mouse strains that are very distant from a B6 mouse, the minimum 
cutoff should be lowered to roughly 90% in order to incorporate the variation of these diverse 
samples. The cutoff threshold will be subject to change depending on the genetic diversity 
within a sample set.  
 The classical laboratory strains that failed to reach the minimum threshold did not fail 
because of errors in design. These samples represented strains from some of the most 
genetically diverse classical laboratory strains available and include the NONcNZO10/LtJ, 
Ma/MyJ, ATEB/LeJ, and A/HeJ strains. These strains are all derived from primarily Mus 
musculus domesticus subspecies; however, they are distant from a B6 mouse. The 
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NONcNZO10/LtJ mouse is actually a congenic mouse on a NON/J genetic background. 
Mice within this particular strain contain alleles from mice originally obtained in New 
Zealand and therefore were very geographically distant from the North American B6 mouse. 
MA/MyJ is a inbred mouse strain that contains a mutation in the hepatic fusion gene and has 
previously genotyped with many SNP differences from a B6 mouse.
49
 ATEB/LeJ is also a 
spontaneous mutant strain homozygous for a mutation in the Glutamine receptor interacting 
protein. If containing a mutation in a gene causes an increase in mutation frequency 
elsewhere in the mouse genome, it is likely to impact how these samples genotype. A/HeJ are 
albino mice that were founded in North America and they are susceptible to a variety of 
diseases including cancers.
45
 As a result, mutations may accumulate at a higher rate within 
the A/HeJ mouse. The accumulation of mutations across the genome, may affect areas where 
SNPs are detectable with the MDGA. As a result, when samples that have mutator 
phenotypes are genotyped, samples may appear to have a higher proportion of NoCalls due 
to off target mutations causing a lack of DNA hybridization to the MDGA. The increased 
proportion of NoCalls in these samples will make mice appear more genetically distant than 
would be expected considering their genealogy. Therefore, when genotyping mutant mice, or 
mice that are highly susceptible to mutations, the call rate threshold may also need to be 
lowered.  
4.5 Most of the SNPs in the filtered SNP list are informative when detecting genetic 
variation within Mus musculus 
The genetic variation that is detectable with the array refers to the total number of 
informative SNPs that are capable of detecting variation within Mus musculus. Of the 336 
samples genotyped from The Jackson Laboratory dataset, over 99% of SNPs in the filtered 
list of SNPs detected one or more genetic variants between genotype calls across the 
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autosomes. Therefore, the vast majority of SNPs are contributing to the analysis of overall 
genotypic differences observed between distantly and closely related mice. 
4.6 Future directions for SNP list filtering 
Further SNP list filtering should be completed to remove probe sets that contain any 
overlap between probe sequences, as there may be competition between digested DNA 
fragments. My initial probe filtering failed to remove probes that overlapped by one 
nucleotide at the 3’ end. Although this slight overlap is unlikely to have an effect on 
genotyping because probe overlap is most concerning when it occurs in the center of the 
probe sequence, I recommend that an additional 948 SNPs be removed from future analyses. 
Furthermore, I only removed one of the two SNPs that were affected by the overlap. To 
increase the accuracy of the genotyping calls even more, both the SNPs affected by the SNP 
overlap should be removed prior to genotyping. At the very least, the SNPs still containing 
one nucleotide overlap with another probe set on the array, as well as those that were capable 
of detecting the SNP that was removed based on overlap should be flagged and watched for 
genotyping inconsistencies (between samples). Further filtering can be completed based on 
probe proximity and template availability by removing probe sets that are competing for 
template. This can be accomplished by determining the minimum distance (bps) that probe 
sets should be spaced in order for a DNA fragment to bind to a single probe set. To do this, 
the average fragment size of the DNA prior to hybridization to the MDGA must be 
determined empirically. This average fragment size can then be compared to the spacing 
between probes in the original SNP list to identify consecutive probe sets that have a spacing 
smaller than the average fragment size. For filtering, the full list of SNP probes must be used 
because although the SNPs are removed from data analysis, they are still present on the array 
and will compete for DNA template.  
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4.7 Genetic distance measures distinguish between 364 distantly and closely related 
mouse strains 
4.7.1 Genetic distance measures between 364 samples represent known mouse 
phylogenies 
 Genetic distance measures calculated using the MDGA could differentiate between 
mice of different subspecies and of different strains. The MDGA was designed with the 
intent of genotyping mice that contain more genetic diversity that traditional laboratory 
mouse strains; therefore we can use known phylogenetic relationships to assess the accuracy 
of MDGA genotyping. Alleles detectable on the MDGA favour those present in the B6 
inbred mouse strain. Therefore, mice that are distant from a B6 mouse strain are going to 
appear more genetically distant when genotyped with the MDGA.  
The ability of the MDGA to distinguish between distantly and closely related mouse 
strains reconstructs known phylogenetic relationships of the mouse and allows for the 
distinction between different mouse strains.
44,45,129
 Distantly related samples, including those 
within classical laboratory strains, that are distant from a B6 mouse, are expected to genotype 
with a lower overall genotype call rate. As samples become more distantly related from 
classical laboratory strains they begin to incorporate alleles from different mouse subspecies 
including Mus musculus musculus and Mus musculus castaneus. As a result, genetic distance 
measures for these samples increases. The increase in genetic distance results from an 
increased representation of alleles (or increased genetic diversity) derived from mouse 
subspecies that are not well represented on the MDGA. The lack of representation for these 
alleles causes an increase in the number of NoCalls when genotyping and results in overall 
lower genotyping call rates for genetically diverse samples.  
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4.7.2 Globally, the original and filtered SNP lists have equal ability to distinguish 
between mouse strains  
 Genetic distance matrices created from pairwise comparisons for the original and 
filtered SNP list are very similar from a global perspective. This indicates that the overall 
outcome of the phylogenetic tree does not change when the probes were removed. With no 
significant differences between the genetic distance values, it can be concluded that the 
MDGA has the capability of detecting differences in genotype when samples are compared 
between subspecies and between strains. The MDGA can be used for its original purpose of 
distinguishing between mice that contain different genetic backgrounds using either the 
original or filtered SNP lists.  
4.7.3 Genetic distance measures calculated in comparison to a homozygous A reference 
strain can distinguish between distantly and closely related strains 
Genetic distance measures calculated from a homozygous A reference strain 
distinguish between distantly and closely related mice. Genetic distance in comparison to a 
homozygous A reference determines how similar a sample is to a B6 mouse strain. Using 
these genetic distance measures, mice within each of the sample types were ordered based on 
their known phylogenetic and genealogical relationships to a B6 mouse. Mice within each of 
the sample types that are genetically distant from a B6 mouse had a genetic distance measure 
that was closest to 1. Mice within each of the sample types that were known to be genetically 
similar to a B6 mouse genotyped with a genetic distance measure closest to 0. Therefore, 
when comparing mice to a reference strain, the genetic distance measures can be used to 
identify samples that are closely and distantly related.  
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4.7.4 Genetic distance values calculated with the filtered SNP list refine the genetic 
distance values to better reflect known relationships to a B6 mouse 
 Genetic distance measures calculated from a reference homozygous A strain were 
similar between the original and filtered SNP lists. When the range of genetic distance values 
was compared between the SNP lists for each of the sample types, the differences in genetic 
distance values observed between the SNPs for each of the sample types reflected known 
relationships to the B6 mouse.
45
 Using the filtered SNP list, mice that are known to be 
distantly related to a B6 mouse have a genetic distance that is closer to 1 when compared 
with the genetic distance value determined using the original SNP list. Likewise, mice that 
are known to be genetically similar to a B6 mouse have a genetic distance closer to 0 when 
compared to values calculated using the original SNP list. Therefore, based on known 
phylogenetic and genealogical relationships for each of the strain types used in The Jackson 
Laboratory dataset, it can be concluded that the change in genetic distance values better 
match what would be expected. 
 The increase in genetic distance values observed for the minimum, maximum, and 
average genetic distances in wild-derived laboratory mice (with an exception for the 
minimum genetic distance), F1 hybrids, CC, and wild caught mice reflect the increased 
genetic diversity of these samples. Mice within these sample types contain more genetic 
variation than classical laboratory strains. This is because wild-derived, F1, CC, and wild 
caught mice contain alleles that are derived from the Mus musculus musculus and Mus 
musculus castaneus subspecies. These subspecies are not well represented in classical 
laboratory mice, and as a result have poor representation on the MDGA.
107
 Therefore, when 
genotyping samples containing many alleles from the Mus musculus musculus and Mus 
musculus castaneus subspecies, there will be a higher proportion of NoCalls. This higher 
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proportion of NoCalls caused by the lack of representation of these subspecies on the MDGA 
ultimately causes samples to have a genetic distance closer to 1. As mice get more 
genetically distant from a B6 mouse (closer to 1), the constantly increasing number of 
NoCalls makes it increasingly difficult to differentiate between samples.  
 The minimum genetic distance for wild-derived laboratory strains decreased. This 
decrease in genetic distance value can be explained by identifying the mouse strain at the 
lowest genetic distance range of this sample type. The mouse strain that contained the 
smallest genetic distance value in wild-derived laboratory strains was the CALB/RkJ mouse. 
This strain was primarily derived from the Mus musculus domesticus subspecies, indicating 
that in comparison to other wild-derived strains, the CALB/RkJ mouse strain is more 
genetically similar to a B6 mouse. Because many of the SNPs on the array distinguish 
between alleles that are present in the Mus musculus domesticus subspecies, the genotyping 
call rate for samples containing alleles derived from this subspecies should be high. When a 
sample contains a high proportion of its genetic background from the Mus musculus 
domesticus subspecies, the genetic distance should be closer to 0. The removal of probe sets 
that contained design flaws reduced the number of false positives that were contributing to an 
increase in genetic distance. The removal of these probe sets resulted in an increased genetic 
distance value for CALB/RkJ mice as would be expected based on genetic background.  
The genetic distance values calculated with the filtered SNP list for the BXD mice 
moved closer towards 0 for both the minimum and maximum values. This shift of both 
values towards 0 is expected, as BXD is a recombinant inbred mouse strain that contains the 
genetic background of the classical laboratory strains B6 and DBA/2J. Therefore, BXD mice 
are genetically similar to a B6 mouse and should genotype with genetic distances very close 
to the reference.  
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Consomic mice contain genetic variation from other mouse strains and would 
therefore be expected to have genetic diversity higher than that of the isogenic founder strain. 
In this study, all consomic mice are on a B6 genetic background and contain a single 
chromosome from the wild-derived mouse strain PWD/PhJ-ForeJ that belongs to the Mus 
musculus musculus subspecies. By introducing genetic variation from a different subspecies 
of mouse, consomic mice are now less related to the reference in comparison to a pure B6 
mouse. Therefore, the shift in genetic distance values for consomic mice was expected to 
shift towards 1, which was observed for the maximum genetic distance.  
Classical laboratory mouse strains encompass the genetic variation found within the 
Mus musculus domesticus subspecies for the majority of laboratory strains. Mice within the 
classical laboratory strain type will therefore have genetic distance values very close to 0, as 
they are the most related to the reference. However, classical laboratory mice will also have 
genetic distance values approaching 1 because of the variation between the different mouse 
subspecies that are found within some laboratory strains. The shift in the minimum genetic 
distance value closer to 0 therefore matches what would be expected based on genetic 
background for each of the strains that are derived from Mus musculus domesticus.   
4.7.4.1 The filtered SNP list was better able to distinguish between genetically diverse 
samples using genetic distance measures in comparison to the original SNP list 
When genetic distance measures were compared between the original and the filtered 
SNP lists, the genetic distance values calculated for the most diverse samples in the sample 
set, the F1 and CC mice were significantly different. This means that the genetic distance 
values calculated with the filtered SNP list were more sensitive at detecting genetic distance 
values within highly diverse mice as compared to the original SNP list. Genetic distance 
values for the F1 and the CC mice had the maximum and average genetic distance values 
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increased. The increase in genetic distance values reflects the increased genetic diversity 
within these samples.
44,65
 By increasing the genetic variation within a mouse, it becomes 
more difficult to genotype accurately. This becomes exacerbated when probes do not perform 
well as a result of their design. This further reduces the accuracy of genotyping calls. 
However, when the probes are removed that do not meet design criteria, a significant 
improvement to the genotyping accuracy of the MDGA is made. Samples containing high 
amounts of genetic variability are genotyped more accurately, which increases the confidence 
of genotyping calls for genetically diverse samples.  
Inaccuracy in genotype calling is particularly high for samples that contain high 
levels of heterozygosity.
108,117
 When assigning a SNP to a specific genotype, the fluorescence 
intensities are used to determine whether a sample is likely homozygous or heterozygous. 
This information is based on predefined clusters that predict the intensities for each of the 
three genotype possibilities (Figure 4-2). The more samples that genotype within a specific 
cluster increases the confidence of genotyping calls within that particular group. Therefore, 
when datasets, such as The Jackson Laboratory dataset contain a high number of isogenic 
strains, genotyping heterozygosity is less accurate.
108,130
 When genotyping clusters do not 
contain a high number of samples, the cluster range increases to accommodate those samples 
that are most likely to be that genotype. As a result genotype calls associated with this cluster 
become less reliable. Because poorly designed probes have poor hybridization and altered 
fluorescence intensities, it makes it more difficult to assign a genotype to the SNP. Therefore, 
by removing probes that contain design flaws, genotyping becomes more accurate, especially 
for those samples that contain high levels of heterozygosity.  
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Figure 4-2: Predefined clusters for genotyping each of the SNPs. There are three 
predefined clusters that associate with the three genotype calls, AA (green), AB (blue), BB 
(red). NoCalls in each of the graphs are represented in grey. These three clusters each have a 
predefined circle (dotted lines) that is based off the expected area where the fluorescence 
intensities will be graphed. As samples are genotyped, each of the clusters adjusts to better fit 
the data set (solid lines). A) Clustering where the clusters are well separated and most of the 
genotype calls fall within the range of the adjusted circle. B) Clustering where the clusters 
are poorly separated and the pre-defined clusters overlap and genotyping is difficult to 
perform.  
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F1 hybrids contain the highest amount of heterozygosity within the Jackson 
Laboratory dataset. F1 hybrid mice contain one half of their genetic background from one 
mouse strain and the second half of their genetic background from a different mouse strain. 
The genetic distance values generated for each of the F1 hybrid mice are indicative of the 
parental strains for each of the samples. Meaning that the genetic distance values for F1 mice 
directly reflect the strains from which the parents belong. When an F1 mouse has a parent 
that is from a wild-derived strain, the genetic distance value increases and when both parents 
of an F1 mouse are wild-derived laboratory strains the genetic distance value increases even 
more. This is because wild-derived strains are primarily members of the Mus musculus 
musculus and Mus musculus castaneus subspecies. These subspecies have poor 
representation on the array therefore, the genetic distance values would be expected to 
increase when poorly performing SNPs were removed. Similarly, when both the parents were 
classical laboratory strains the genetic distance values decreased. The genetic distance value 
for F1 hybrids is expected to be near the upper range of values calculated for classical 
laboratory strains because classical laboratory strains contain alleles derived primarily from 
the Mus musculus domesticus subspecies. Therefore, most of the alleles present within the F1 
mouse should be detectable on the array when both parents are classical laboratory strains. 
Collaborative cross mice, although primarily homozygous across the genome within 
an individual line, contain very high levels of genetic variation across CC lines because they 
incorporate alleles from eight different founder populations.
67
 The genetic distance values for 
CC mice from different CC lines would therefore be expected to be higher than classical 
laboratory strains because there is a lot of genetic diversity across the different lines. Of the 
eight founder strain used to create the CC mouse lines, three were wild-derived laboratory 
mice. This means that the MDGA is unlikely to detect alleles that were contributed by these 
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strains because of the lack of representation for the Mus musculus musculus and Mus 
musculus castaneus subspecies on the microarray. The remaining mice were from the 
classical laboratory strains, only one of which was very closely related to the reference, the 
B6 inbred strain. Because the majority of alleles contributing to the CC mouse were not from 
a B6 genetic background, the genetic distance values for CC mice are expected to be at the 
higher end of the genetic distance measures. The increase in genetic distance measures when 
using the filtered SNP list indicates that there is an improvement in detecting genotypes for 
mice that contains high levels of genetic variation.  
Although classical laboratory strains, consomic, congenic, BXD, wild caught, and 
wild-derived laboratory strains did not show any significant difference in the genetic distance 
values calculated in comparison to a reference strain of homozygous A genotypes, the 
removal of SNPs from genotyping analysis increased the accuracy of genotyping. This ability 
to better distinguish between samples that contain the most genetic variation in the sample set 
refines the ability of the MDGA to distinguish between strains that contain high levels of 
genetic variation. Therefore, when samples begin to accumulate heterozygosity within the 
genome, the filtered SNP list will perform better. This allows for more accurate genotype 
calls when using mouse samples that mimic the diverse genetic backgrounds of the human 
population.  
4.7.5 Genetic distance can be used to distinguish between mice with different percent 
admixture between C57BL/6J and CBA/CaJ strains 
The MDGA is capable of distinguishing between mice that range from pure B6 to 
pure CBA/CaJ genetic backgrounds using a variety of different ordering methods. Genetic 
distance measures can be used to differentiate between samples and compared to breeding 
records. For genetic distance measures determined between paired samples and in 
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comparison to an AA reference correctly grouped each sample based on the percentage of B6 
and CBA/CaJ genetic backgrounds that were determined from their genealogical records. 
Mice genotyping with the highest genetic distance values were those of a pure CBA/CaJ 
genetic background. As mice are continually bred from a B6 to a CBA/CaJ genetic 
background, the number of CBA/CaJ alleles within a sample increases. Therefore, as mice 
become more CBA/CaJ, the genetic distance values increase. Although these two mouse 
strains are both classical laboratory strains the genetic distance value increases when a 
sample is bred to a CBA/CaJ genetic background because the MDGA is biased to detecting 
the genetic background of a B6 mouse.
107
 Therefore, it was expected that the samples with 
the highest percentage B6 genetic background would genotype with a genetic distance value 
closest to 0. Because the MDGA was able to differentiate between samples containing 
varying amounts of B6 and CBA/CaJ genetic backgrounds, the MDGA can be used to 
distinguish between closely related mice.
45 The MDGA can even be used to differentiate 
between mice within a small pedigree.  
4.7.6 The percentage of C57BL/6J and CBA/CaJ genotypes can be used to differentiate 
between mice within a family pedigree  
The MDGA can also be used to detect genetic variation existing between an 
admixture of B6 and CBA/CaJ genetic backgrounds. By determining the total number of 
genotype calls detecting the B6 and CBA/CaJ mouse strains, mice can be correctly identified 
based on their admixture and known percentage of B6 genetic background. Mice on a pure 
CBA/CaJ genetic background will never genotype as 100% CBA/CaJ. This is because the 
CBA/CaJ and B6 mouse strains share the same allele at over 369,000 SNP locations (more 
than 70% of SNPs on the array), and will by default be genotyped as a B6 allele due to the 
MDGA bias towards this strain. The MDGA has sufficient SNPs on the array to distinguish 
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between varying degrees of admixture between the closely related B6 and CBA/CaJ inbred 
mouse strains. 
4.8 Genetic distance measures between C57BL/6J mice are consistent with reports of 
genetic variation within an isogenic mouse strain 
Genetic distance values calculated for B6 mice were the lowest out of the 362 
samples. More than 99% of SNPs are capable of detecting a B6 allele in the filtered SNP list. 
Therefore, B6 mice would be expected to genotype with the lowest genetic distance values 
because the array was specifically designed to detect genetic variation in comparison to a B6 
mouse. The genetic distance values calculated for the B6 mouse were the values closest to 0, 
indicating that the MDGA is capable of differentiating between samples that were pure B6 
and those that were not. However, differences in genetic distance values between mice within 
the B6 mouse strain, indicates that the MDGA can also distinguish between mice of a single 
strain.   
The variation that was observed between the eight B6 mice shows that there is 
enough variation between the genotyping calls to cause a significant difference between each 
of the samples. This can mean one of two things, technical error or biological variation is 
causing the B6 mice to genotype differently. Samples within a single mouse strain are 
believed to be isogenic. Because mice of an isogenic strain are genetically identical, when 
genotyping multiple mice from the same isogenic mouse strain, different mouse samples 
should be indistinguishable as all genotypes would be the same at each location. However, 
because differences were observed between the samples there is either variation within an 
isogenic mouse strain, there is technical error causing these differences, or there is a 
combination of both phenomena.  
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4.8.1 Observed variation within the C57BL/6J mouse may be due to variation within 
the mouse strain. 
The variation detected within a mouse strain has not been investigated fully; however, 
studies suggest that genetic variation does exist within a mouse strain.
30,131
 One such study 
highlights how large scale genetic variants, such as CNVs, are variable between mice of a 
pure B6 genetic background.
131
 This study showed that there is genetic variation between 
mice of the same isogenic mouse strain. A CNV affecting a 112 kb region located on 
chromosome 19 in B6 mice was observed between individuals within the B6 inbred strain. 
This CNV appeared to be inherited as it affected many individuals within a B6 population 
and was detected in multiple stock populations of frozen embryos in The Jackson Laboratory. 
Although there is limited research looking at the variation within an isogenic mouse strain, 
studies on somatic mosaicism indicates that variation does exist between what were once 
thought to be identical tissues or individuals.
61,73
 As a result, mouse strains should not be 
presumed to be isogenic due to the genetic variation found between samples. 
Genetic variation can accumulate within a mouse strain due to mutations. These 
mutations cause genetic variation within an “isogenic” population and can be inherited (as it 
affects the germline) or occur as de novo mutations and result in somatic mosaicism. Somatic 
mosaicism is the most studied form of genetic variation affecting inbred mouse strains. 
Somatic mosaicism refers to the accumulation of genetic differences between cell types or 
tissue types of an individual. As a result, different cell/tissue types within these individuals 
no longer contain identical genetic sequences. These differences begin to accumulate shortly 
after conception, and result in genetic variation between tissues.
60
  
In humans, somatic mosaicism has been identified between identical twins. Identical 
twins were once thought to have genomes that were genetically identical because they 
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develop from the same zygote. However, monozygotic twins have been found to contain 
genetic variation, particularly in terms of copy number.
96,132,133
 Genetic variation begins to 
accumulate between monozygotic twins very early in development. The most well studied 
type of variation between twins is CNV. CNVs between twins have been linked to many 
diseases including multiple sclerosis, schizophrenia, and diabetes. Using twin studies, 
researchers have identified CNVs associated with each disease in identical twins that are 
discordant for the diseased phenotype. The difference in copy number between discordant 
twins reflects the genetic variation that accumulated during development and those 
differences that were the result of environmental factors.  
In mice, somatic mosaicism has traditionally been studied using single gene 
approaches. These studies have shown that mutations accumulate in a tissue-specific manner, 
and contribute to the genetic complexity of an individual.
60,61,78
 Other variation previously 
found naturally within the population is associated with immunity and the Major 
histocompatibility complex (Mhc).
134
 The Mhc accumulates mutations over the lifespan of an 
individual because it is highly plastic and susceptible to modification. The Mhc has been 
shown to contain variation in the expression patterns and copy number between tissues of a 
B6 mouse.
135
 This variation was observed as a duplication in the liver of the B6 mouse in 
comparison to the cerebellum in adult tissue. This observed variation within an individual 
makes it impossible for all mice of the same inbred mouse strain to contain identical genetic 
sequences. These studies have reported the genetic variation is present within a single mouse, 
and as a result, it is unlikely that the isogeneity of inbred mouse strains is true. Rather, mouse 
strains may contain genetic variation within and between individuals, while sharing localized 
regions of isogeneity.   
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4.8.2 Observed genetic variation within the C57BL/6J mouse strain may be due to 
technical error 
4.8.2.1 Technical error can occur during DNA preparation for microarray 
hybridization 
Technical error can occur as a result of poor microarray design or inconsistencies in 
the microarray platform. These errors inflate the number of genotype differences detected 
between samples. Technical errors can also be introduced at a number of different stages 
during DNA extraction, processing, hybridization, and genotyping. Technical error 
introduced prior to genotyping can be caused by protocols that are not optimized to extract or 
prepare the DNA for hybridization. When protocols are not optimized, the DNA can be 
contaminated with reagents, such as salts and proteins.
136
 When DNA contains these 
contaminants, downstream DNA preparation procedures can be affected, such as digestion, 
ligation, and PCR amplification, and the resulting hybridization and genotyping calls can be 
inaccurate. For example, the type of tissue from which DNA is being extracted is important 
when selecting a DNA extraction procedure. Tissue containing high fat contents such as the 
cerebellum, or high protein, such as the liver, may need to be modified in order to reduce the 
amount of protein contamination.
137
 Similarly, the conformation of DNA within each of these 
tissues with respect to open or closed chromatin may affect genotype calls when DNA 
extraction does not remove all protein. If too much of the DNA is bound up in the histones, 
and not enough of the proteins are removed from a sample, the DNA that is still wrapped 
around the histones that are present may not be accessible for genotyping. As a result, SNPs 
within these inaccessible regions are not going to have any genotype calls associated with 
them; therefore, resulting in technical errors during genotyping. Because the conformation of 
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DNA is dependent on gene expression (which is tissue specific), technical errors caused by 
DNA conformation may occur in a tissue-specific manner.  
Technical error can also be introduced due to contamination with salt.
138
 High salt 
concentrations reduce the optimal hybridization conditions for an array as it affects how 
DNA binds to the probe sequence. Contamination with salt is most likely to occur during 
DNA extraction but can also be introduced in buffers added during steps after DNA 
extraction. When too much salt is present in samples ready for microarray hybridization, it 
can cause non-specific binding of the DNA to the microarray. When DNA binds non-
specifically to probe sequences, it causes the genotypes to be unreliable because the probe no 
longer is detecting one specific sequence of the genome.  
During the processing of DNA, errors can again be introduced if the digestion is not 
completed. When the DNA digestion is not a full digestion, the fragment sizes will be too 
long for PCR amplification. This will cause no DNA template to be available during 
hybridization because it could not be amplified. DNA amplification can also introduce errors 
because mutations can occur from DNA polymerase. DNA polymerase adds errors at a rate 
of 10
-5 
errors/pb/duplication.
139
 These errors can affect hybridization and genotyping calls. 
Finally, after hybridization, errors can be introduced from the genotype calling algorithm.
108
 
Because genotyping is based on fluorescence intensities, errors in clustering these intensities 
can result in an incorrect genotype call. When many samples contain the same genotype call, 
the cluster for that particular genotype call becomes more stringent. However, when few 
samples contain a specific genotype call, the cluster for that genotype is more flexible. 
Genotype clusters are calculated based on the number of samples in the proximity of a pre-
defined area.
108,130
 When few samples are within this area, the cluster becomes less defined 
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and therefore, sample that are close to the pre-defined cluster but not within the area have a 
tendency to be called as that genotype.  
4.8.2.2 Technical error can result from imperfections on the microarray 
Technical error can also be caused by an imperfection in the design of the microarray. 
In the case of microarray technologies, these imperfections can manifest as inconsistencies in 
probe design. When probes are not designed to the same standards on microarrays, I have 
demonstrated that the genotyping accuracy for that microarray decreases. Because 
microarrays are designed to detect genotype calls at over hundreds of thousands of locations 
across the genome, probes detecting these locations are designed using a strict set of criteria. 
By designing probes with such strict criteria, they function optimally within the same 
temperature ranges. Therefore, probes that have flaws in their design impact the overall 
genotyping accuracy of the array because they have a tendency to produce failing genotype 
calls. Additionally, when manufacturing microarrays, artifacts occurring during preparation, 
such as scratches, can affect the hybridization of probes and result in poor genotyping calls.  
4.8.3 The distribution of differences detected between C57BL/6J mice may in part be 
the result of technical error  
Microarrays have high rates of false positive and false negative errors, typically in the 
range of 9-20%.
140,141
 Hybridization technologies also have poor reproducibility, with some 
studies indicating as little as 30-40% correlation within inbred strains.
142
 The high error rates 
and poor reproducibility of microarray technologies may be associated with the random 
failure of probes on the microarray.
142,143
 Therefore, it is reasonable to expect genotype 
differences to occur at random across the genome in proportion to the number of SNPs 
representing each chromosome. The random distribution of genotype differences detected 
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between B6 mice, lends itself to the hypothesis that the observed genotype differences 
between the samples may, in part, be due to the random failure of probe sets on the MDGA.  
The accumulation of genotype differences across the genome would not be expected 
to be uniform based on sequence context. There are known sequence contexts, such as CpG 
dinucleotides and tandem repeats that accumulate mutations.
60,73,77
 Previous research using 
transgenic mutation detection approaches discovered that mutations occur at a frequency of 
10
-6
 to 10
-5
 mutations per base pair per cell generation in somatic genomes,
76,144,145
 
translating to a mutation rate of roughly 10
-8
 mutations per base pair per year.
59,146,147
 
Although this mutation rate is conventionally applied across the genome, it only represents 
selectively neutral (containing no genes) regions across the genome. Mutations that lead to 
phenotypes with lower fitness would be expected to be lost, due to negative selection 
pressures. Selection can therefore lead to a non-random distribution of mutations across the 
genome. Genomic plasticity has been observed and associated with certain genes. 
7,8
 Mhc and 
olfactory genes are examples of higher mutations due to positive selective pressures. 
Mutations on the X chromosome reflect strong negative selective pressures. Technical errors 
in genotypes may mask the true landscape of mutations across the genome.  
4.8.4 True biological variants likely contribute to genotype differences detected in 
multiple C57BL/6J mice  
The majority of genotype differences among B6 mice were the result of one sample 
having a different genotyping call from the remaining seven. There is greater confidence in 
calling the variant biologically relevant if more than one of the samples contains the alternate 
genotyping call. When the eight B6 mice are evenly split between two genotype calls, it is 
likely to represent variation within the B6 mouse strain. This is because, it is less likely for 
three or more sample to have the same technical error detected. Whereas, when only one or 
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two samples contain a different genotype from the remainder of the B6 samples, it is more 
likely that these were just one off technical errors in each of the samples. Although variation 
could be detected between eight B6 mice, further research needs to be completed to increase 
the sample size and sequencing needs to be completed to identify where true genetic 
variation is present within the B6 mouse strain.  
4.8.5 Genetic differences detected within inbred and wild caught mouse strains may be 
true biological variation 
When wild caught mice were compared to each other, the majority of SNPs used in 
the comparison showed differences in genotype calls between samples. This would be 
expected because wild caught mice contain genetic variation from mouse subspecies that are 
different from the subspecies predominant in classical laboratory strains. However, there are 
regions of the genome that showed variation within wild caught mice and within B6 mice. 
Such areas are likely accumulating genetic differences due to de novo mutational events. The 
accumulation of new mutations within each of these mouse types is likely explanation 
because of the geographic separation and mouse subspecies of the wild caught and B6 
samples. Since samples belong to different subspecies and are separated by entire continents 
(due to the comparisons with the North American B6 mouse), mutations that appear to be 
shared among these samples are likely the result of mutational hotspots within the Mus 
musculus species.  
SNPs that share genetic variation within B6 mice and within wild caught mice affect 
a total of 14 genes, all of which have previously been shown to have genetic variation (MGI). 
These genes are involved in general functions within the mouse, primarily associated with 
binding to nucleic acids or proteins (MGI).  Several have more specific activities such as 
calcium binding of Capn1, insulin receptor binding of Tln2, and metal ion binding for Mbnl2 
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and Mppel (MGI). These processes are not obviously indicative of any mutational hotspots 
that affect genes; as would be found with specific genes that require a lot of genomic 
plasticity such as those involved in the immune response and the Major histocompatibility 
complex (Mhc) or olfaction in wild mice.
135,148
 
4.8.6 Interpretations made using inbred mouse studies must now take into account 
genome-wide variation within a mouse strain. 
 Inbred mice are used to mimic complex phenotypes in humans. However, with the 
identification that genetic variation exists within an inbred mouse strain, this variation must 
now be taken into account. Inbred mice are not as isogenic as they were once thought to be. 
Although specific genes may not contain variation within a mouse, the remainder of the 
genome may have variation that affects the outcome of these complex interactions. 
Therefore, when conducting studies on complex traits researchers must also consider the 
genome-wide effects of somatic mosaicism. As a result, by using high-resolution 
technologies such as the MDGA to study complex phenotypes, researchers can gain a more 
accurate understanding of complex phenotypes and how they are affected by genomic 
variation.   
4.9 The Mouse Diversity Genotyping Array can detect variation between tissues of the 
C57BL/6J mouse.  
 The MDGA can detect genotype differences between the spleen and cerebellum of a 
B6 mouse. This is indicative of somatic mosaicism occurring early in development causing 
genetic differences between these tissues. Previous research has shown that the spleen and 
the cerebellum differ in the total number of mutations using single gene mutation detection 
systems.
60,73,74
 The accumulation of mutations within these tissues is specific to their 
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developmental histories. However, because the known differences observed between these 
two tissues were initially based on single gene mutation detection systems, the genomic 
variation that exists between these tissues is still unknown. Therefore, the MDGA can be 
used as the first genome-wide mutation detection system to identify tissue-specific 
differences between the spleen and the cerebellum of a B6 mouse.  
4.9.1 Comparable levels of genotype differences were observed for the spleen and 
cerebellum of a C57BL/6J mouse. 
Replicate samples from a pure B6 mouse tissue show significant variation in the 
number of genotype differences. Although the total number of differences detected between 
each of the replicates differs, the distribution of these differences is similar. Each of the 
replicates within a tissue contains roughly the same number of differences on each of the 
chromosomes of the mouse genome. These observed differences may be a combination of 
technical error and biological variation. Because the reproducibility of genotyping results can 
be as low as 60%,
142
 it would not be surprising to find a great deal of technical error 
contributing to the observed differences. Additionally, a total of 622 SNPs accounting for 
0.16% of the genotyping calls for the array detected differences within the spleen replicates 
and within the cerebellum replicates. Because these differences were detected as a one off 
genotype differences between two different tissues they are likely genotyping errors and 
provide a very rough estimate for an error rate associated with the array. Therefore, it is 
possible that the differences observed between the replicates are in part the result of variation 
introduced by the inherent limitations of hybridization technologies.  
Although there is a strong case for technical error introducing the differences detected 
between tissue replicates, the biological differences cannot be discounted. Tissues contain 
many different cell types. When tissue replicates do not contain the same composition of 
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cells, differences may be detected based on these cell types. Each of these cell types will 
accumulate genetic variation at their own rate.
60,61,73,77
 It is the genetic variation between all 
of the cell types that contribute to the genetic variation of a tissue. Therefore, certain 
replicates may appear to have more variation if the cell type that was most predominant 
within the replicate had higher variation in comparison to the predominant cell types of a 
different replicate.  
Differences detected between replicates may be due to large clonal mutations 
occurring within different regions of the same tissue. For example, cancer is an extreme 
example of the extent of genetic variation that can arise de novo within a tissue. The de novo 
genetic variants that arise in tumor tissues cause the clonal expansion of mutations resulting 
in greater heterogeneity within tumor samples. Therefore, tissue replicates taken from areas 
affected by these clonal mutations, will appear to have a higher number of genetic differences 
in comparison to a tissue replicate that was not affected by the clonal mutation.
58
  
A limited sample size makes conclusions about tissue-specific mutation accumulation 
unreasonable. However, the consistent under-representation of genotype differences on the X 
chromosome reflects the known negative selection that occurs for this chromosome.
149
 In 
male mice, mutations occurring on the X chromosome are selected against the resulting 
phenotype because of its hemizygosity in male mice. Without a second copy of the X 
chromosome, mutations cannot be masked, and as a result are selected against. The 
biological evidence supporting an under-representation of genotype differences on this 
chromosome indicates that the MDGA is capable of detecting biologically relevant genotype 
differences. 
   
  231 
4.10 Somatic mosaicism could be detected using the Mouse Diversity Genotyping Array 
between tissues that have different cell turnover rates  
Somatic mosaicism analysis shows that for WT mice the total number of tissue-
specific differences in the spleen, cerebellum, and liver is different. This is consistent with 
analyses of mutation accumulation during development which indicates that tissues differ in 
mutation frequency.
60,61,73,78,95
 Tissues accumulate mutations in a manner that is specific to 
their developmental timeline. One such factor that contributes to this accumulation is the cell 
turnover rate for each of the respective tissues. 
Cell turnover rate directly impacts the proportion of cells containing a mutated DNA 
sequence. These mutations arise from DNA damage that was failed to be repaired during 
DNA replication and cell division. As DNA damage occurs and DNA replication takes place, 
these changes to the genetic sequence, caused by DNA damage, become fixed within the cell 
populations of these tissues. Tissues with high replication rates contain mutations at clonal 
levels since mutations occurring are continually passed on to subsequent cell generations. 
The highly replicative nature of these tissues makes it easier to detect mutations, as a higher 
proportion of cells will contain the mutated DNA sequences. Therefore, tissues that contain 
high cell turnover rates, such as the spleen, are going to have a higher number of mutations 
as compared to tissues that are post-mitotic. 
Post-mitotic tissues, like the cerebellum, have minimal replication. The DNA damage 
occurring within primarily non-replicative tissues is not passed onto daughter cells. As a 
result there is no clonal expansion of the mutated DNA sequence, which makes the detection 
of damage difficult with microarray technologies. Microarrays detect genotypes after PCR 
amplification of genomic DNA. This means, that the total number of cells containing the 
mutated DNA sequence has a large impact on the ability to detect these differences. When 
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one in a million cells contains a difference in the nucleotide sequence, it will be out 
competed by the wild-type sequence, and come time for hybridization the mutant allele will 
be completely masked.  
4.10.1 Variation detected in the liver consistently showed the highest number of 
genotype differences 
The liver being a highly replicative tissue is also involved in the filtering of toxins 
from the body. Filtering of toxic materials exposes the liver to a high level of mutagens. High 
exposure to mutagens would result in a high level of DNA damage.
92
 As the liver replicates, 
this DNA damage is fixed within the cell population and over time becomes present in clonal 
amounts. The clonal expansion of mutations within the liver allows for the detection of the 
mutation using microarray technologies. This is also consistent with previous mutation 
studies of exogenous genes which show that the liver has a higher accumulation of mutations 
in comparison to the spleen and the cerebellum.
95
  
Liver-specific differences are also distributed non-randomly across the genome. This 
non-random distribution indicates that there is some biological basis to the observed number 
of differences. The liver has one of the highest mutation rates detected using single gene 
mutation studies. Therefore it is expected that the liver would also display the highest 
number of differences in each sample. The distribution of these differences across the 
genome reflects a tissue-specific mutation accumulation pattern. Because mutations are not 
distributed at random, there may be specific regions across the genome prone to mutation 
accumulation in the liver. The over- or under-representation of differences on specific 
chromosomes across the genome is indicative of liver-specific mutation hotspots. This may 
be due to the function of the liver and a result of specific genomic regions being accessible 
during certain time points across development and replication.  
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The replicate liver from mouse 911.50 is an outlier due to a large number of genotype 
differences detected within this sample. Although this tissue replicate is consistent with the 
liver containing more genotyping differences, many may be attributed to errors that are 
associated with this particular sample. The distribution of genotype differences detected for 
this sample, cluster at specific regions along each of the chromosomes. Although a biological 
reason may explain this specific clustering, without confirmation no conclusions can be made 
about the biological relevance of the observations. Histological assays can be conducted to 
determine if there are pathological differences in areas across the liver that may be associated 
with the large variation seen between the replicates. However, there are several technical 
factors associated with this sample that may explain part of the variation. The liver sample 
was extracted with the Wizard
®
 Genomic DNA Purification Kit, whereas the spleen and 
cerebellum samples, to which it was compared, were extracted using the Gentra
®
 Puregene
®
 
Kit. The liver also had a call rate of 97.50%, which is near the cut off threshold, and was 
accompanied by lower 260/280 and 260/230 ratios (1.8 and 1.93 respectively) meaning that 
there may have been contamination prior to DNA hybridization. The concentration 
immediately prior to DNA hybridization for this sample alone was also not checked meaning 
that the DNA hybridizes to the microarray may not have been at the proper concentrations 
for optimal genotyping. The probes that detected genotype differences within this sample 
could be checked for sequence context, such as GC content to determine if hybridization 
conditions or poor DNA concentration could result in the reduced accuracy of genotyping.  
4.10.2 Biological reasons, other than SNP differences, that may account for genotype 
differences between samples 
Genome-wide mutation detection also allows for the identification of large-scale 
genomic modifications. Insertions, deletions, and genomic rearrangements that cannot be 
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detected using single gene mutation detection approaches, are now detected using genomic 
technologies. With microarray technologies, many of these modifications rely on the 
implementation of copy number variant calling algorithms; however, there is one type of 
variant that can be detected using genotype calls alone. Copy number deletions that result in 
the loss of two copies of a segment of DNA will result in the failure of one or multiple probe 
sets to determine a genotype. When the loss of the sequence does not occur in every tissue 
studied, this copy number deletion will be picked up as a genotype difference when tissues 
are compared. A genotype difference will be detected because one tissue will contain a 
genotype and the other tissue (containing the deletion) a NoCall. Therefore, not all the 
differences identified by the genotype calls are associated with point mutations. Rather, these 
large-scale deletions can impact the total number of differences observed between tissues.  
4.11 Equivalent levels of genotype differences between the spleen and the cerebellum 
reflect recent literature on mutation accumulation in the harlequin mouse 
The limited sample size for the hq mouse prevents any statistically significant 
conclusions about the accumulation of mutations in the spleen and the cerebellum. However, 
the observed genotype differences detected between the spleen and the cerebellum is 
consistent with recent reports of mutation accumulation within these tissues. Originally, the 
cerebellum of the hq mouse was thought to have an increase in mutations in comparison to 
other tissues as a result of an increase in ROS.
51
 However, recent research contradicts these 
reports as mutation accumulation does not appear to be elevated in the cerebellum as a result 
of an increase in ROS associated mutation accumulation.
54
 In this study, the total number of 
spleen-specific and cerebellum-specific genotype differences was not consistently elevated in 
any one tissue. This may be indicative of a comparable level of mutation accumulation 
between these two tissues.   
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4.12 Future directions and recommendations 
Future experiments conducted using the MDGA must first address technical 
variability. Currently, the MDGA does not have an optimized workflow for data analysis 
from DNA isolation to genotype calling as the pipeline for data analysis was directly taken 
from the Human 6.0 array without any modifications. Therefore, the first step in 
accomplishing this is to optimize each step involved in the processing of DNA prior to 
hybridization to the MDGA for the new array design. Guidelines must be set outlining the 
ideal DNA extraction protocols to be used for each tissue type, as variation in tissue 
composition can result in varying amounts of DNA contamination.  A minimum cut off value 
for 260/280 and 260/230 ratios of DNA immediately prior to restriction enzyme digestion 
should be provided to limit the amount of contamination that may affect downstream 
processing. The microarray also needs to be optimized so that the hybridization temperature 
is 5 degrees above the average melting temperature for the probes.
109
 Ultimately, a whole 
new framework specific to the MDGA will be created that should yield the most accurate 
genotyping results when combined with the filtered SNP list that I have provided.  
 I have determined to what degree (within a tissue, between tissues, between mice, of 
within an inbred strain, and between closely and distantly related strains) genetic variation 
can reliably be detected using genotype differences determined with the MDGA. The MDGA 
can detect genetic variation consistently and accurately between distantly and closely related 
mice, between an admixture of two genetic backgrounds, and within an inbred mouse strain. 
However, there is low power to draw conclusions about detecting variability between and 
within tissues of the same mouse. Future experiments must therefore address the issue of 
small sample size by increasing the number of sample within each analysis and sequencing 
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must be completed for the observed genotype differences to identify a false positive rate for 
the MDGA.  
The genotype differences detected using the MDGA currently are a combination of 
true biological variation and an unknown false positive rate. Therefore, no conclusions can 
be made about the accumulation of genetic differences between tissues, within tissues, or 
about the hq genotype. To make any strong conclusions about specific genotype differences, 
the false positive rate for the MDGA must first be determined. Apart from sequencing the 
genotype differences detected in each of the samples, to determine false positive rate I 
recommend three experimental designs. Reconstruction experiments, which contain known 
amounts and locations of genomic variation can be analysed using the MDGA to determine 
the sensitivity of the array to identify the location of variation within the mouse genome. 
Known mutagen testing using a range of doses will determine the minimum amount of 
genetic variation required for the MDGA to detect significant differences between samples. 
Testing for known tissue-specific differences in mutation frequencies associated with age 
will help determine the threshold of mutation accumulation that is required for a significant 
differences to be detected. Further statistical analyses can also be conducted to not only 
determine differences in the total number and distribution of differences across different 
chromosomes, but also along individual chromosomes to identify regions prone to 
accumulate genotype differences.  
4.13 Conclusion 
The MDGA has the capability to be used to determine the overall genetic diversity 
between mouse samples. This is the first application demonstrating the range of genetic 
distances that the MDGA can be used to detect. The MDGA can distinguish between mice of 
different subspecies, between samples ranging in percentage of pure B6 to pure CBA/CaJ 
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genetic backgrounds, and between mice within a B6 “isogenic” strain. However, when it 
comes to the fine scale analysis and application as a mutation detection system the MDGA 
requires further study with larger sample sizes. The inherent errors associated with 
hybridization technologies make it difficult to distinguish between technical errors and 
biologically relevant data. Once the above has been accomplished, the MDGA does have the 
potential to be used for the analysis of genome-wide mutation accumulation at a better cost 
than whole genome sequencing technologies.  
After a framework has been optimized for the MDGA, the future directions will be to 
increase the number of tissue replicates in order to better understand intra-tissue variation. 
Increasing to the number of tissues that are analyzed will also give a better understanding as 
to how somatic mosaicism is accumulating throughout an individual. An exciting future 
application for the MDGA may be the elucidation of important mechanisms that are 
responsible for mutation accumulation during the developmental histories of each tissue type.  
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(http://www.uwo.ca/biology/Faculty/hill/)  
 This section contains an electronic file for the full annotations of the filtered SNP list. 
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Filtered SNP list annotation description 
The annotated filtered SNP list contains information from my reannotations (headers 
highlighted in blue) and from the Didion et al 2012 reannotation (headers in orange). Probe 
sequences that are highlighted indicate the presence of a cut site for either the NspI (indicated 
in purple (5’-ACATGT-3’) or blue (5’-GCATGCC-3’)) or StyI (indicated in green (5’-
CCATGG-3’) or orange (5’-CCATGG-3’)) restriction enzymes. Note, sequences must be 
searched for in reverse (3’-5’) because the probe sequence in the annotation file is in the 3’-
5’ orientation. If probes are cut by a single restriction enzyme, they were not removed from 
the analysis.  
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Annotations for the filtered SNP list 
Column Column Header Description 
A PROBESET_ID The Jackson laboratory probe ID for each SNP 
in the filtered SNP list 
B Chromosome The chromosome that the SNP is located on 
C Chromosome position (bp) The chromosome position in base pairs of the 
SNP 
D SNP The nucleotide (A, G, C, or T) of allele A of the 
SNP 
E Alternate SNP The alternate nucleotide (A, C, G, or T) of 
allele B of the SNP 
F rsNumber The reference sequence number for the SNP 
G probe start position (+) The start position of the probe sequence in base 
pairs on the positive strand 
H probe end position (+) The end position of the probe sequence in base 
pairs on the positive strand 
I probe start position (-) The start position of the probe sequence in base 
pairs on the negative strand 
J probe end position (-) The end position of the probe sequence in base 
pairs on the negative strand 
K target sequence (5'-3') (+) The target sequence that the probe on the 
positive strand will detect (5'-3') 
L target sequence (5'-3') (-) The target sequence that the probe on the 
negative strand will detect (5'-3') 
M PROBE_SEQUENCE (3'-5') 
(+) 
The probe sequence for the positive strand (3'-
5') 
N probe sequence (3'-5') (-) The probe sequence for the negative strand (3'-
5') 
O RefGene Genes identified from the UCSC known gene 
golden path database 
P known Genes identified from the UCSC for the 
swissprot/uniprot database for the golden path 
Q in gene Indicates whether a SNP is located within the 
region of the gene with a Yes or a No by 
combining information from "RefGene" and 
"known" 
R SNP source Indicates from which strategy the SNP was 
identified from (Classical, NIEHS, B6, Wild, 
MSM, Y, or Mit) 
S C57BL/6J Lists the nucleotide at the location of the SNP 
for a C57BL/6J mouse strain 
T CBA/CaJ Lists the nucleotide at the location of the SNP 
for a CBA/CaJ mouse strain 
U MSM/Ms Lists the nucleotide at the location of the SNP 
for a Mus musculus molossinus  
V Allele A strain Indicates if a C57BL/6J (B6), CBA/CaJ (CBA) 
or MSM strain is detected by Allele A 
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Column Column Header Description 
W Allele B strain Indicates if a C57BL/6J (B6), CBA/CaJ (CBA) 
or MSM strain is detected by Allele B 
X B6:CBA/CaJ Annotations Indicates if the SNP is capable of detecting a 
B6 strain, a CBA/CaJ (CBA) strain, a B6 and a 
CBA/CaJ (CBA) strain, or neither a B6 nor a 
CBA/CaJ (CBA) strain. 
Y B6 same as CBA Indicated if a B6 and a CBA/CaJ mouse contain 
the same allele 
Z Substitution type The SNP's substitution type (transition or 
transversion). 
AA Orientation The originally annotated probe orientation. 
There will always be two records for each probe 
set, one in the forward orientation (+) and one 
in the reverse orientation (-).  
AB Alignment score Alignment score: -3 = Non-unique probe set: 
No probe in the probe set aligned uniquely, -2 = 
Unaligned: The probe failed to align with <= 1 
mismatch, -1= Non-unique probe: This probe 
aligned equally well to more than one location 
in the genome, but other probes in the probe set 
aligned uniquely, 1 = Mismatch: The probe 
aligned uniquely with 1 off-target mismatch, 2 
= Perfect: The probe aligned uniquely with no 
off-target mismatches 
AC Probes that match to strain The IDs of the probes that map to this strain. 
There are eight probes on the array for every 
SNP probe set (two replicates each of four 
different sequences):  * 2 for the reference 
allele in the forward orientation, * 2 for the 
variant allele in the forward orientation, * 2 for 
the reference allele in the reverse orientation, * 
2 for the variant allele in the reverse orientation 
AD Probe base Probe base: The target base of these probes. 
AE Probe sequence Probe sequence: The genomic sequence these 
probes were designed to interrogate. 
AF Suboptimal alignments Suboptimal alignments: Number of alternative 
alignments of lower quality than the best 
alignment. 
AG Chromosome Chromosome: The chromosome to which the 
probe mapped. Probes from the same probe set 
may be mapped to different chromosomes 
AH Chromosome position (bp) Target physical position (in bp): The physical 
position to which the target (polymorphic) base 
mapped 
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Column Column Header Description 
AI Target Genetic position (cM) Target genetic position (in cM): The genetic 
position to which the target (polymorphic) base 
mapped. This is a sex-averaged position, and is 
not defined for chromosomes Y or M. 
AJ Target Base Target base: The nucleotide at the target 
position in the genomic sequence.  
AK rsID Target rsID: The rsID of the SNP at the target 
position. 
AL Target Deleted Target deleted: 0 = The polymorphic base in the 
probe set (the position intended to interrogate 
the SNP in the genomic sequence) has been 
deleted in the genome sequence; 1 = no 
deletion. 
AM OTV position OTV position: If the alignment score = 1, the 
position of the OTV (off-target variant). 
AN OTV type OTV type: s = SNP, i = insertion, d = deletion 
AO OTV probe base OTV probe base: The nucleotide at the OTV 
position in the probe. This will always be a 
single base unless the OTV type is 'i', in which 
case it will be empty 
AP OTV target position OTV target position: The nucleotide at the OTV 
position in the genomic sequence. This will 
always be a single base unless the OTV type is 
'd', in which case it will be empty. 
AQ OTV rsID OTV rsID: rsID (if any) of the OTV. 
AR Orientation Orientation: The orientation in which the probe 
mapped (+ or -). 
AS Start Position Probe start position: Physical position to which 
the first base of the probe mapped. 
AT End Position Probe end position: Physical position to which 
the last base of the probe mapped.  
AU Target Sequence Target sequence: The genomic sequence to 
which the probe best aligns.  
AV Probe C/G fraction Probe C/G fraction [0-1]: Fraction of bases in 
the probe that are C or G. 
AW SNP source SNP source: See Yang 2009 for a description of 
the different data sources used to design the 
array 
AX Nsp I proximal NspI proximal position: proximal (starting) 
position of the NspI fragment containing this 
probe. 
AY Nsp I distal NspI distal position: distal (ending) position of 
the NspI fragment containing this probe. 
AZ Nsp I C/G fraction NspI C/G fraction [0-1]: Fraction of bases in the 
NspI fragment that are C or G. 
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Column Column Header Description 
BA Sty I proximal StyI proximal position: proximal (starting) 
position of the StyI fragment containing this 
probe. 
BB Sty I distal StyI distal position: distal (ending) position of 
the StyI fragment containing this probe. 
BC Sty I C/G fraction StyI C/G fraction [0-1]: Fraction of bases in the 
StyI fragment that are C or G. 
BD Ensembl Gene IDs ENSEMBL gene IDs: ENSEMBL ID(s) 
(comma-delimited) of the gene within which 
this probe aligns (if any). 
BE Function Function: Functional annotation of the gene 
within which this probe aligns (if any). 
BF Target coverage depth Target coverage depth: 0 = the coverage depth 
was below the threshold, 1 = the coverage depth 
was above the threshold. 
BG Target sequence low 
coverage 
Target sequence low coverage: Number of 
bases in the probe for which the genomic 
sequence had below-threshold coverage depth. 
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Appendix C - Supplementary Figures 
This section contains supplementary figures used to aid in the understanding of 
genetic distance measures. 
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Table C-1: CEL file sample identifiers for each of the Hill 
Laboratory samples. 
Mouse ID
a 
CEL file identifier
b 
904.9 Sp SNP_mDIV_A4-SNP10_188_091610 
904.11 Sp SNP_mDIV_A5-SNP10_189_091610 
911.49 Sp SNP_mDIV_A6-SNP10_190_091610 
911.50 Sp SNP_mDIV_A7-SNP10_191_091610 
904.9 Cl SNP_mDIV_A8-SNP10_192_091610 
904.11 Cl SNP_mDIV_A9-SNP10_193_091610 
911.49 Cl SNP_mDIV_A10-SNP10_194_091610 
911.50 Cl SNP_mDIV_A11-SNP10_195_091610 
911.143 Cl SNP_mDIV_B1-SNP10_196_091610 
911.148 Cl SNP_mDIV_B2-SNP10_197_091610 
300.6 Cl DNA3158 
300.6 Sp
c
 DNA3159 
900.3 Li DNA3160 
900.3 Sp DNA3161 
911.50 Cl-2 DNA3162 
911.50 Sp-2 DNA3163 
904.9 Li
c
 DNA3253 
904.11 Li
c
 DNA3254 
904.12 Li
c
 DNA3255 
911.49 Li
c
 DNA3256 
911.47 Li
c 
DNA3257 
911.50 Li DNA3258 
300.7 Cl-1 DNA3296 
300.7 Cl-2 DNA3293 
300.7 Cl-3 DNA3294 
300.7 Sp-1 DNA3295 
300.7 Sp-2 DNA3297 
300.7 Sp-3 DNA3298 
911.17 Sp DNA3299 
911.17 Cl DNA3301 
911.17 Li DNA3302 
911.49 Li DNA3300 
911.50 Li-2 DNA3303 
a
 the identifier used for each of the samples including the 
mouse number, tissue type, and replicate number if there are 
replicates 
b
 the specific identifier given to each specific CEL file  
that correspond with each of the samples 
c
 failed genotyping samples that were not included in analyses 
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Table C-2: Genotyping results for passing samples
a
 after the 2
nd
 round of genotyping using the filtered SNP list 
MDGA samples identifier Mouse 
Gender 
Overall call rate
b 
Sample Type
c 
Mouse Strain 
336 
samples 
362 
samples 
 
SNP_mDIV_C2-283_112108 male 99.88 99.88 BXD BXD34 
SNP_mDIV_A4-SNP08_002_103008 male 99.87 99.87 classical laboratory strain C57BL/6J 
SNP_mDIV_A9-382_012709 male 99.87 99.87 classical laboratory strain C57BL/6NCr 
SNP_mDIV_B1-385_012709 male 99.87 99.87 classical laboratory strain C57BL/6NCr 
SNP_mDIV_A9-SNP08_003_103008 female 99.84 99.85 classical laboratory strain C57BL/6NJ 
SNP_mDIV_B1-267_112108 male 99.84 99.84 BXD BXD12 
SNP_mDIV_A2-304_120908 male 99.83 99.83 BXD BXD74 
SNP_mDIV_B7-391_012709 male 99.83 99.83 classical laboratory strain A/WySnJ 
SNP_mDIV_A11-384_012709 male 99.82 99.82 classical laboratory strain C57BL/6NTac 
SNP_mDIV_C6-287_112108 male 99.82 99.82 BXD BXD43 
SNP_mDIV_B9-279_112108_2 male 99.82 99.81 BXD BXD29 
SNP_mDIV_C4-285_112108 male 99.81 99.81 BXD BXD40 
SNP_mDIV_C6-401_012709 male 99.80 99.81 classical laboratory strain LT/SvEiJ 
SNP_mDIV_C9-290_112108 male 99.82 99.81 BXD BXD49 
SNP_mDIV_A7-SNP10_191_091610 male  99.80 
 
C57BL/6J/CBA/CaJ 
SNP_mDIV_A3-421_022709 male 99.78 99.79 BXD BXD100 
SNP_mDIV_C8-SNP09_014_022709 male 99.79 99.79 consomic (NOD.NON-Thy1 (N13F21) 
SNP_mDIV_D3-409_012709 male 99.79 99.79 classical laboratory strain SEC/1ReJ 
SNP_mDIV_D6-298_112108_2 male 99.77 99.78 BXD BXD67 
SNP_mDIV_D8-414_012709 male 99.78 99.78 BXD BXD9 
SNP_mDIV_A11-265_112108 male 99.77 99.77 BXD BXD8 
SNP_mDIV_B1-SNP08_004_103008_4 male 99.76 99.77 classical laboratory strain C57BL/6NJ 
SNP_mDIV_B5-123_091708 male 99.75 99.76 classical laboratory strain BPH/2J 
SNP_mDIV_D2-408_012709 male 99.76 99.76 classical laboratory strain SEC/1GnLeJ 
SNP_mDIV_D9-261_111308 male 99.77 99.76 BXD BXD1 
SNP_mDIV_D11-263_111308 male 99.77 99.76 BXD BXD5 
SNP_mDIV_B1-SNP10_196_091610 male   99.76   C57BL/6J/CBA/CaJ 
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MDGA samples identifier Mouse 
Gender 
Overall call rate
b
 Sample Type
c
 Mouse Strain 
336 
samples 
362 
samples 
SNP_mDIV_A6-424_022709 male 99.75 99.75 classical laboratory strain IHOT1 
SNP_mDIV_A8-381_012709 male 99.75 99.75 classical laboratory strain C57BL/6NCrl 
SNP_mDIV_B8-132_091708 male 99.75 99.75 classical laboratory strain HPG/BmJ 
SNP_mDIV_C11-406_012709 male 99.75 99.75 classical laboratory strain NONcNZO5/LtJ 
SNP_mDIV_A7-153_111308 male 99.74 99.74 classical laboratory strain TKDU/DnJ 
SNP_mDIV_C9-404_012709 male 99.74 99.74 classical laboratory strain NOD/ShiLtJ 
SNP_mDIV_B2-SNP10_197_091610 male  99.74  C57BL/6J/CBA/CaJ 
SNP_mDIV_A1-SNP08_001_103008 female 99.73 99.73 classical laboratory strain C57BL/6J 
SNP_mDIV_A3-3_081308 male 99.72 99.73 classical laboratory strain AKR/J 
SNP_mDIV_A4-4_081308 male 99.73 99.73 classical laboratory strain BALB/cByJ 
SNP_mDIV_B6-274_112108 male 99.73 99.73 BXD BXD20 
SNP_mDIV_B10-21_081308 male 99.73 99.73 classical laboratory strain FVB/NJ 
SNP_mDIV_B11-281_112108 male 99.74 99.73 BXD BXD32 
SNP_mDIV_A5-SNP10_189_091610 male  99.73  C57BL/6J/CBA/CaJ 
SNP_mDIV_A9-71_090908 male 99.72 99.72 consomic C57BL/6J-Chr12/ForeJ 
SNP_mDIV_A11-313_120908 male 99.71 99.72 BXD BXD83 
SNP_mDIV_A11-361_121608 male 99.72 99.72 BXD BXD61 
SNP_mDIV_B10-280_112108 male 99.73 99.72 BXD BXD31 
SNP_mDIV_A4-SNP10_188_091610 male  99.72  C57BL/6J/CBA/CaJ 
SNP_mDIV_A6-SNP10_190_091610 male  99.72  C57BL/6J/CBA/CaJ 
SNP_mDIV_A8-SNP10_192_091610 male  99.72  C57BL/6J/CBA/CaJ 
SNP_mDIV_C3-398_012709 male 99.70 99.71 classical laboratory strain DBA/1LacJ 
SNP_mDIV_A10-SNP10_194_091610 male  99.71  C57BL/6J/CBA/CaJ 
SNP_mDIV_A6-356_121608 male 99.70 99.70 BXD BXD45 
SNP_mDIV_C7-288_112108 male 99.70 99.70 BXD BXD44 
SNP_mDIV_A2-420_022709 male 99.69 99.69 BXD BXD99 
SNP_mDIV_A9-SNP10_193_091610 male  99.69  C57BL/6J/CBA/CaJ 
SNP_mDIV_A11-SNP08_004_103008 male 99.68 99.68 classical laboratory strain C57BL/6NJ 
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MDGA samples identifier Mouse 
Gender 
Overall call rate
b
 Sample Type
c
 Mouse Strain 
336 
samples 
362 
samples 
SNP_mDIV_B10-394_012709 male 99.69 99.68 classical laboratory strain BXSB/MpJ 
SNP_mDIV_D4-410_012709 male 99.68 99.68 classical laboratory strain SJL/Bm 
DNA3294 male  99.68  C57BL/6J 
SNP_mDIV_A3-SNP08_001_103008 female 99.68 99.67 classical laboratory strain C57BL/6J 
SNP_mDIV_B1-314_120908 male 99.68 99.67 BXD BXD84 
SNP_mDIV_D7-299_112108 male 99.67 99.67 BXD BXD68 
SNP_mDIV_D11-303_112108 male 99.66 99.66 BXD BXD73 
SNP_mDIV_A1-50_091708 male 99.64 99.65 classical laboratory strain NZB/BINJ 
SNP_mDIV_B1-432_022709 male 99.65 99.65 classical laboratory strain ISS 
SNP_mDIV_B9-373_121608 male 99.65 99.65 BXD BXD103MK88 
SNP_mDIV_C5-286_112108 male 99.66 99.65 BXD BXD42 
SNP_mDIV_D5-411_012709 male 99.65 99.65 classical laboratory strain ST/bJ 
SNP_mDIV_A9-429_022709 male 99.64 99.64 classical laboratory strain IBWSR2 
SNP_mDIV_B8-19_081308 male 99.64 99.64 classical laboratory strain DBA/2J 
SNP_mDIV_B9-138_091708 male 99.65 99.64 classical laboratory strain P/J 
SNP_mDIV_D2-SNP09_024_022709 male 99.64 99.64 classical laboratory strain C57BLKS/J 
SNP_mDIV_A8-427_022709 male 99.62 99.63 classical laboratory strain ICOLD2 
SNP_mDIV_A10-SNP08_004_103008 male 99.63 99.63 classical laboratory strain C57BL/6NJ 
SNP_mDIV_B11-88_090908 male 99.63 99.63 classical laboratory strain C57L/J 
SNP_mDIV_C3-284_112108 male 99.63 99.63 BXD BXD39 
SNP_mDIV_A8-154_111308 male 99.63 99.62 classical laboratory strain TSJ/LeJ 
SNP_mDIV_B1-362_121608 male 99.62 99.62 BXD BXD86 
SNP_mDIV_C7-333_120908 male 99.60 99.62 F1 hybrid (C57BL/6JxBALB/cJ)F1 
SNP_mDIV_A10-72_090908 male 99.61 99.61 consomic C57BL/6J-Chr14/ForeJ 
SNP_mDIV_A10-264_112108 male 99.62 99.61 BXD BXD6 
SNP_mDIV_D5-253_111308 male 99.61 99.61 classical laboratory strain BALB/cJ 
SNP_mDIV_B9-393_012709 male 99.60 99.60 classical laboratory strain BDP/J 
SNP_mDIV_C11-337_120908 male 99.58 99.60 F1 hybrid (DBA/2JxC57BL/6J)F1 
SNP_mDIV_D7-413_012709 male 99.60 99.60 classical laboratory strain YBR/EiJ 
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MDGA samples identifier Mouse 
Gender 
Overall call rate
b
 Sample Type
c
 Mouse Strain 
336 
samples 
362 
samples 
SNP_mDIV_A1-1_081308 male 99.60 99.59 classical laboratory strain 129S1SvlmJ 
SNP_mDIV_A2-48_082108 male 99.59 99.59 classical laboratory strain NON/ShiLtJ 
SNP_mDIV_A3-49_082108 male 99.60 99.59 classical laboratory strain NOR/LtJ 
SNP_mDIV_B4-15_081308 male 99.58 99.59 classical laboratory strain CBA/CaJ 
SNP_mDIV_B8-392_012709 male 99.59 99.59 classical laboratory strain AEJ/GnRk 
SNP_mDIV_C4-93_090908 male 99.59 99.59 classical laboratory strain LP/J 
SNP_mDIV_A5-5_081308 male 99.59 99.58 classical laboratory strain BTBRT+tf/J 
SNP_mDIV_A7-SNP08_003_103008 female 99.59 99.58 classical laboratory strain C57BL/6NJ 
SNP_mDIV_D1-126_090908 male 99.58 99.58 classical laboratory strain C3HeB/FeJ 
SNP_mDIV_D8-256_111308 male 99.58 99.58 classical laboratory strain CBA/J 
SNP_mDIV_A5-423_022709 male 99.57 99.57 BXD BXD102 
SNP_mDIV_B3-387_022709 male 99.57 99.57 classical laboratory strain 129P1/ReJ 
SNP_mDIV_C3-92_090908 male 99.58 99.57 classical laboratory strain LG/J 
SNP_mDIV_A1-282_120908 male 99.57 99.56 BXD BXD33 
SNP_mDIV_B1-68_091708 male 99.57 99.56 consomic C57BL/6J-Chr10.3/ForeJ 
SNP_mDIV_B5-271_112108 male 99.56 99.56 BXD BXD16 
SNP_mDIV_A11-SNP10_195_091610 male  99.56  C57BL/6J/CBA/CaJ 
SNP_mDIV_B8-370_121608 male 99.54 99.55 BXD BXD96 
SNP_mDIV_A3-305_120908 male 99.54 99.54 BXD BXD75 
SNP_mDIV_B3-380_121608 male 99.51 99.54 F1 hybrid (C57B6/JxDBA/2J)F1 
SNP_mDIV_C8-32_081308 male 99.54 99.54 classical laboratory strain NZW/LacJ 
DNA3297 male  99.52  C57BL/6J 
SNP_mDIV_B6-82_090908 male 99.52 99.51 consomic C57BL/6J-ChrX.2/ForeJ 
SNP_mDIV_C10-336_120908 male 99.50 99.51 F1 hybrid (BALB/cJxC57BL/6J)F1 
SNP_mDIV_B4-118_091708 male 99.51 99.50 classical laboratory strain AEJ/GnLeJ 
SNP_mDIV_D6-412_012709 male 99.52 99.50 classical laboratory strain STX/Le 
SNP_mDIV_D11-139_090908 male 99.50 99.49 classical laboratory strain PN/nBSwUmabJ 
DNA3298 male  99.49  C57BL/6J 
SNP_mDIV_A4-150_111308_2 male 99.48 99.48 classical laboratory strain SSL/LeJ 
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MDGA samples identifier Mouse 
Gender 
Overall call rate
b
 Sample Type
c
 Mouse Strain 
336 
samples 
362 
samples 
SNP_mDIV_A7-7_081308 male 99.49 99.48 classical laboratory strain C57BL/6J 
SNP_mDIV_B5-389_012709 male 99.49 99.48 classical laboratory strain 129T2/SvEmsJ 
SNP_mDIV_C6-30_081308 male 99.49 99.48 classical laboratory strain NOD/ShiLtJ 
SNP_mDIV_D2-339_120908 male 99.46 99.48 F1 hybrid (NZW/LacJxC57BL/6J)F1 
SNP_mDIV_D1-SNP09_023_022709 male 99.45 99.47 congenic (NODxC57BLKS)F1 
SNP_mDIV_A2-2_081308 male 99.48 99.46 classical laboratory strain A/J 
SNP_mDIV_A6-SNP08_002_103008 male 99.48 99.46 classical laboratory strain C57BL/6J 
SNP_mDIV_A7-425_022709 male 99.44 99.45 classical laboratory strain IHOT2 
SNP_mDIV_B2-75_103008_4 male 99.46 99.45 consomic C57BL/6J-Chr18/ForeJ 
SNP_mDIV_B11-22_081308 male 99.44 99.43 classical laboratory strain KK/HIJ 
SNP_mDIV_C2-91_090908 male 99.44 99.43 classical laboratory strain JE/LeJ 
SNP_mDIV_D1-407_012709 male 99.43 99.43 wild-derived laboratory strain RBB/DnJ 
SNP_mDIV_D6-254_111308 male 99.44 99.43 classical laboratory strain 129X1/SvJ 
DNA3163 male  99.43  C57BL/6J/CBA/CaJ 
SNP_mDIV_A5-SNP08_002_103008 male 99.43 99.42 classical laboratory strain C57BL/6J 
SNP_mDIV_A9-155_111308 male 99.43 99.42 classical laboratory strain ZRDCT Rax+/ChUmdJ 
SNP_mDIV_D8-345_120908 male 99.41 99.42 F1 hybrid (C57BL/6JxAKR/J)F1 
SNP_mDIV_A6-152_111308 male 99.43 99.41 classical laboratory strain TALLYHO/JngJ 
SNP_mDIV_A2-352_121608 male 99.40 99.40 BXD BXD18 
SNP_mDIV_A5-151_111308 male 99.42 99.40 classical laboratory strain SWR/J 
SNP_mDIV_B7-275_112108 male 99.42 99.40 BXD BXD21 
SNP_mDIV_C8-97_090908 male 99.42 99.40 classical laboratory strain RIIIS/J 
SNP_mDIV_B2-433_022709 male 99.39 99.39 classical laboratory strain ILS 
SNP_mDIV_B4-81_103008_4 male 99.39 99.39 consomic C57BL/6J-Chr9/ForeJ 
SNP_mDIV_B2-268_112108 male 99.39 99.38 BXD BXD13 
SNP_mDIV_A7-357_121608 male 99.38 99.37 BXD BXD48 
SNP_mDIV_A8-SNP08_003_103008 female 99.38 99.37 classical laboratory strain C57BL/6NJ 
SNP_mDIV_B9-86_090908 male 99.37 99.36 classical laboratory strain C57BLKS/J 
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MDGA samples identifier Mouse 
Gender 
Overall call rate
b
 Sample Type
c
 Mouse Strain 
336 
samples 
362 
samples 
DNA3295 male  99.36  C57BL/6J 
DNA3301 male  99.36  C57BL/6J/CBA/CaJ 
SNP_mDIV_A6-6_081308 male 99.35 99.35 classical laboratory strain C3H/HeJ 
SNP_mDIV_D4-130_090908 male 99.35 99.35 classical laboratory strain DLS/LeJ 
SNP_mDIV_A2-148_111308 male 99.34 99.34 classical laboratory strain SM/J 
SNP_mDIV_C5-94_090908 male 99.36 99.34 classical laboratory strain NZL/LtJ 
SNP_mDIV_B10-143_103008_3 male 99.31 99.32 classical laboratory strain RSV/LeJ 
SNP_mDIV_D9-415_012709 male 99.34 99.32 BXD BXD24 
SNP_mDIV_B5-84_103008_4 male 99.32 99.30 consomic C57BL/6J-ChrY/ForeJ 
DNA3293 male  99.30  C57BL/6J 
SNP_mDIV_D1-36_081308 male 99.29 99.27 classical laboratory strain SJL/J 
SNP_mDIV_A2-SNP08_001_103008 female 99.27 99.26 classical laboratory strain C57BL/6J 
SNP_mDIV_C7-31_081308 male 99.23 99.22 classical laboratory strain NZO/HILtJ 
SNP_mDIV_B10-140_091708 male 99.20 99.19 wild-derived laboratory strain RBF/DnJ 
SNP_mDIV_C1-89_090908 male 99.18 99.18 classical laboratory strain C58/J 
SNP_mDIV_A1-147_111308 male 99.19 99.17 classical laboratory strain PN/nBSwUmabJ 
SNP_mDIV_B9-20_081308 male 99.18 99.17 classical laboratory strain DDY/JclSidSeyFrkJ 
SNP_mDIV_D10-137_090908 male 99.16 99.14 classical laboratory strain NZM2410/J 
DNA3296 male  99.13  C57BL/6J 
SNP_mDIV_A11-431_022709 female 99.13 99.11 classical laboratory strain IBWSP2 
SNP_mDIV_B7-18_081308 male 99.12 99.11 classical laboratory strain DBA/1J 
SNP_mDIV_D9-144_103008_3 male 99.14 99.11 classical laboratory strain SB/LeJ 
SNP_mDIV_A8-199_091708 male 99.13 99.10 classical laboratory strain 129S6 
SNP_mDIV_D9-136_090908 male 99.12 99.10 classical laboratory strain NU/J 
DNA3162 male  99.10  C57BL/6J/CBA/CaJ 
DNA3303 male  99.10  C57BL/6J/CBA/CaJ 
SNP_mDIV_B11-141_091708 male 99.09 99.07 classical laboratory strain RF/J 
SNP_mDIV_A11-202_091708 male 99.06 99.06 CC-UNC G2:F1 OR1244m19 
SNP_mDIV_A8-56_082108 female 99.06 99.03 classical laboratory strain DDK/Pas 
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MDGA samples identifier Mouse 
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Overall call rate
b
 Sample Type
c
 Mouse Strain 
336 
samples 
362 
samples 
SNP_mDIV_C9-120_090908 male 99.05 99.03 classical laboratory strain ALS/LtJ 
DNA3299 male  99.03  C57BL/6J/CBA/CaJ 
SNP_mDIV_D8-300_112108 male 99.02 99.00 BXD BXD69 
SNP_mDIV_A4-481_012709 male 99.00 98.99 wild-derived laboratory strain STRA 
SNP_mDIV_C11-125_090908 male 99.02 98.99 classical laboratory strain BUB/BnJ 
SNP_mDIV_D10-262_111308 male 99.00 98.98 BXD BXD2 
SNP_mDIV_A5-482_012709 male 98.98 98.97 wild-derived laboratory strain STRB 
SNP_mDIV_D5-131_090908 male 99.00 98.97 classical laboratory strain EL/SuzSeyFrkJ 
SNP_mDIV_D11-417_012709 male 98.99 98.97 BXD BXD65 
SNP_mDIV_C9-335_120908 male 98.96 98.96 F1 hybrid (C57BL/6JxNZW/LacJ)F1 
SNP_mDIV_A10-201_091708 male 98.96 98.95 CC-UNC G2:F1 OR615m104 
SNP_mDIV_A6-119_090908 male 98.95 98.94 classical laboratory strain ALR/LtJ 
SNP_mDIV_C6-95_090908 male 98.97 98.94 classical laboratory strain PL/J 
SNP_mDIV_C7-402_012709 male 98.94 98.93 wild-derived laboratory strain MOR/RkJ 
SNP_mDIV_D2-128_090908 male 98.95 98.92 classical laboratory strain CE/J 
SNP_mDIV_D3-129_090908 male 98.94 98.92 classical laboratory strain CHMU/LeJ 
SNP_mDIV_D8-185_082108 female 98.91 98.90 CC-UNC G2:F1 OR804f103 
SNP_mDIV_C5-331_120908 male 98.87 98.89 F1 hybrid (AKR/JxC57BL/6J)F1 
SNP_mDIV_D10-145_103008_3 male 98.92 98.89 classical laboratory strain SEA/GnJ 
SNP_mDIV_A9-200_091708 male 98.88 98.88 CC-UNC G2:F1 OR496m20 
SNP_mDIV_B8-85_090908 male 98.92 98.88 classical laboratory strain C57BL/10J 
SNP_mDIV_D2-178_082108 male 98.87 98.87 CC-UNC G2:F1 OR95m20 
SNP_mDIV_D11-348_120908 male 98.87 98.87 F1 hybrid (NZW/LacJxWSB/EiJ)F1 
SNP_mDIV_D3-179_082108 female 98.85 98.85 CC-UNC G2:F1 OR95f16 
SNP_mDIV_A6-483_012709 male 98.85 98.84 wild-derived laboratory strain STLT 
SNP_mDIV_A7-69_090908 male 98.84 98.82 consomic C57BL/6J-Chr11.1/ForeJ 
DNA3302 male  98.82  C57BL/6J/CBA/CaJ 
SNP_mDIV_A1-350_121608 male 98.81 98.80 F1 hybrid (WSB/EiJxNZW/LacJ)F1 
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b
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c
 Mouse Strain 
336 
samples 
362 
samples 
SNP_mDIV_B8-278_112108 male 98.83 98.80 BXD BXD28 
SNP_mDIV_C3-25_081308 female 98.81 98.80 CC-UNC G2:F1 OR294f18 
SNP_mDIV_C4-26_081308 female 98.80 98.80 CC-UNC G2:F1 OR1109f19 
SNP_mDIV_A2-64_090908 female 98.80 98.79 CC-UNC G2:F1 OR447f19 
SNP_mDIV_B1-60_082108 male 98.80 98.79 CC-UNC G2:F1 OR1587m104 
SNP_mDIV_A10-383_012709 male 98.78 98.76 classical laboratory strain C57BL/6NTac 
SNP_mDIV_D1-177_082108 female 98.76 98.74 CC-UNC G2:F1 OR88f16 
SNP_mDIV_D9-44_081308 male 98.76 98.74 CC-UNC G2:F1 OR1400m105 
SNP_mDIV_C7-462_012209 male 98.74 98.72 wild-derived laboratory strain DJO 
SNP_mDIV_C8-463_012209 male 98.71 98.70 wild-derived laboratory strain DOT 
SNP_mDIV_A2-51_091708 male 98.71 98.69 wild-derived laboratory strain PERA/EiJ 
SNP_mDIV_C1-23_081308 male 98.71 98.69 wild-derived laboratory strain LEWES/EiJ 
SNP_mDIV_C7-96_090908 male 98.71 98.69 wild-derived laboratory strain RBA/DnJ 
SNP_mDIV_C11-466_012209 male 98.68 98.67 wild-derived laboratory strain DMZ 
SNP_mDIV_A3-156_091708 male 98.69 98.66 wild caught KCT222 
SNP_mDIV_A10-58_082108 male 98.67 98.66 CC-UNC G2:F1 OR151m105 
SNP_mDIV_A11-59_082108 female 98.67 98.66 CC-UNC G2:F1 OR1587f101 
SNP_mDIV_D4-180_082108 male 98.67 98.66 CC-UNC G2:F1 OR656m18 
SNP_mDIV_B2-90_091708 male 98.67 98.65 classical laboratory strain I/LnJ 
SNP_mDIV_B9-162_082108 male 98.67 98.65 wild caught MWN1026 
SNP_mDIV_C11-176_082108 male 98.66 98.65 CC-UNC G2:F1 OR88m19 
SNP_mDIV_D11-146_103008_3 male 98.68 98.65 classical laboratory strain SH1/LeJ 
SNP_mDIV_B6-124_091708 male 98.67 98.64 classical laboratory strain BPN/3J 
SNP_mDIV_A11-11_081308 male 98.65 98.63 CC-UNC G2:F1 OR1005m105 
SNP_mDIV_B3-98_091708 female 98.65 98.63 wild caught RDS12763 
SNP_mDIV_B4-388_012709 male 98.66 98.63 classical laboratory strain 129P3/J 
SNP_mDIV_A6-183_091708 female 98.63 98.62 CC-UNC G2:F1 OR672f102 
SNP_mDIV_B6-159_082108 female 98.60 98.61 wild caught MWN1214 
SNP_mDIV_D1-467_012209 male 98.63 98.61 wild-derived laboratory strain BZO 
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MDGA samples identifier Mouse 
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Overall call rate
b
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c
 Mouse Strain 
336 
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SNP_mDIV_A1-62_090908 male 98.61 98.60 CC-UNC G2:F1 OR294m21 
SNP_mDIV_D5-181_082108 female 98.60 98.59 CC-UNC G2:F1 OR656f14 
SNP_mDIV_C2-166_082108 male 98.57 98.58 wild caught MWN1198 
DNA3160 female  98.58  C57BL/6J x CBA/CaJ 
DNA3158 male  98.57  C57BL/6J 
SNP_mDIV_C5-460_012209 male 98.58 98.56 wild-derived laboratory strain WMP 
SNP_mDIV_D7-184_082108 male 98.57 98.55 CC-UNC G2:F1 OR804m105 
SNP_mDIV_D2-294_112108 male 98.56 98.54 BXD BXD60 
SNP_mDIV_B9-142_103008_3 male 98.58 98.53 classical laboratory strain RHJ/LeJ 
SNP_mDIV_B3-14_081308 male 98.53 98.51 CC-UNC G2:F1 OR1048m20 
SNP_mDIV_B7-160_082108 male 98.52 98.51 wild caught MWN1194 
SNP_mDIV_D3-38_081308 male 98.54 98.51 wild-derived laboratory strain TIRANO/EiJ 
SNP_mDIV_D9-186_082108 female 98.53 98.51 CC-UNC G2:F1 OR873f102 
SNP_mDIV_A1-434_012209 male 98.51 98.50 wild-derived laboratory strain BIK/g1 
SNP_mDIV_B1-12_081308 female 98.52 98.50 CC-UNC G2:F1 OR1018f102 
SNP_mDIV_C1-456_012209 male 98.52 98.50 wild-derived laboratory strain WLA 
SNP_mDIV_B2-76_090908 male 98.53 98.49 consomic C57BL/6J-Chr19/ForeJ 
SNP_mDIV_A11-444_012209 male 98.49 98.48 wild-derived laboratory strain DCP 
SNP_mDIV_A3-149_111308 male 98.49 98.47 wild-derived laboratory strain SOD1/EiJ 
SNP_mDIV_B11-164_082108 female 98.47 98.46 wild caught MWN1030 
SNP_mDIV_D6-343_120908 male 98.46 98.46 F1 hybrid (PWD/PhJxNOD/ShiJ)F1 
SNP_mDIV_A9-442_012209 male 98.47 98.45 wild-derived laboratory strain DCA 
SNP_mDIV_D5-219_103008_3 male 98.47 98.45 CC-UNC G2:F1 OR873m106 
SNP_mDIV_D3-340_120908 male 98.43 98.43 F1 hybrid (NZW/LacJxPWD/PhJ)F1 
SNP_mDIV_D5-40_081308 female 98.43 98.42 CC-UNC G2:F1 OR1262f101 
SNP_mDIV_A10-10_081308 female 98.41 98.40 CC-UNC G2:F1 OR1005f102 
SNP_mDIV_A9-57_082108 female 98.41 98.38 CC-UNC G2:F1 OR151f102 
DNA3160 female  98.37  C57BL/6J x CBA/CaJ 
SNP_mDIV_C5-27_081308 male 98.37 98.36 CC-UNC G2:F1 OR1109m20 
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SNP_mDIV_D6-182_082108 male 98.37 98.36 CC-UNC G2:F1 OR672m106 
SNP_mDIV_D6-220_103008_3 male 98.37 98.36 CC-UNC G2:F1 OR978m21 
SNP_mDIV_D7-221_103008_3 female 98.37 98.36 CC-UNC G2:F1 OR906f102 
SNP_mDIV_C1-165_082108 female 98.34 98.35 wild caught MWN1287 
SNP_mDIV_C4-241_111308 male 98.36 98.35 F1 hybrid (PWK/PhJxA/J)F1 
SNP_mDIV_C5-207_103008_3 male 98.35 98.35 F1 hybrid (129S1/SvImJIxPWK/PhJ)F1 
SNP_mDIV_B1-227_111308 male 98.36 98.34 F1 hybrid (C57BL/6JxPWK/PhJ)F1 
SNP_mDIV_C3-205_103008_3 female 98.35 98.34 F1 hybrid (129S1/SvImJIxPWK/PhJ)F1 
SNP_mDIV_C5-400_012709 male 98.36 98.34 classical laboratory strain DBA/2HaSmnJ 
SNP_mDIV_C9-211_103008 male 98.35 98.34 F1 hybrid (PWK/PhJx129S1/SvImJ)F1 
SNP_mDIV_A5-378_121608 male 98.35 98.32 classical laboratory strain C57BL/6J 
SNP_mDIV_C4-206_103008_3 female 98.33 98.32 F1 hybrid (129S1/SvImJIxPWK/PhJ)F1 
SNP_mDIV_A4-52_082108 male 98.33 98.31 wild-derived laboratory strain PERC/EiJ 
SNP_mDIV_A4-437_012209 male 98.32 98.31 wild-derived laboratory strain DEB 
SNP_mDIV_D4-218_103008_3 female 98.33 98.31 CC-UNC G2:F1 OR496f18 
SNP_mDIV_D7-344_120908 male 98.31 98.30 F1 hybrid (PWD/PhJxNZW/LacJ)F1 
SNP_mDIV_C10-212_103008_3 male 98.30 98.29 F1 hybrid (PWK/PhJx129S1/SvImJ)F1 
SNP_mDIV_C10-247_111308 male 98.30 98.29 F1 hybrid (PWK/PhJxNOD/ShiJ)F1 
SNP_mDIV_B2-228_111308 male 98.30 98.28 F1 hybrid (CAST/EiJx129S1/SvImJ)F1 
SNP_mDIV_D6-41_081308 female 98.29 98.28 CC-UNC G2:F1 OR1305f101 
SNP_mDIV_C2-239_111308 male 98.25 98.24 F1 hybrid (NOD/ShiJxPWK/PhJ)F1 
SNP_mDIV_D3-217_103008_3 male 98.24 98.23 CC-UNC G2:F1 OR1611m121 
SNP_mDIV_A11-224_111308 male 98.23 98.21 F1 hybrid (A/JxPWK/PhJ)F1 
SNP_mDIV_D10-347_120908 male 98.22 98.21 F1 hybrid (CAST/EiJxNZW/LacJ)F1 
SNP_mDIV_C8-210_103008_3 female 98.20 98.19 F1 hybrid (PWK/PhJx129S1/SvImJ)F1 
SNP_mDIV_B7-451_012209 male 98.20 98.18 wild-derived laboratory strain DIK 
SNP_mDIV_D2-216_103008_3 male 98.19 98.18 CC-UNC G2:F1 OR1305m105 
SNP_mDIV_D4-252_111308_2 male 98.22 98.18 wild-derived laboratory strain ZALENDE/EiJ 
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SNP_mDIV_D5-342_120908 male 98.18 98.17 F1 hybrid (PWD/PhJxC3H/HeJ)F1 
DNA3300 male  98.17  C57BL/6J/CBA/CaJ 
SNP_mDIV_D9-346_120908 male 98.15 98.16 F1 hybrid (CAST/EiJxC3H/HeJ)F1 
SNP_mDIV_B4-230_111308 male 98.15 98.15 F1 hybrid (CAST/EiJxA/J)F1 
SNP_mDIV_B10-87_090908 male 98.19 98.15 classical laboratory strain C57BR/cdJ 
SNP_mDIV_C9-246_111308 female 98.16 98.15 F1 hybrid (PWK/PhJxNOD/ShiJ)F1 
SNP_mDIV_B8-452_012209 male 98.16 98.14 wild-derived laboratory strain DGA 
SNP_mDIV_B3-229_111308 female 98.14 98.13 F1 hybrid (CAST/EiJxA/J)F1 
SNP_mDIV_B3-316_120908 male 98.16 98.12 classical laboratory strain BPL/1J 
SNP_mDIV_D1-249_111308 male 98.13 98.12 F1 hybrid (WSB/EiJxCAST/EiJ)F1 
SNP_mDIV_B8-234_111308 male 98.11 98.11 F1 hybrid (CAST/EiJxNOD/ShiJ)F1 
SNP_mDIV_C4-399_012709 male 98.14 98.11 classical laboratory strain DBA/2DeJ 
SNP_mDIV_D8-222_103008_3 male 98.12 98.09 CC-UNC G2:F1 OR906m104 
SNP_mDIV_A10-223_111308 female 98.09 98.08 F1 hybrid (A/JxPWK/PhJ)F1 
SNP_mDIV_A6-SNP08_005_103108 male 98.08 98.07 F1 hybrid (129X1/SvJxCAST/EiJ)F1 
SNP_mDIV_D7-134_090908 male 98.13 98.07 classical laboratory strain MRL/MpJ 
SNP_mDIV_A8-225_112108 male 98.06 98.05 F1 hybrid (C57BL/6JxCAST/EiJ)F1 
SNP_mDIV_B8-161_082108 male 98.07 98.05 wild caught MWN1279 
SNP_mDIV_C3-240_111308 female 98.06 98.05 F1 hybrid (PWK/PhJxA/J)F1 
SNP_mDIV_A2-479_012709 male 98.06 98.03 wild-derived laboratory strain BULS 
SNP_mDIV_D2-250_111308 female 98.03 98.02 F1 hybrid (WSB/EiJxPWK/PhJ)F1 
SNP_mDIV_D3-251_111308 male 98.04 98.02 F1 hybrid (WSB/EiJxPWK/PhJ)F1 
SNP_mDIV_C7-209_103008_3 female 98.02 98.00 F1 hybrid (PWK/PhJx129S1/SvImJ)F1 
SNP_mDIV_B6-232_111308 male 98.01 97.98 F1 hybrid (CAST/EiJxC57BL/6J)F1 
SNP_mDIV_A3-480_012709 male 98.01 97.97 wild-derived laboratory strain BUSNA 
SNP_mDIV_C6-208_103008_3 male 97.97 97.96 F1 hybrid (129S1/SvImJIxPWK/PhJ)F1 
SNP_mDIV_C11-213_103008_3 female 97.97 97.96 F1 hybrid (CAST/EiJx129S1/SvImJ)F1 
SNP_mDIV_A5-53_082108 male 97.97 97.95 wild-derived laboratory strain SF/CAMEiJ 
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SNP_mDIV_C10-34_081308 male 97.99 97.95 wild-derived laboratory strain PWD/PhJ 
SNP_mDIV_B2-13_081308 female 97.97 97.94 CC-UNC G2:F1 OR1048f18 
SNP_mDIV_A1-478_012709 male 97.96 97.92 wild-derived laboratory strain STUS 
SNP_mDIV_B10-236_111308 male 97.93 97.91 F1 hybrid (CAST/EiJxPWK/PhJ)F1 
SNP_mDIV_D11-189_082108 male 97.95 97.91 wild caught BAG99 
SNP_mDIV_A2-435_012209 male 97.91 97.88 wild-derived laboratory strain MDH 
SNP_mDIV_C6-243_111308 male 97.89 97.88 F1 hybrid (PWK/PhJxC57BL/6J)F1 
SNP_mDIV_A9-226_112108 female 97.85 97.85 F1 hybrid (C57BL/6JxPWK/PhJ)F1 
SNP_mDIV_C7-244_111308 female 97.85 97.84 F1 hybrid (PWK/PhJxCAST/EiJ)F1 
SNP_mDIV_A1-47_082108 male 97.86 97.83 wild-derived laboratory strain MOLG/DnJ 
SNP_mDIV_A5-158_091708 female 97.85 97.82 wild caught RDS13554 
SNP_mDIV_C11-248_111308 female 97.83 97.82 F1 hybrid (WSB/EiJxCAST/EiJ)F1 
SNP_mDIV_C5-242_111308 female 97.82 97.80 F1 hybrid (PWK/PhJxC57BL/6J)F1 
SNP_mDIV_B5-231_111308 female 97.77 97.76 F1 hybrid (CAST/EiJxC57BL/6J)F1 
SNP_mDIV_B11-237_111308 female 97.79 97.76 F1 hybrid (CAST/EiJxWSB/EiJ)F1 
SNP_mDIV_B1-445_012209 male 97.79 97.75 wild-derived laboratory strain MBS 
SNP_mDIV_B7-233_111308 female 97.70 97.68 F1 hybrid (CAST/EiJxNOD/ShiJ)F1 
SNP_mDIV_D3-469_012209 male 97.72 97.67 wild-derived laboratory strain MCZ 
SNP_mDIV_D11-46_081308 male 97.69 97.66 wild-derived laboratory strain MOLD/RkJ 
SNP_mDIV_C4-459_012209 male 97.68 97.65 wild-derived laboratory strain 22MO 
SNP_mDIV_D7-255_111308_2 male 97.66 97.64 wild-derived laboratory strain IS/CamRK 
SNP_mDIV_D7-42_081308 female 97.65 97.62 CC-UNC G2:F1 OR1325f102 
SNP_mDIV_B10-163_082108 female 97.60 97.59 wild caught MWN1106 
SNP_mDIV_B5-449_012209 male 97.59 97.57 wild-derived laboratory strain MBT 
SNP_mDIV_C5-169_082108 female 97.59 97.55 wild caught BAG3 
SNP_mDIV_B7-127_091708 male 97.59 97.54 wild-derived laboratory strain CALB/RkJ 
SNP_mDIV_D1-214_103008_3 female 97.54 97.53 F1 hybrid (129S1/SvImJxCAST/EiJ)F1 
SNP_mDIV_B5-16_081308 male 97.56 97.52 wild-derived laboratory strain CZECHI/EiJ 
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DNA3258 male  97.50  C57BL/6J/CBA/CaJ 
SNP_mDIV_C8-334_120908 male 97.51 97.49 F1 hybrid (C57BL/6JxNOD/ShiJ)F1 
SNP_mDIV_B11-395_012709 male 97.51 97.47 classical laboratory strain C57BL/10ScNJ 
SNP_mDIV_D4-39_081308 male 97.52 97.46 wild-derived laboratory strain WSB/EiJ 
SNP_mDIV_D5-471_012209 male 97.50 97.45 wild-derived laboratory strain MH 
SNP_mDIV_D11-477_012209 male 97.47 97.42 wild-derived laboratory strain STUP 
SNP_mDIV_B6-17_081308 male 97.46 97.41 wild-derived laboratory strain CZECHII/EiJ 
SNP_mDIV_B9-235_111308 female 97.44 97.41 F1 hybrid (CAST/EiJxPWK/PhJ)F1 
SNP_mDIV_C3-167_082108 male 97.44 97.40 wild caught BAG74 
SNP_mDIV_B4-448_012209 male 97.41 97.37 wild-derived laboratory strain MBK 
SNP_mDIV_D10-476_012209 male 97.40 97.35 wild-derived laboratory strain STUF 
SNP_mDIV_D8-43_081308 male 97.37 97.33 CC-UNC G2:F1 OR1325m106 
SNP_mDIV_C4-168_082108 male 97.28 97.26 wild caught BAG56 
SNP_mDIV_C6-461_012209 male 97.29 97.25 wild-derived laboratory strain CTP 
SNP_mDIV_B3-190_082108 female 97.25 97.20 wild caught BAG68 
SNP_mDIV_B10-454_012209 male 97.18 97.15 wild-derived laboratory strain MGA 
SNP_mDIV_C2-24_081308 male 97.15 97.13 wild-derived laboratory strain MOLF/EiJ 
SNP_mDIV_C1-396_012709 male 97.16 97.10 classical laboratory strain C57BL/10ScSnJ 
SNP_mDIV_D10-45_081308 male 97.11 97.08 wild-derived laboratory strain JF1/Ms 
SNP_mDIV_B5-486_022709 male 97.03 96.98 wild caught Yu2097m 
SNP_mDIV_B8-489_022709 male 96.91 96.87 wild caught Yu2115m 
SNP_mDIV_B6-487_022709 female 96.90 96.85 wild caught Yu2099f 
a 
Samples are ordered in highest to lowest overall genotyping call rate based on the 364 sample set 
b
 overall call rate refers to the total number of genotypes determined as AA, AB, or BB for each sample 
c 
samples without a sample type listed are Hill laboratory samples 
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Appendix D – Genetic distance matrix samples used to create phylogenetic 
trees 
 This section contains examples of genetic distance matrices that were used to create 
the phylogenetic trees. 
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Table D-1: Genetic distance matrix representing each of the seven sample types used for generating phylogenetic trees.  
 Sample 
Sample OR1611m121 MOR/RkJ BXD32 
(CAST/EiJx 
PWK/PhJ)F1_1 Yu2099f MBT 129P3/J C57BL/6J_1 KCT222 
OR1611m121 0 0.39086 0.41793 0.47254 0.51901 0.49304 0.41189 0.40568 0.42097 
MOR/RkJ 0.39086 0 0.21885 0.56400 0.48733 0.48371 0.25829 0.11432 0.27100 
BXD32 0.41793 0.21885 0 0.55446 0.44952 0.45648 0.18582 0.14327 0.23382 
(CAST/EiJx 
PWK/PhJ)F1_1 0.47254 0.56400 0.55446 0 0.35138 0.30942 0.55158 0.55330 0.52558 
Yu2099f 0.51901 0.48733 0.44952 0.35138 0 0.22966 0.44356 0.44492 0.43387 
MBT 0.49304 0.48371 0.45648 0.30942 0.22966 0 0.45397 0.45325 0.43341 
129P3/J 0.41189 0.25829 0.18582 0.55158 0.44356 0.45397 0 0.19394 0.23746 
C57BL/6J_1 0.40568 0.11432 0.14327 0.55330 0.44492 0.45325 0.19394 0 0.23238 
KCT222 0.42097 0.27100 0.23382 0.52558 0.43387 0.43341 0.23746 0.23238 0 
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Table D-2: Genetic distance matrix for C57BL/6J samples and the CBA/CaJ sample in The Jackson Laboratory dataset. 
 Sample 
Sample CBA/CaJ 
C57BL/6J_
1 
C57BL/6J_
6 
C57BL/6J_
7 
C57BL/6J_
8 
C57BL/6J_
5 
C57BL/6J_
4 
C57BL/6J_
3 
C57BL/6J_
2 
CBA/CaJ 0 0.17828 0.17852 0.17875 0.18422 0.17781 0.17839 0.17953 0.17801 
C57BL/6J_1 0.17828 0 0.00195 0.00227 0.00917 0.00095 0.00177 0.00326 0.00125 
C57BL/6J_6 0.17852 0.00195 0 0.00236 0.00937 0.00121 0.00197 0.00343 0.00149 
C57BL/6J_7 0.17875 0.00227 0.00236 0 0.00965 0.00152 0.00227 0.00366 0.00176 
C57BL/6J_8 0.18422 0.00917 0.00937 0.00965 0 0.00845 0.00914 0.01045 0.00871 
C57BL/6J_5 0.17781 0.00095 0.00121 0.00152 0.00845 0 0.00101 0.00252 0.00049 
C57BL/6J_4 0.17839 0.00177 0.00197 0.00227 0.00914 0.00101 0 0.00320 0.00125 
C57BL/6J_3 0.17953 0.00326 0.00343 0.00366 0.01045 0.00252 0.00320 0 0.00276 
C57BL/6J_2 0.17801 0.00125 0.00149 0.00176 0.00871 0.00049 0.00125 0.00276 0 
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Table D-3: Genetic distance matrix example used to generate phylogenetic trees for all samples containing three tissues types 
from the Hill laboratory samples.  
 Sample 
Sample 911.50 Li-2 911.17 Li 911.17 Cl 911.49 Li 911.17 Sp 911.50 Cl 911.49 Cl 911.50 Sp 911.49 Sp 
911.50 Li-2 0 0.067051 0.064964 0.074507 0.066062 0.004296 0.067783 0.003377 0.067816 
911.17 Li 0.067051 0 0.006448 0.084721 0.007757 0.066143 0.078524 0.065374 0.078497 
911.17 Cl 0.064964 0.006448 0 0.08282 0.004626 0.06342 0.075835 0.062567 0.075799 
911.49 Li 0.074507 0.084721 0.08282 0 0.083449 0.073643 0.010593 0.072823 0.010509 
911.17 Sp 0.066062 0.007757 0.004626 0.083449 0 0.064734 0.077087 0.063883 0.077054 
911.50 Cl 0.004296 0.066143 0.06342 0.073643 0.064734 0 0.065905 0.001284 0.065897 
911.49 Cl 0.067783 0.078524 0.075835 0.010593 0.077087 0.065905 0 0.065123 0.000824 
911.50 Sp 0.003377 0.065374 0.062567 0.072823 0.063883 0.001284 0.065123 0 0.065114 
911.49 Sp 0.067816 0.078497 0.075799 0.010509 0.077054 0.065897 0.000824 0.065114 0 
 
  
  276 
 
 
  
Table D-4: Genetic distance matrix example used to generate phylogenetic trees for tissue 
replicates of a B6 mouse from the Hill laboratory samples 
 Sample 
Sample 300.7 Sp-3 300.7 Sp-2 300.7 Cl-1 300.7 Sp-1 300.7 Cl-3 300.7 Cl-2 
300.7 Sp-3 0 0.002947 0.004195 0.003859 0.002407 0.004235 
300.7 Sp-2 0.002947 0 0.004218 0.003861 0.002349 0.004245 
300.7 Cl-1 0.004195 0.004218 0 0.004982 0.003683 0.005312 
300.7 Sp-1 0.003859 0.003861 0.004982 0 0.003286 0.004917 
300.7 Cl-3 0.002407 0.002349 0.003683 0.003286 0 0.00367 
300.7 Cl-2 0.004235 0.004245 0.005312 0.004917 0.00367 0 
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